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ABSTRACT 
The thioredoxin and y-glutamylcysteine synthetase genes of Thiobacillus ferrooxidans were 
isolated by complementation of an Escherichia coli trxA gshA double mutant for growth on 
minimal medium lacking glutathione. Transduction of a T. ferrooxidans genome cos mid library 
into the E. coli mutant resulted in the identification of two groups of complementing cosmids. 
One of these groups was able to complement the TrxA + requirement of an E. coli trxA met 
mutant for conversion of methionine sulfoxide to methionine. 
The nucleotide sequence of a 1.1 kbp Hindiii-Psti T.ferrooxidans chromosomal DNA fragment 
containing the cloned trxA gene, was determined. An open reading frame (ORF) corresponding 
to the thioredoxin gene and part of an ORF corresponding to the N-terminal region of the rho 
gene were identified. A 14 kDa protein corresponding to the T. ferrooxidan$ ·thioredoxin was 
synthesised in an E. coli-derived in vitro transcription/translation system. The predicted amino 
acid sequence of the T.ferrooxidans trxA gene showed 70.6% identity to that of E. coli. 
The cloned T. ferrooxidans trxA gene was able to support T7 phage replication in an E. coli 
trxA mutant to almost the same level as a TrxA + wild type strain. However, it was not able to 
satisfy the thioredoxin requirement of M13 phage. 
Crude extracts of the E. coli trxA gshA mutant containing the cloned T. ferrooxidans trxA gene 
were able to reduce insulin far more rapidly those that did not contain the cloned gene, 
indicating that the T.ferrooxidans thioredoxin has disulfide reductase activity. 
DNA:RNA hybridisation analysis was carried out on transcripts prepared from the E. coli trxA 
gshA double mutant, the mutant containing the cloned trxA gene and T. ferroxidans cells. A 
single transcript of about 0.5 kbp was obtained for RNA from T. ferrooxidans cells. Several 
transcripts were produced from the cloned T. ferrooxidans trxA gene in E. coli. One of these 
transcripts corresponded in size to the 0.5 kbp transcript produced by T. ferrooxidans cells, 
whereas the other transcripts were larger (1.35, 1.40, 1.60 and 1.80 kbp) and presumably 
represented transcription products originating from the lac promoter of the vector. 
Primer extension analysis of the thioredoxin gene with RNA prepared from T. ferrooxidans 
gave three transcription start sites. RNA derived from the cloned trxA gene in E. coli only gave 
two transcription start sites, which were identical to two of the three found with T. ferrooxidans 
RNA. 
The second group of cosmids which was able to complement the gshA trxA double mutant for 
growth on minimal media but which did not allow growth of the E. coli trxA met mutant on 
minimal media plus methionine sulfoxide was also examined. The nucleotide sequence of a 2.3 
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kbp Clai-BamHI T. ferrooxidans chromosomal DNA fragment containing the complementing 
DNA, was determined. Two ORFs, separated by 9 bp, corresponding to a citrate synthase gene 
and a y-glutamylcysteine synthetase gene were identified. The predicted amino acid sequence 
of the T. ferrooxidans gltA gene showed 37% identity to that of E. coli, whereas the predicted 
amino acid sequence of the T. ferrooxidans gshA gene only showed 18% identity to that of E. 
coli. The low homology of the gshA gene products is not abnormal, as the y-glutamylcysteine 
synthetases studied to date differ widely in amino acid sequence and structure. Partial 
sequencing of the cloned T. ferrooxidans chromosomal DNA upstream of the gltA gene 
indicated regions of homology to the genes of the pyruvate dehydrogenase complex. 
Synthesis of proteins corresponding to the T. ferrooxidans citrate synthase (43 kDa) and y-
glutamylcysteine synthetase (49 kDa) enzymes were confirmed using an E. coli-derived in vitro 
transcription/translation system. The identity of the proposed citrate synthase gene was 
confirmed by complementation of an E. coli gltA mutant. Similarly, the DNA upstream of the 
gltA gene, was found to complement an E. coli mutant for the pyruvate dehydrogenase complex, 
confirming that this region contained the T. ferrooxidans pyruvate dehydrogenase complex, as 
predicted from the partial sequence analysis. 
The identity of the T. ferrooxidans y-glutamylcysteine synthetase gene was confmned by 
determining the levels of glutathione in crude extracts of the E. coli gshA trxA double mutant, . 
the mutant containing the cloned T. ferrooxidans gshA gene, and an E. coli parental strain. 
Crude extracts prepared from E. coli double mutant contained niuch lower levels of glutathione 
than crude extracts prepared from the E.coli mutant containing the cloned gshA gene, 
indicating that the gene from T. ferrooxidans encoded a protein with y-glutamylcysteine 
synthetase activity. 
RNA:DNA hybridisation analysis was carried out using probes specific to the gshA gene, the 
gltA gene and the aceF gene (pyruvate dehydrogenase transacetylase gene). All three probes 
gave transcripts of 9 kbp and a number of smaller transcripts with RNA derived from T. 
ferrooxidans cells. The 9 kbp transcripts indicated transcriptional linkage of the y-
glutamylcysteine synthetase gene, the citrate synthase gene and the genes of the pyruvate 
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1.1 Bioleaching bacteria 
The increased use of microorganisms in industrial mineral leaching operations and their 
potential use in waste treatment and coal desulphurization, have generated considerable interest 
in the unusual physiological capabilities of these organisms. Industrial bioleaching operations 
are usually carried out using an assortment of bacteria, as conditions are not sterile and mixed 
cultures of bacteria are often more efficient than any one species alone (Norris, 1990). At 
temperatures between 2ooc and 400C, the bioleaching bacteria may include Thiobacillus 
ferrooxidans, Thiobacillus thiooxidans, Leptospirillum ferrooxidans and acidophilic, 
heterotrophic bacteria of the genus Acidiphilum (Harrison, 1984; Kelly, 1988). At temperatures 
greater than 45oc other bacteria such as the Thiobacillus TH strains and members of the genus 
Sulfobacillus are predominant, and at even higher temperatures extremely thermophilic Archaea 
such as Sulfolobus and Acidianus species are found (Norris, 1990). The potential for the 
improvement of bacterial leaching systems by genetic manipulation, has contributed greatly to 
the interest in the molecular biology of these bacteria. 
The bacterium considered to play a principal role in most bioleaching operations was T. 
ferrooxidans, and it has therefore been studied more extensively than other organisms associated 
with metal extraction. However, recent evidence has indicated that T. ferrooxidans may not be 
the predominant organism in the bioleaching of gold from arsenopyrite ores in a continuous flow 
system. T. ferrooxidans appears to have been inadvertently selected for under the batch culture 
conditions employed to isolate bacteria from the arsenopyrite ore leachate in the laboratory, and 
was thus thought to be the predominant organism (Rawlings, 1995; Pizarro et al., 1996). 
T. ferrooxidans attacks sulfide-containing minerals and converts the insoluble sulfides of metals 
such as copper, lead, zinc or nickel to their soluble metal sulfates, which can then be recovered 
from the leachate. In addition T. ferrooxidans can obtain energy from the oxidation of ferrous 
iron or reduced sulfur compounds. In contrast, T. thiooxidans can use only reduced sulfur 
compounds, and L. ferrooxidans can only use ferrous iron (Kelly & Harrison, 1989). The three 
metals recovered in the largest quantities through direct or indirect bacterial action are copper 
(Brierley, 1978), uranium (McCready et al., 1990) and gold (Livesey-Goldblatt et al., 1983). 
1.1.1 Bioleaching of copper ores 
The use of bioleaching to recover copper is growing as remaining ore bodies are depleted and 
conventional extraction techn.ology becomes uneconomic (Rawlings & Silver, 1995). In 1990, it 
was estimated that at least 15% of the world production of copper was recovered using 
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bioleaching. Chemolithotrophic bacteria attack and oxidize a variety of copper sulfide ores 
converting them to their soluble metal sulfates • 
4CuFeS2 + 1702 + 2H2S04 ~ 4CuS04 +2F~(S04)3 + 2H20 
chalcopyrite 
CuS + 202 ~ CuS04 
covellite 
Copper is usually leached from waste dumps, by irrigation of the dump. In some cases the 
leachate is collected and recycled, thus speeding up the process. The solubilized copper is then 
recovered from the leachate. 
1.1.2 Bioleaching of uranium ores 
Uranium can be solubilized from ores by direct microbial oxidation of the insoluble tetravalent 
uranium to the soluble hexavalent uranyl ion. 
DiSpirito & Touvinen (1982), showed that T. ferrooxidans was capable of direct uranium 
oxidation and demonstrated a linkage between C02 fixation and uranium oxidation. However 
most uranium deposits ~ found underground in oxygen-depleted environments. In these 
situations uranium is solubilized indirectly. Pyrite is often found associated with these uranium 
ores, and thus T.ferrooxidans and othe~. chemolithotrophic bacteria are able to convert the pyrite 
to ferric iron and sulfuric acid. The ferric iron and sulfuric acid can then react with the insoluble 
uranium oxides to produce soluble uranyl sulfates (Kelly et al., 1979). 
The spent ferrous iron containing leach liquors may be regenerated by aeration in the presence 
ofT. ferrooxidans and the ferric iron recycled to the leaching process. 
1.1.3 Leaching of gold-bearing arsenopyrite ores 
A considerable amount of gold is found in recalcitrant ores. These are ores in which the gold is 
encased in a matrix of pyrite and arsenQpyrite and as a result cannot be solubilized by the usual 
process of cyanidation. Traditionally, pressure leaching or roasting of the recalcitrant ores to 
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decompose the arsenopyrite was required to render the gold accessible to cyanide extraction. 
However, these methods are very energy intensive. Oxidation of the arsenopyrite using T. 
ferrooxidans is a low energy alternative, and is used commercially to expose the gold for 
cyanide extraction in South Africa, Brazil, Western Australia and Ghana. The leaching is 
carried out in a tank or vat. Greater than 95% of the gold can be recovered in this way. 
2FeAsS + 702 + 2H20 ~ 2FeAs04 + 2H2S04 
arsenopyrite 
1.1.4 Physiology ofT. ferrooxidans 
T. ferrooxidans is a Gram-negative, rod-shaped, mesophilic bacterium, that has a physiology 
which is well suited for growth in an acidic, inorganic, metal-rich, mining environment. It 
obtains its energy by the oxidation of either ferrous ions to ferric ions or reduced-sulfur 
compounds to sulfuric acid. The bacterium is acidophilic with an optimum pH within the range 
pH 1.5 to 2.5. It grows best in an aerobic environment with oxygen as an electron acceptor 
(Rawlings & Kusano, 1994). However, if oxygen is lacking, reduced-sulfur compounds or 
formate are used as the electron donor and ferric ions can serve as the electron acceptor (Pronk 
et al., 1991). Other compounds besides iron and sulfur may be oxidised. ThreeT. ferrooxidans 
strains, including the type strain ATCC 23270, grow on basal-salts medium when incubated in 
the presence of C02 and 02, with H2 as the sole energy source (Drobner et al., 1990). 
T. ferrooxidans obtains its carbon by fixing atmospheric carbon dioxide and is obligately 
autotrophic (Kelly & Harrison, 1989). The reduction of pyridine nucleotides (NAD, NADP), 
provides T. ferrooxidans with reducing power, required for C02 fixation, and these reactions are 
energised by the oxidation of ferrous iron or reduced sulfur-compounds (Lundgren & Silver, 
1980). One strain has been reported to grow mixotrophically in the presence of iron and glucose 
(Barros et al., 1984) but in general, organic compounds inhibit growth (Alexander et al., 1987; 
Touvinen, 1971). Formic acid can replace carbon dioxide as a carbon source in most, but not 
all, T. ferrooxidans strains examined (Pronk et al., 1991 ). 
T. ferrooxidans is also capable of fixing atmospheric nitrogen (Mackintosh, 1978). Of 15 T. 
ferrooxidans strains examined, every one had the genes for nitrogen fixation (Pretorius et al., 
1986; Rawlings, 1988). 
The direct physical attachment of T. ferrooxidans to pyrite (FeS2) crystals has been observed 
(Lundgren & Silver, 1980), and results in localised oxidation of pyritic sulfide to sulfate (1), and 
ferrous iron to ferric (2): 
2FeS2 + 702 + 2H20 ~ 2Fe~02 + 2H2S04 (1) 
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(2) 
These reactions generate ferric iron, a strong oxidising agent, which participates in the indirect 
oxidation of pyrite, generating sulfate and elemental sulfur (3): 
(3) 
On aeration this ferrous iron is reoxidised to ferric iron. The elemental sulfur may be reoxidised 
to generate additional sulfuric acid (4) (Monticello & Finnerty, 1985): 
(4) 
The production of sulfuric acid during microbial leaching of ores continually lowers the pH of 
the leach solution. The cytoplasmic pH of T. ferrooxidans is neutral, thus maintaining a 
transmembrane gradient of 4.5 pH units (Lundgren & Silver, 1980). The movement of protons 
across the membrane, against 'the transmembrane gradient, is chemiosmotically coupled to A TP 
production, with oxygen usually serving as the terminal electron acceptor. 
T. ferrooxidans also has an inherent resistance to high concentrations of metallic and other ions 
(Tuovinen et al., 1971), and has been grown in media containing, for example Zn (120gll), Ni 
(72gll), Co (30g/l), Cu (55 gil), U308 (12gll) and Fe2+ (113gll) (Torma, 1977). Another feature 
is the remarkable adaptability of the organism when faced with adverse growth conditions. 
Previously sensitive strains have become adapted to high concentrations of arsenic (Rawlings & 
Woods, 1995) and copper (Holmes & Ul Haq, 1989), lower-than-optimum pH (Vian et al., 
1986) and a number of other factors. 
Recent studies incorporating 5S and 16S rRNA base sequences have been useful in predicting 
phylogenetic relationships among the sulfur and iron-oxidising eubacteria, including T. 
ferrooxidans. Most of the T.ferrooxidans and T. thiooxidans strains form a tight cluster in the f3 
subdivision, towards the root of the f3/'y subdivision of the proteobacteria (Lane et al., 1992). An 
exception was the T. ferrooxidans strain m-1, which falls within the proteobacteria y . 
subdivision. 
1.1.5 Molecular genetics ofT. ferrooxidans 
The economic significance of bacteria to the mining industry warrants a thorough understanding 
of all aspects of the physiology of these organisms. In this respect, the molecular biological 
research of the.se organisms is of great importance. To improve the economic viability of 
biomining, the rates of cell growth and ore oxidation by microbes need to be increased. The 
growth rates ofT. ferrooxidans, for example, are slow, 6-7 hour average generation time in 
ferrous iron-containing batch cultures. Furthermore T. ferrooxidans oxidises up to 30 times its 
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own weight in ferrous ironlh and its cell yields are low (Kelly et al., 1979). Since this organism 
does not settle, there is no ready means of recycling and the minimum retention time in a 
leaching vat is restricted by the low growth rate of the bacteria .. It may be possible to solve these 
problems by increasing our knowledge of the nutrition and energy generation mechanisms of 
leaching bacteria, and developing a genetic system to carry out physiological studies and 
manipulate commercial strains of the bacteria. Studies of the molecular genetics of T. 
ferrooxidans were usually carried out with these objectives in mind. 
Several native plasmids have been isolated from T. ferrooxidans. Martinet al. (1981) reported 
that 11 out of 15 strains studied contained 1 to 5 plasmids per strain, ranging in size from 7.4 to 
75 kbp. In a survey of more that 100 strains from six Japanese mining sites, 73% were found to 
carry one or more plasmids ranging in size from 2.0 to 30 kbp (Shiratori, 1991). Plasmids have 
also been reported in T. ferrooxidans strains in other countries (Lau et al., 1993). Two T. 
ferrooxidans plasmids pTF1 (Holmes et al., 1984) and pTF-FC2 (Rawlings et al., 1984; 
Rawlings et al., 1993) have been studied in some detail. 
Two families of repetitive DNA sequences in the genome of T. ferrooxidans have been 
identified (Yates & Holmes, 1987). It has been suggested that transposition of family 1 
insertion sequences (ISTJ) might be involved in phenotypic switching of T. ferrooxidans, 
including the reversible loss of its iron-oxidising capacity (Schrader & Holmes, 1988). 
A number of genes have been cloned from T. ferrooxidans and expressed in E. coli. These 
include genes involved in carbon dioxide fixation, nitrogen fixation and regulation, iron 
oxidation, mercury resistance and energy production (Rawlings & Kusano, 1994). 
1.1.5.1 Gene transfer studies 
In the absence of confirmed reports of bacteriophages and numerous unsuccessful attempts at 
producing a state of transformation competence, conjugation and electroporation are the most 
likely means of transferring DNA into T.ferrooxidans (Rawlings & Kusano, 1994). 
(i) Conjugation systems 
The growth requirements of T. ferrooxidans and E. coli are so different that the lack of a mating 
medium in which both bacteria could meet their energy needs, may have been the cause of 
previous failures to demonstrate transfer between the two bacteria (Peng et al., 1994). However, 
recently the conjugal transfer of plasmids from E. coli to T. ferrooxidans has been reported 
(Peng et al., 1994). The broad-host-range IncP plasmids RP4, R68.45, RP1::Tn50J, and 
pUB307 were transferred to T. ferrooxidans from E. coli by conjugation (Peng et al., 1994). 
The broad-host-range IncQ vector pJRD215 (Kmr, smr, lncQ, Mob+) was also mobilized into T. 
ferrooxidans with the aid of the plasmid RP4 integrated in the chromosome of E. coli SMIO. 
The transfer frequency rang~d from 1.1 X 1o-7 to 2.8 X w-5, for the different plasmids. By use 
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of the suicide vector pSUP1011, transposon Tn5 was introduced into T. jerrooxidans. More 
recently two arsenic-resistant plasmids were introduced into T. jerrooxidans by conjugation 
(Peng et al., 1994). The plasmids were stable and the arsenic resistance genes were expressed in 
T. ferrooxidans. 
(ii) Electroporation 
Kusano et al. (1992) electroporated mercury-sensitive T.je"ooxidans cells with shuttle vectors 
consisting of the T. jerrooxidans mer resistance determinant cloned into four natural T. 
jerrooxidans plasmids, as well as plasmid pKT240, a plasmid containing an IncQ-type replicon. 
Of 30 T. jerrooxidans strains electroporated, only 1 gave transformants at a low efficiency of 
120 to 200 colonies per mg of plasmid DNA. In addition, selection for mercury resistance was 
not a very stringent selection procedure and only 13 of the 22 colonies which grew on mercury 
contained the recombinant plasmid. 
1.2 Thioredoxin 
Thioredoxins are small (Mr 11 700), ubiquitous, heat-stable proteins with conserved redox-
active sites -Trp-Cys-Gly-Pro-Cys- (Holmgren, 1968). Thioredoxin participates in redox 
reactions through the reversible oxidation of its active center dithiol, to a disulfide. Two 
cellular reductants, reduced ferredoxin. and NADPH, supply the equivalents for reduction via 
different enzymes. In the first system, thioredoxin is reduced by ferredoxin via the iron-sulfur 
enzyme, ferredoxin-thioredoxin reductase (ferredoxin is reduced by the electron transport chain 
of illuminated chloroplast thylakoid membranes). Whereas in the NADP/thioredoxin system the 
reduction of thioredoxin is linked to NADP via a flavin enzyme NADP-thioredoxin reductase. 
Thioredoxin was first purified in 1964 from Escherichia coli as an in vitro hydrogen donor for 
ribonucleotide reductase (Laurent- et al., 1964). Since then research has revealed numerous 
functions of thioredoxin in many important biological phenomena. The reduced form of the 
protein is a strong disulfide oxidoreductase that is involved in the reduction of enzymes that 
reduce sulfate and methionine sulfoxide (Gonzalez Porque et al., 1970). Thioredoxin is also a 
highly efficient disulfide reductase of wide specificity, catalyzing many dithiol-disulfide redox 
reactions. It has been identified as an essential subunit of the T7 DNA polymerase (Mark & 
Richardson, 197 6), and is also required for filamentous phage assembly (Russel & Model, 
1986). In plant cells, thioredoxin is involved in the regulation of enzymes of carbon dioxide 
fixation (Buchanan, 1980). 
1.2.1 General properties of thioredoxin 
Thioredoxin negative mutants of E. coli are viable, making the precise cellular, physiological 
functions of thioredoxin unknown. Anacystis nidulans, a photosynthetic.bacterium, is the only 
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organism in which a single thioredoxin gene has been shown to be essential for cell viability 
(Muller & Buchanan, 1989). 
The reduced form of thioredoxin acts as a hydrogen donor for the reductive enzymes 
ribonucleotide reductase (Laurent et a/., 1964), methionine _sulfoxide reductase (Ejiri et a/., 
1980) and PAPS reductase· (Tsang, 1981). However, glutaredoxin can also act as a hydrogen 
donor for all the above enzymes, except methionine sulfoxide reductase, which has a specific 
requirement for thioredoxin. 
Thioredoxin can effectively catalyse the reduction of exposed disulfides in proteins and is thus a 
protein disulfide reductase. Reduction of insulin has been used as an assay for thioredoxin. The 
reduction of two interchain disulfide bonds of insulin leads to the precipitation of the B-chain 
which can easily be monitored as an increase in turbidity (Holmgren, 1979). Thioredoxin is 
thought to operate via a ping-pong mechanism, governed by the reduction of TRX-S2 and the 
oxidation of TRX-(SH)2 (Gleason & Holmgren, 1988). Thioredoxin can also act as a protein 
disulfide isomerase (Gleason & Holmgren, 1988). 
Thioredoxin is involved in the redox control of various enzymes. For example, the reduction 
and oxidation of critical disulfide bonds of certain proteins is known to regulate the activity of 
various photosynthetic enzymes, such as malate dehydrogenase (Scheibe et a/., 1986), and 
fructose-1 ,6-bisphosphatase (Buchanan, 1980). 
There is a growing body of evidence that thioredoxin occupies a central position in controlling 
the division and proliferation of animal cells (Buchanan et al., 1994). Principal sites of. 
thioredoxin action lie at the levels of transcription (Mathews et al., 1992), cellular proliferation 
(Biguet et al., 1994), hormone action (Grippo et al., 1985) and removal of oxidative stress 
(Fernando et al., 1992). In addition, thioredoxin was demonstrated to be required for oogenesis 
in Drosophila (Salz et al., 1994), artd early embryonic division in both Drosophila (Salz et al., 
1994) and Xenopus (Hartman et a/., 1993), and is implicated in the developmental cycle of 
Dictyostelium discoideum (Wetteraurer eta/., 1992). 
1.2.2 Escherichia coli thioredoxin 
1.2.2.1 Location 
Thioredoxin is present at a relatively high concentration of 10 000 to 20 000 molecules per cell 
in E. coli (Holmgren eta/., 1978). Separation of the membrane and soluble fractions of E. coli 
by gentle lysis and centrifugation showed that thioredoxin was located in the soluble fraction. 
However, cytochemical studies have indicated that thioredoxin is associated with the bacterial 
cell membrane (Nygren eta/., 1981). A peripheral localization at the inner membrane was also 
indicated from the quantitative release of thioredoxin by osmotic shock and its partial · 
association with a membrane fraction prepared after gentle lysis (Lunn & Pigiet, 1982). 
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Immunoelectron microscopy showed thioredoxin localized close to the membrane, however, in 
some cells a localization in the nucleoid region was also observed. Similar studies using cross-
linking agents suggested a more precise localization on the inner membrane and adhesion sites 
where inner and outer membranes are contiguous (Bayer et al., 1987). 
Localization of thioredoxin at the cell membrane could be related to its function in filamentous 
phage assembly and possibly disulfide bond formation in proteins exported into the periplasmic 
space. Soluble or nucleoid-associated thioredoxin may be involved in deoxyribonucleotide 
metabolism, although the localization of ribonucleotide reductase has not been determined 
(Gleason & Holmgren, 1988). 
1.2.2.2 Structure of thioredoxin 
Thioredoxins, from Archaea to humans, have 27-69% sequence identity to E. coli thioredoxin. 
However, despite large differences in amino acid sequence all the proteins have similar three-
dimensional structures, and as expected, residues in the active site region are highly conserved 
(Eklund et al., 1991). 
E. coli thioredoxin consists of a single polypeptide chain of 108 amino acid residues (Holmgren, 
1968). The active site is formed by a 14 membered disulfide ring. Amino acids Cys-32 and 
Cys-35 form the disulfide bridge. Crystallization of TRX-S2 was obtained close to the. 
isoelectric point at pH 4.5, with alcohol, in the presence of copper ions (Holmgren & S&lerberg, 
1970). The TRX-S2 crystals were formed from dimers linked into layers of molecules by the 
copper ions (S&lerberg et al., 1974). The 3-D structure of the oxidised thioredoxin has been 
solved to 2.8A by X-ray crystallography (S&lerberg et al., 1974; Holmgren et al., 1975) and 
more recently refined to 1.68A (Katti et al., 1990). The molecule consisted of two 
conformational domains, papap and ppa, connected by a single-tum a-helix and a 3u)- helix. 
There were also four reverse turns in the molecule. Most of the residues (90%) were in a-
helices, P-sheets or reverse turns, which explains the very high stability of the protein. The two 
Cys residues of the active site formed a protruding loop between the C-terminal end of the p2 
sheet and the a 3 helix, which was only accessible from one side of the structure (Fig. 1.1). A 
flat hydrophobic surface was formed on this side of the molecule by residues Gly-33, Pro-34, 
Ile-75, Pro-76, Val-91, Gly-92 and Ala-93. This area is thought to be involved in binding of 
thioredoxin to other protein molecules (Eklund et a/., 1984 ). 
No crystals of TRX-(SH)2 have been obtained. However the 3-D solution structure has been 
determined by NMR spectroscopy. The molecule also consisted of central a five-strand P-sheet 
and 3 a-helices. The P strands were packed in the sheet in the order P 1• P3. P2. P4. P 5• with P 1, 
P3 and P2 parallel and P4 and P5 arranged in an antiparallel fashion. The a1 helix connected 
P 1 and P2 strands and the a2 helix connected the P2 and P3 strands. Strands ~4 and ~5 were 
connected by a short loop that contained a P bulge. Strands P3 and ~4 were connected by a long 
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loop that contained a series of tum-like or 3u) helical structures. As in the oxidized form the 
active site formed a protruding loop between strands ~2 and helix a2. The structure was very 
similar to the oxidized form, but differed slightly around the active site loop. The distance 
between the sulfurs of Cys-32 and Cys-35 increased from 2.05A in the disulfide bridge to 
approximately 6.8A in the dithiol of the reduced thioredoxin as a result of the rotation of the 
side chain of Csy-35 and a significant change in the position of Pro-34 (Dyson eta/., 1990). 
Fig. 1.1 (a) Primary structure of E. coli thioredoxin. R =reverse turn. (b) Schematic drawing of 
three-dimensional structure of oxidized E. coli thioredoxin. 
Langsetmo et a/., ( 1989) examined urea-induced denaturation of E. coli TRX and TRX variants, 
by electrophoresis on urea gradient slab gels. TRX-S2 and TRX-(SH)2 each had two folded 
isomers with different stability to urea d~naturation. The data suggested that these were cis and 
trans isomers of the Pro-76 peptide bond. Urea gel experiments with the mutant P76A, 
corroborated this interpretation. Since cis TRX-S2 was much more stable than trans, folded 
TRX-S2 was essentially all cis, and in the absence of urea, only a very low percentage of the 
folded TRX-(SH)2 existed as the trans isomer. 
1.2.2.3 Structure/function relationship 
Subtle increases in the polypeptide backbone dynamics were observed for TRX-(SH)z 
compared to TRX-S2 (Stone et al., 1993). This was interpreted as an increased flexibility for 
the active site sequence and its contacting loops, consistent with the reported decreased thermal 
stability of TRX-(SH)2 compared tq that of TRX-S2 (Hiraoki et al., 1988). The flexibility was 
suggested as a possible explanation for the differential reactivity of the oxidized and reduced 
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forms of the TRX, particularly in complex formation with the gene 5 protein of the 17 DNA 
polymerase (Hiraoki et al., 1988). 
Jeng et al. (1995), studied the hydrogen exchange behaviour of reduced and oxidized 
thioredoxin. Significant changes were observed in the active site sequence and in the regions of 
the protein that were close to this sequence, including portions of the ~strand and a.-helical 
sequences immediately adjacent to the active site. In particular the exchange rate of the Cys-35 
amide proton was significantly slowed for oxidized thioredoxin compared with the reduced 
form. In general, the amide proton exchange rates were consistently lower for the oxidized form 
of thioredoxin. The rather generalized loosening of the protein structure upon reduction 
indicated by the hydrogen exchange measurements, provides further evidence that the functional 
differences observed between the two forms of thioredoxin can most likely be ascribed to the 
greater flexibility of the reduced form of the protein. 
In contrast, circular dichromism (Reutimann et al., 1981. Brown et al., 1987) and optical 
density dispersion spectra (Stryer et al., 1967) showed no change between the oxidized and 
reduced states. Nor were any detectable changes found between the two forms for backbone 
amide vibrations by Raman spectroscopy (Li eta/., 1993). 
Characterization by 1 H NMR of a C32S, C35S double mutant of E. coli thioredoxin confirmed 
its resemblance to the reduced form of the wild type protein (Dyson et al., 1994). The mutant 
protein was able to substitute for the reduced thioredoxin in T7 phage and filamentous phage 
assembly systems. This work also confirmed that the major titrating group near the active site 
was most likely to be the Asp-26 carboxyl group. The ionization and hydrogen bonding states 
of the Cys-32 and Cys-35 residues in reduced TRX were determined by Raman spectroscopy 
(Li et al., 1993). The results indicated; (i) one sulfhydryl was a stronger H-bond donor than the 
other (ii) the weaker H-bond donor (Cys-32) was preferentially titrated to the thiolate ion as the 
solution pH was increased from pH 4 to 7. Water or hydroxyl oxygens were the possible 
acceptors for the Cys-32 S-H donor (iii) Cys-35 resisted ionization until approximately 50% of 
the more acidic sulfhydryl had been titrated. A carbonyl oxygen was proposed as the likely 
acceptor of the Cys-35 S-H donor (iv) Raman titration data indicated pK 1 = 7.1 and pK2 = 7.9 
for the two thiol-thiolate equilibria. The lower pKa was thought to be assigned to Cys-32. 
Conformation-sensitive Raman bands of Trp, Asp and Glu carboxylate groups and aliphatic side 
chains indicated significant changes in the environment and interactions of these side chains 
with thiol titrations, although the secondary structure was largely conserved (Li eta/., 1993 ). 
Elofsson et al. ( 1991 ), determined the picosecond fluorescence of the four aromatic amino acid 
residues (Trp-28, Trp-31, Tyr-49 and Tyr-70) in wild type thioredoxin and a mutant thioredoxin 
with Trp-31 replaced by Phe. The major features of the lifetime distribution of tryptophan 
fluorescence were unchanged in the mutant. However the mutation changed the mobility of 
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residue Trp-28, but not Tyr-49 or Tyr-70. The mobility of the two tyrosines increased on 
reduction of the active site disulfides indicating a looser structure with reduction. This 
increased motion could also be seen from molecular dynamics simulation (Elofsson et al., 
1991). 
A comparison of backbone and side chain dynamics of TRX-(SH)2 using 15N-NMR relaxation 
measurements revealed that Trp-31 was more mobile that Trp-28 and lay on the surface of the 
molecule, while Trp-28 was buried in the hydrophobic core (Stone et al., 1993). Backbone 
regions that were more mobile than average included; the N -terminus, the C-terminus, residues 
20-22 (forms a linker between a1 helix and ~2 strand), and residues 73-75 and 93-94 which are 
located adjacent to the active site. Oxidation of both Trp residues by N-bromosuccinimide 
inactivated TRX, whereas modifications of only Trp-31 lead to partial activity as a substrate for 
thioredoxin reductase. Thus Trp-28 seems to be an essential part of the surface required for 
interactions with other proteins. 
Tryptophan emission of TRX-S2 was strongly quenched over the pH range 2-10 (Holmgren, 
1972). In contrast the fluorescence ofTRX-(SH)2 was strongly pH dependent with a maximum 
at pH 5 (Holmgren, 1972) and an apparent titration curve for a quenching group with a pKa of 
6.35 (Reutimann et al., 1981). This·quenching group was proposed to be the deprotonated form 
of the sulfuydryl group of Cys-32, which has an estimated pH value of 6.7 judged from the 
chemical modifications by iodoacetate (Kallis & Holmgren, 1980). The alkylation of cysteine 
residues using iodoacetamide, below pH 8, lead to labelling of only Cys-32, and the reaction 
was strongly pH dependent. Both cysteine residues were alkylated when the protein was 
denatured with guanidine hydrochloride, showing that the folded structure was responsible for 
the reactivity of TRX-(SH)2. It was proposed that the thiolate ion of Cys-32 may be stabilized 
and its activity enhanced by interaction with the £-amino group of Lys-36. However, Nikkola et 
al. (1993) showed that the conserved positive charge at position 36 was not essential for E. coli 
TRX activity, as a TRX mutant that had Lys-36 substituted with a negatively charged glutamic 
acid residue could still function with approximately 75% of the catalytic efficiency of the wild 
type protein. The authors concluded that the pKa of Cys-32 was lowered by its interaction with . 
the a2 helix dipole (a-helix structures create a positive charge at their N-termini), and that the 
positively charged residue at position 36 was conserved to optimize protein interactions and did 
not increase the reactivity of the active site thiol group. 
In addition, site-directed mutagenesis of Lys-36 in human thioredoxin to either glutamic acid or 
leucine, affected the reduction rates and growth stimulation but was not essential for the redox 
protein's biochemical or biological properties (Oblong et al., 1995). 
Gly-92 has been found to be essential for the function of TRX-(SH)2 as a subunit of T7 phage 
DNA polymerase (NordstrOm et al., 1981, Holmgren et al., 1981). The altered thioredoxin 
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isolated from E. coli 7007 had Gly-92 changed to an Asp residue. It had about 20% activity in 
its reduced form with ribonucleotide reductase and altered activity with thioredoxin reductase. 
A Pro to His mutation in the active site increased disulfide isomerase activity of thioredoxin 10-
fold (Lundstrom et al., 1992). This mutation mimicked the proposed protein disulfide 
isomerase active site -W-C-G-H-C- (Lundstrom et al., 1992). However, a Pro-34 to Ser-34 
mutation had little effect on the redox activity of thioredoxin (Gleason et al., 1990). The 
authors proposed that Pro-34 maintains the stability of the protein rather than being involved in 
the redox function. This theory was supported by Russel & Model ( 1986), whose results 
showed that the P34S thioredoxin mutant supported f1 phage replication at 37°C, but not at 
42°C. 
Asp-26 in E. coli thioredoxin is located at the bottom of a hydrophobic cavity, near the redox 
active disulfide of the active site. Examination of the sequence from a number of species 
revealed that Asp-26 is a highly conserved residue (Eklund et al., 1991). The titration 
behaviour of both oxidized and reduced TRX appeared to implicate Asp-26 in the electron-
proton transfer in thioredoxin, consistent with its close proximity to the active site (Dyson et al., 
1991). Langsetmo et al. (1991) have determined the pKa of Asp-26 by a novel electrophorectic 
method based on the relative electrophoretic mobilities of wild type thioredoxin and of the 
mutant D26A (Asp replaced with Ala). The pKa was found to be 7.5, more than 3 units above 
the pKa of a solvated carboxyl side chain. The titration of Asp-26 was found to be 
thermodynamically linked to the stability of TRX. The 60 of denaturation of the wild type 
TRX varied with pH in the vicinity of pH 7.5, but the 60 of denaturation of the mutant D26A 
was independent of pH, indicating that the stabilization of D26A TRX compared to the wild 
type was primarily due to the removal of the Asp-26 residue. More recently Wilson et al. 
(1995), found the pKa of TRX-(SH)2 to be greater than 9. The authors proposed that the 
increase in pKa of Asp-26 in TRX-(SH)2 accounts for the lower stability of TRX-(SH)2 
compared to TRX-S2. The higher pKa of Asp-26 in TRX-(SH)2 also offers an explanation for 
the requirement of thioredoxin in the reduced conformation by phages. The binding of a phage 
factor may be inhibited by a partial negative charge of Asp-26 at physiological pH, which is 
neutralised in the reduced form. 
Cleavage of TRX with cyanogen bromide resulted in two structureless fragments: TRX-C(l-
37) and TRX-C(38-108) (Holmgren & Reichard, 1967). The TRX-C(l-37) containing the 
active site was inactive, but on mixing with TRX-C(38-l08) it was reconstituted, non-covalently 
to an active form. The reconstituted form showed 50% activity with thioredoxin reductase on 
comparison to the native form (Slaby & Holmgren, 1975). However, it was not active as a H-
donor for ribonucleotide reductase or as an insulin disulfide reductant. In immunoprecipitation 
it showed full activity as an antigen. These results suggested that Met-37 and its peptide bond 
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are essential for the conformational changes taking place in the oxidation of TRX-(SH)2 (Slaby 
& Holmgren, 1975). 
Cleavage of TRX by trypsin, after reversible blocking of the lysine residues by citraconic 
anhydride, generated two structureless and inactive fragments: TRX-T(l-73) and TRX-T(74-
108) (Slaby & Holmgren, 1975; Holmgren & Slaby, 1979). Mixing the two fragments 
generated a complex with full immunoprecipitation activity with antibodies against TRX (Slaby 
& Holmgren, 1979), but low activity with thioredoxin reductase, and ribonucleotide reductase 
(Slaby & Holmgren, 1979). Spectroscopic studies showed that it was induced to fold to a 
structure similar to TRX-S2 at low pH (Reutimann et al, 1981). Therefore it appeared that the 
area around Arg-73 was of critical importance for the interaction with both thioredoxin 
reductase and ribonuleotide reductase (Holmgren & Slaby, 1979). 
1.2.3 Genetics 
The thioredoxin gene from E. coli has been cloned, sequenced and studied in several 
laboratories (Wallace & Kushner, 1984; HOOg et al., 1984; Lim et al., 1985). The trxA gene 
was located at 84.7 min, directly upstream of rho, the gene encoding the transcription 
termination factor Rho (Matsumoto et a/., 1986). The gene order in this region of the E. coli 
chromosome is: ilvC ... rep ... trxA-rho ... cya .. .metE (Aldea et al., 1988). 
The position of the E. coli trxA gene promoter has been reported by three different groups. 
Wallace & Kushner (1984) suggested that the start site of the trxA pro_moter was located 63 . 
nucleotides upstream from the trxA start codon, based on the size of RNA transcribed from trxA 
in vitro. On the other hand Lim et al. (1985) identified two transcription initiation sites located 
approximately 114 and 74 nucleotides upstream from the trxA start codon, by S 1 mapping 
analysis of RNA isolated from a· strain containing trxA cloned on a multicopy plasmid. 
Matsumoto et al. (1986) located the tr.xA promoters at Ill and 114 nucleotides upstream of the 
start codon using S 1 mapping and only at 111 nucleotides upstream of the start codon using in 
vitro transcription analysis. They suggested that initiation from the upstream site (nucleotide 
114) may be hindered under in vitro conditions due to an unfavourable helical configuration of 
the DNA as linearised DNA fragments were used. Thus both Lim eta/. (1985) and Matsumoto 
et al. ( 1986) detected transcription start sites at 114 nucleotides upstream of the start codon. 
However Matsumoto et al.'s results suggest that transcription from the second promoter reported 
by Lim et al. is undetectably weak if it functions at all. The helical configuration of the plasmid 
DNA used by Lim et al. may also have affected transcription from the second promoter, leading 
to differing results. Matsumoto et a/. proposed that the discrepancies between their results and 
those of Wallace & Kushner may be due to differences in conditions used for in vitro . 
transcription and subsequent analytical procedures. 
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A near consensus cyclic-AMP binding protein (CRP) recogmtlon site 
(AATGTGTTTTGCfCATAGT) was located between the -35 and -10 sequences. Binding of a 
cyclic AMP-CRP complex at this site would interfere with the entry of RNA polymerase to the 
trxA promoters (Wallace & Kushner, 1984; Matsumoto et a/., 1986). Such a situation may 
explain the observed enhancement of trxA transcription in a cya- strain, in which the assumed 
interference should be reduced by the absence of the cofactor, cyclic AMP (Matsumoto eta/., 
1986). In addition, the apparent level of thioredoxin has been found to decrease about 4-fold in 
rich medium as opposed to minimal medium (Holmgren, 1983). 
The tenninator for trxA was located so close to the rho promoter that it was situated between its 
-35 and -10 regions (Matsumoto eta/., 1986). The possibility that transcription from trxA might 
influence initiation from the rho promoter was excluded by the observation that rho 
transcription was almost unchanged when the trxA promoter was deleted. A small amount of 
trxA tenninator read-through gave rise to a 2.1 kb mRNA encoding both the trxA and rho genes. 
About 10% of rho mRNA seemed to be made this way. This read-through tended to increase in 
a temperature-sensitive rho mutant, suggesting that the trxA tenninator is at least partially Rho 
dependent (Matsumoto et al., 1986). 
Lim eta/. (1985) reported a Rho-independent tenninator-like sequence at the 3' end of the trxA 
gene. However, Matsumoto eta/. (1986) found no increase in transcription of rho when they 
deleted this putative tenninator, nor did they detect any RNA tenninating at this site in S 1 
mapping experiments. In addition to the tenninator located within the rho promoter, 5 other 
tennination sites downstream of the rho promoter were also located. The sequence proceeding 
these tenninator sites invariably contained potential stem-loop structures. The first two sites lay 
within the leader region of rho and appeared to be Rho dependent. The remaining 3 sites were 
localized within the structural gene of rho and were therefore thought to be intracistronic · 
tenninators. 
The genes encoding thioredoxin (TRX) and thioredoxin reductase (TR) have been characterised 
for a number of bacteria, and from these studies it has become clear that the genes are organised 
on the genome in a different fashion in different bacterial species. In E. coli, for example, the 
genes are widely separated on the genome, whereas in Streptomyces clavuligerus (Cohen eta/., 
1993) and Eubacterium acidaminophilum (LUbbers & Andreesen, 1993), both genes are closely 
linked. In mycobacteria at least three modes of organisation of thioredoxin and thioredoxin 
reductase genes can exist within a single bacterial genus. (i) In the majority of mycobacterial 
strains the genes encoding TRX and TR are located at separate sites on the genome. (ii) 
However, in all pathogenic mycobacteria from the Mycobacterium tuberculosis complex group 
both genes are found on the same locus. The start codon of TRX overlaps with the stop codon 
of TR by one nucleotide, requiring the ribosomes to shift frames. (iii) In the pathogen 
Mycobacterium leprae, TR and TRX are encoded by a single gene. The N-tenninal part of the 
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protein corresponds to TR and the C-tenninal part to TRX (Wieles et a/., 1995). The authors 
postulate that the various types of gene organisation may be associated with different modes of 
expression of the TRX and TR proteins. 
1.2.4 Thioredoxin in bacteriophage life cycles 
1.2.4.1 Filamentous phage 
Filamentous phage assembly in vivo shows an absolute requirement for thioredoxin and a partial 
requirement for thioredoxin reductase (Russel & Model, 1985). Mutants in which one or both · 
of the thioredoxin active site cysteine residues were changed to alanine or serine were still able 
to support filamentous phage assembly (Russel & Model, 1986). The mutants were inactive in 
an assay which couples oxidation of NADPH to reduction of 5,5'-dithiobis-(2-nitrobenzoic) acid 
via thioredoxin reductase and thioredoxin. These results suggest filamentous phage assembly 
requires the participation of thioredoxin in the reduced confonnation but not as a reductant. The 
authors isolated a variety of mutants that were unable to support filamentous phage assembly. 
These mutants had alterations at amino acid positions Pro-34(trxA2), Gly-74(trxA11), Pro-
76(trxA76) and Gly-92(trxA12, trxA13). These mutations fall within the "molecular surface 
area" that Eklund eta/. (1984) identified as the binding surface for redox-interactions between 
thioredoxin and other proteins. This area is comprised of three regions, the first amino acids 33-
34, the second 75-76 and the third 91-93. Revertants of mutants in these regions that were able 
to support filamentous phage assembly were identified. Changes in the amino acids that 
connect two of the conserved domains (residues 64-70) restored competence in phage assembly 
to mutant trxA12. One revertant of trxA12, and all four of trxA11 and trxA13 had regained the 
wild type Gly codons. As in both mutants trxAll and trxA13 Gly residues had been altered tp 
Asp residues, the authors proposed that the positively charged Asp residue perturbed the 
"molecular surface area" (Russel & Model, 1986). Mutants in Gly-33 or Pro-34 were tested for 
the ability to support growth of T? and f1 phages, and it was found that amino acids with 
smaller side-chain groups were indispensable for the growth of phages (Minarik eta/., 1993). 
Thioredoxin does not appear to be required for DNA synthesis, as DNA synthesis of f1 and T7 
phages was nonnal in trxA mutants. The conversion of the single-stranded DNA-gene V 
complex to phage required two events; the removal of the gene V DNA binding protein and the 
binding of the major coat protein to the DNA. This process required the action of the gene I and 
IV products (neither of which are phage structural components), since mutations in either of 
these genes blocked filamentous phage assembly but did not affect synthesis of either the DNA 
or protein components of the phage (Webster & Lopez, 1984). Despite strong evidence for an 
interaction between thioredoxin and the product of gene /, efforts to demonstrate complex 
fonnation by immune precipitation of extracts of gently lysed, phage fl-infected cells with anti-
thioredoxin serum were unsuccessful (Russel & Model, 1983). 
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1.2.4.2 T7 phage 
Two classes of E. coli mutants designated tsnB and tsnC, were isolated (Chamberlain, 1974). 
These mutants grew normally but were unable to support growth of T7 phage. E. coli tsnC 
mutants were found to be defective in cell-free replication of duplex T7 DNA and T7 DNA 
polymerase activity. Modrich & Richardson (1975) identified a 12 k.Da protein designated 
TsnC protein, that was necessary for viral DNA synthesis. The TsnC protein was found to be 
identical to thioredoxin. The T7 DNA polymerase complex was found to be composed of a 1:1 
complex of an 84 k.Da protein specified by the gene 5 protein of the phage and a 12 k.Da "TsnC" 
protein from E. coli (Mark & Richardson, 1976). The polymerase activity of the complex did 
not depend on reducing agents, suggesting that the active site merely plays a conformational 
role in a protein:protein interaction (Alder & Modrich, 1983). A mutant thioredoxin Ser-32, 
Ser-35 was able to support T7 phage DNA replication to the same level as the wild type 
thioredoxin if present at about 100-fold·higher concentration (Huber et al., 1986). Thus neither 
a reduction step nor an intermolecular disulfide bridge were necessary for a functional 
polymerase complex. In the absence of thioredoxin the T7 DNA polymerase dissociated from 
the primer after the incorporation of 1 to 50 nucleotides, depending on the salt concentration. In 
contrast, in the presence of thioredoxin, synthesis was highly processive. The gene 5 protein-
thioredoxin complex could incorporate 1000s of nucleotides from a given primer without 
dissociation (Taboret a/., 1987). Dissociation was accelerated by excess single stranded DNA 
in an apparent second order reaction, indicating transfer of the polymerase between DNA 
fragments. High salt concentrations also increased dissociation, indicating that thioredoxin 
stabilized the primer-template complex mainly through additional charge-charge interactions 
(Huber et a/., 1987). A highly specific interaction between complementary surfaces of 
thioredoxin and the gene 5 protein appeared to be required, as mutants of thioredoxin affecting 
the conserved, flat, hydrophobic surface were inactive as T7 DNA polymerase subunits (Huber 
et al., 1986). Furthermore, only reduced thioredoxin from E. coli, T.ferrooxidans, Rhodobacter 
sphaeroides and a few other bacteria, has been found to activate the T7 gene 5 protein. Reduced 
thioredoxins from spinach chloroplasts,· mammals, T4 phage, Anabaena, C. nephridii and many 
other bacteria cannot activate the gene 5 protein. 
There is extensive amino acid homology between the Klenow fragment of E. coli DNA 
polymerase I, the T7 gene 5 protein and other DNA-dependent DNA polymerases. The 
strongest homology between the Klenow fragment and the T7 gene 5 protein lies in the residues 
that form the putative DNA-binding groove of the Klenow fragment (Ollis et al., 1985). In the 
crystals of the Klenow fragment a "thumb-like" protrusion over the DNA-binding crevice was 
postulated to close the cleft, reducing the DNA dissociation rate of the subunits (Ollis et al., 
1992). Him a wan et a/. ( 1992) suggested that the thioredoxin binds the gene 5 protein at the 
edge of this crevice in the T7 polymerase such that the two proteins together clamp the primer-
template into position. A thioredoxin mutant in which Gly-74 was replaced by Asp could not 
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support T7 phage replication. The authors analysed the interaction between the gene 5 protein 
and thioredoxin by selecting revertant T7 phage that were able to suppress this thioredoxin . 
mutation. The authors proposed that the suppressor mutations compensated for the thioredoxin 
defect either by creating a conformational change in the gene 5 protein or by relieving ionic 
repulsion between Asp-7 4 and amino acids in the gene 5 protein. 
1.2.4.3 T4 phage 
T4 phage was found to encode its own ribonucleotide reductase and thioredoxin but the 
thioredoxin was reduced by NADPH and the host thioredoxin reductase (Berglund, 1969). 
Reduced T4 thioredoxin was a hydrogen donor for the T4 ribonucleotide reductase; this enzyme 
showed no activity with E. coli thioredoxin, and T4 thioredoxin was not active with E. coli 
ribonucleotide reductase. 
T4 thioredoxin contained 87 amino acids and its primary structure showed no homology with E. 
coli thioredoxin (Sj<>berg & Holmgren, 1972). The three-dimensional structure of T4 
thioredoxin has been solved by X-ray crystallography to 2.8A resolution (Eklund et al., 1984). 
The protein had a similar folding pattern to E. coli TRX. It had two simple folding units: a ~a.~ 
unit from theN-terminal end (residues 1-36) and a ~~a. unit from the C-terminal end (residues 
67-87). The redox active disulfide bridge formed part of a protrusion from the molecule as in E. 
coli. The T4 thioredoxin lacked the first 22 residues and therefore the a.1 and ~ 1 of the E. coli 
thioredoxin. Both molecules have a similar flat hydrophobic surface that is thought to be 
involved in binding to thioredoxin reductase and other protein molecules (Eklund et al., 1984). 
T4 thioredoxin was able to catalyze glutathione-dependent ribonucleotide reduction and thus 
also has glutaredoxin activity (Holmgren, 1978). In addition, glutaredoxin from E. coli was a 
hydrogen donor for T4 ribonucleotide reductase. T4 thioredoxin also had a GSH-disulfide 
transhydrogenase activity similar to glutaredoxin and 32% identity to E. coli glutaredoxin (Hoog 
et al., 1983). T4 thioredoxin has the active site sequence -Cys-Val-Tyr-Cys- which is closer to 
the glutaredoxin active site sequence -Cys-Pro-Tyr-Cys- than that of E. coli thioredoxin -Cys-
Giy-Pro-Cys-. Immunologically, T4 thioredoxin and E. coli thioredoxin showed no cross-
reactivity (Holmgren & Sj<>berg, 1972). Holmgren (1985) proposed that T4 thioredoxin had . 
resulted from a modification of a gene for "glutaredoxin" to include reactivity with thioredoxin 
reductase, as T4 ribonucleotide reductase could not function with E. coli thioredoxin and the 
low amounts of glutaredoxin in E. coli were insufficient for reduction of the viral ribonucleotide 
reductase. This adapted system therefore enabled T4 phage to utilize all available reducing 
power for T4 replication. 
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1.2.5 Thioredoxins of Anaerobic bacteria 
The obligately anaerobic, fermentative bacteria have been reported to lack glutathione (Fahey et 
al., 1978). In the absence of glutathione, thioredoxin might be a particularly important cellular 
reductant. A thioredoxin system was found in the classical saccharolytic fermenter Clostridium 
pasteurianum (Hammel & Buchanan, 1981). It was found that reduced ferredoxin rather than 
NADPH served as the physiological reductant In this respect, this anaerobic bacterium 
resembled the oxygenic photosynthetic cells rather than aerobic heterotrophic cells. However, 
the clostridial thioredoxin reductase required hydrogen and hydrogenase to provide reduced 
ferredoxin for the reaction (Hammel et al., 1983). Also, unlike the plant reductase, the bacterial 
protein had a typical flavin spectrum and presumably contains no iron. It was also highly 
specific for C. pasteurianum thioredoxin and would not reduce E. coli, Chromatium or 
Rhizobium thioredoxins. There is no known function for the clostridial thioredoxin system, as 
activation of higher plant enzymes was the only reaction studied by these workers. However, 
since the organism lacks glutathione, it is possible that thioredoxin is essential for 
ribonucleotide reduction (Gleason & Holmgren, 1988). 
E. acidaminophilum and Clostridium litoralis are physiologically closely related anaerobic 
organisms, specialized with respect to fermentation of glycine and serine if no additional 
hydrogen donor or acceptor is present In E. acidaminophilum dihydrolipoamide dehydrogenase 
activity was found associated with a protein of exceptionally small molecular size (68kDa) that 
was attached to the cytoplasmic membrane and formed a complex with the selenoprotein P A of 
glycine reductase (Freudenberg et a/., 1989). This protein and the corresponding electron-
transferring flavoprotein in Clostridium sporogenes exhibited strong homology to E. coli 
thioredoxin reductase but not to dihydrolipoamide dehydrogenases of other anaerobic bacteria 
(Dietrichs et a/., 1990). C. litoralis contained two enzymes for oxidizing dihydrolipoamide. 
The first was found to be a genuine dihydrolipoamide dehydrogenase, but the second consisted 
of two proteins, a thioredoxin reductase and a thioredoxin (Dietrichs eta/., 1990; Meyer eta/., 
1991 ). The thioredoxin system was found to be responsible for most of the dihydrolipoamide 
dehydrogenase activity in cell extracts of C. litoralis. The thioredoxin did not bind to DEAE, 
was heat stable, and had a molecular mass of about 15kDa. N-terminal amino acid sequence 
data of the E. acidaminophilum and C. litoralis thioredoxins provided convincing evidence that 
both proteins were thioredoxins. However, two differences were noted at the strongly 
conserved redox-active site, a Gly residue replaced Trp-31 of E. coli and Val replaced Gly-33 
(Meyer eta/., 1991). 
LUbbers & Andreesen (1993), cloned and sequenced the genes for thioredoxin reductase, 
thioredoxin, protein P A of glycine reductase and the first 23 amino acids of the large subunit of 
protein Pc of glycine reductase from E. acidaminophilwn. The organisation of the genes 
corresponded exactly to the predicted order of their physiological involvement. The thioredoxin 
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reductase gene was separated from the thioredoxin gene by 85 base pairs, and the thioredoxin 
gene was followed by the protein P A after a 91 base pair intergenic region. The thioredoxin 
system was found to reduce the oxidized selenoprotein P A• enabling it to participate in a new 
cycle of reductive deamination. The trxA gene contained 110 codons corresponding to a protein 
of 11.7 kDa and exhibited 36% amino acid identity to the E. coli thioredoxin (LUbbers & 
Andreesen, 1993). 
The thioredoxin and thioredoxin reductase proteins were also found in high amounts in 
sarcosine and betaine grown cells of E. acidaminophilwn. It therefore seems quite possible that · 
the thioredoxin system is involved in the three corresponding reductase systems specific for 
glycine, sarcosine and betaine (LUbbers & Andreesen, 1993). 
1.2.6 Thioredoxins of Gram positive bacteria 
Corynebacteriwn nephridii is a facultative organism, which can grow anaerobically using 
nitrate as its terminal electron acceptor. A thioredoxin was purified from C. nephridii (C-1) that 
had 50% amino acid identity to E. coli thioredoxin but had no His or Tyr residues (Meng & 
Hogenkamp, 1981). C. nephridii thioredoxin (C-1) could be reduced by E. coli thioredoxin 
reductase, and was able to act as a reducing agent for yeast methionine sulfoxide reductase, 
Lactobacillus leichmannii ribonucleotide reductase, spinach chloroplast fructose-1,6-
bisphosphatase and NADP-malate dehydrogenase. However C. nephridii thioredoxin (C-1) was 
unable to serve as a reducing agent for its own ribonucleotide reductase. The ribonucleotide 
reductase of C. nephridii did not fit into either the category of the iron-containing protein found 
in E. coli or the adenosylcobalamin-dependent ribonucleotide reductase characteristic of L. 
leichmannii, cyanobacteria and other "primitive" bacteria. The C. nephridii ribonucleotide 
reductase also required adenosylcobalamin but like the E. coli protein it was composed of two 
subunits and reduced nucleotides at the diphosphate level. The authors suggested that C. 
nephridii thioredoxin C-1 is a gene~ protein disulfide reductase and not an obligatory reductant 
for deoxyribonucleotide synthesis. 
A second thioredoxin was cloned and characterised from C. nephridii by complementation of an 
E. coli trxA mutant (Lim et al., 1987). The second thioredoxin, designated C-2, showed 
approximately 50% identity to both E. coli and the first C. nephridii thioredoxin isolated. 
Thioredoxin C-2 was able to support filamentous phage assembly but it was unable to support 
D phage replication. The active site of thioredoxin C-2 differed from all known thioredoxins 
as Gly-33 was replaced by an Ala residue. However, this probably did not affect the overall 
conformation as both are small, neutral amino acids. C-2 thioredoxin was found to be a 
hydrogen donor for yeast and E. coli methionine sulfoxide reductase, but not for its own 
ribonucleotide reductase. This is the first example of a second thioredoxin found in a 
prokaryotic, non-photosynthetic organism. Thioredoxin C-2 may not have been detected 
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initially as thioredoxin C-1 was isolated anaerobically whereas C-2 was isolated aerobically. So 
far no function has been established for thioredoxin in the denitrifiers. 
Streptomyces clavuligerus produces penicillin and cephalosporin antibiotics. The activity of 
isopenicillin-N-synthetase (lPNS), a key enzyme in the biosynthesis of these f3-lactam 
compounds, and its tripeptide 0-(L-a.-aminoadipyl)-L-cysteinyl-D-valine (ACV) are dependent 
on the redox state of their cysteine amino acid residues (Aharonowitz et a/., 1992). A 
disulfide reductase able to reduce bis-ACV to its thiol form and modulate the activity of lPNS 
was identified. The disulfide reductase was composed of a flavoprotein, containing two 35 kDa 
subunits and a 12 kDa, heat stable protein. The 35 kDa protein was identified as thioredoxin 
reductase and the 12 kDa protein as thioredoxin (Cohen et a/., 1993). On cloning and 
sequencing, the S. clavuligerus thioredoxin and thioredoxin reductase genes were found to be 
separated by 33 nucleotides and orientated in the same direction. The thioredoxin was unable to 
complement the E. coli trxA mutation for f1 phage growth or conversion of methionine 
sulfoxide to methionine. However, it was closely related to other thioredoxins with which it 
shared 48-56% amino acid identity. 
1.2.7 Thioredoxins of Photosynthetic bacteria 
Rhodobacter sphaeroides, is a purple non-sulfur bacterium which belongs to the group 
Rhodospirillaceae. It can grow anaerobically in the light and aerobically both in the light and 
the dark. Light intensity and: molecular oxygen are the most prominent environmental factors 
that effect synthesis of bacterio-chlorophyll. The thioredoxin system in R. sphaeroides is 
involved in oxygen regulation of bacteriochlorophyll synthesis by the redox control of the 
activity of 5'-aminolevulinic acid synthetase, the first enzyme that occurs in the 
bacteriochlorophyll synthesis pathway. Thioredoxin has been shown to activate purified 
preparations of this enzyme (Clement-Metral, 1979). 
R. sphaeroides thioredoxin was able to act as a hydrogen donor for E. coli methionine sulfoxide 
reductase and to support the growth of phages f1 and T7. It had 49% amino acid identity to E. 
coli thioredoxin and the active sites were identical except R. sphaeroides contained an Arg 
residue at position 33 instead of a Gly residue. The protein had a MW of 10.8 kDa and 
contained 102 amino acid residues (Pille eta/., 1990) 
Thioredoxin has also been purified and characterized from another member of the group, 
Rhodospirillum rubrum (Johnson et al., 1988). The amino acid sequence was determined by 
high performance tandem spectrometry. R. rubrum thioredoxin exhibited 53% amino acid 
identity to that of R. sphaeroides which was not much greater than its homology to the 
thioredoxins from other photosynthetic bacteria or E. coli. The data suggested the presence of a 
NADPH-dependent thioredoxin reductase in R. rubrum rather than the ferredoxin-thioredoxin 
reductase system found in plant chloroplasts. 
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Chromatiwn vinoswn a purple, non-sulfur bacterium is an obligate anaerobe, which uses 
reduced sulfur compounds such as hydrogen sulfide as a source of electrons for photosynthetic 
electron transport. Thioredoxin was detected in extracts of this organism by its ability to . 
activate chloroplast NADP-malate dehydrogenase using dithiothreitol (DTT) as a reductant 
(Johnson et al., 1984). The protein was found to have a MW of 13 kDa. Unlike other 
thioredoxins it was found to be heat sensitive. 
Antibodies prepared against E. coli thioredoxin cross-reacted with C. vinoswn thioredoxin as 
well as those of other bacteria. By contrast antibodies prepared against spinach chloroplast 
thioredoxin m cross-reacted with E. coli and N. muscorwn thioredoxins but only showed 
marginal reactivity with C. vinoswn thioredoxin (Johnson et al., 1984). A NADPH-dependent 
thioredoxin reductase was also isolated from C. vinoswn. These results support the conclusion 
that C. vinoswn thioredoxin is of the bacterial type. This seems appropriate since the organism 
utilizes ATP-driven reverse electron transport rather than direct photoreduction to reduce 
electronegative receptors such as NAD+ and ferredoxin; and thioredoxin reduction via NADP 
would be energetically less costly than via ferredoxin. The role of thioredoxin in anoxygenic, 
photosynthetic organisms seems to lie outside the regulation of photosynthesis and carbon 
dioxide assimilation and in an area as yet unknown (Johnson et al., 1984). 
1.2.8 Thioredoxins of Archaea 
A small redox-active protein was purified from Methanobacterium thermoautotrophicum 
(McFarlan et al., 1992). The protein was initially thought to be a glutaredoxin as it had the 
redox-active site -Cys-Pro-Tyr-Cys- typical of glutaredoxins. However, the protein did not 
function as a glutathione-disulfide oxidoreductase in the presence of glutathione and glutathione 
reductase, nor did it interact with the thioredoxin reductases from E. coli or C. nephridii or the 
ribonucleotide reductase from C. nephridii. It was able to catalyse the reduction of insulin and 
serve as a hydrogen donor for E. coli ribonucleotide reductase. The authors proposed that this 
glutaredoxin-like protein may be a component of the ribonucleotide reductase system distinct 
from the described systems utilizing thioredoxin or glutaredoxin. It was similar to T4 phage 
"glutaredoxin" in that it had properties of both thioredoxins and glutaredoxins but did not 
conform completely to either group of proteins (McFarlan eta/., 1992). 
Recently a thioredoxin was isolated from the extreme thermophilic Archaea Sulfolobus · 
solfataricus (Guagliardi et al., 1994). The protein was found to be highly heat resistant (no loss 
of activity after 3 hours at 90°C), it had a typically acid pi value of 4.5, but it differed from 
classical thioredoxins in molecular size. A molecular weight of 24.8 kDa was estimated under 
strongly denaturing conditions, furthermore the molecular weight detennined by amino acid 
composition analyses agreed with that detennined by SDS-PAGE. Other high MW fonns of 
thioredoxin have been identified in plant species (Jacquot et al., 1978}, unicellular green algae 
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Scenedesmus obliquus (Langlotz et al., 1986) and cyanobacterium Anabaena PCC7119 
(Whittaker & Gleason, 1984). 
1.2.9 Thioredoxins of Fungi 
Penicilliwn chrysogenwn is a fungus that produces penicillins which are sulfur-containing ~­
lactam compounds. As inS. clavuligerus, thioredoxin and thioredoxin reductase are responsible 
for the redox state of isopenicillin-N-synthetase (a key enzyme in the biosynthetic pathway of~­
lactam compounds) and its tripeptide ACV. The P. chrysogenwn thioredoxin was found to be a 
heat-stable 12 .kDa protein that showed strongest homology to the thioredoxins of Aspergillus 
niger (59.6% identity; Le Marechal et al., 1992) and Saccharomyces cerevisiae (53% identity; 
Gan, 1991). It contained the active site sequence -W-C-G-P-C- as well as several other highly 
conserved residues common to most thioredoxins. The trxA gene consisted of 2 exons and 1 
intron (Cohen et al., 1994). At present little is known about the regulatory mechanisms 
operating on the thioredoxin-thioredoxin reductase system and less about their involvement in 
the synthesis of antibiotics. Analysis of the roles of the glutathione and thioredoxin systems in 
penicillin production in P. chrysogenwn and their regulation is required. 
A thioredoxin that showed maximum identity (45%) to that of yeast and minimum identity to 
the spinach thioredoxin m, was isolated from a filamentous fungus, Aspergillus nidulans (Le 
Marechal et al., 1992). The authors' results indicated that the A. nidulans thioredoxin belonged 
to the "h" type of thioredoxins, which are more eukaryotic-like. It exhibited an unusual 
fluorescence emission spectrum, characterized by a high number of Tyr residues. However, no 
fluorescence peak at 340nm, corresponding to a Trp residue was observed, as A. nidulans 
thioredoxin only contained one Trp residue and this was quenched by the disulfide bridge. The 
amino acid corresponding to Trp-28 of E. coli thioredoxin was a Phe residue in A. nidulans. 
The amino acid sequence contained the characteristic disulfide active site and some well-
conserved amino acids; Pro-40, Pro-76, Lys-82 and Gly-92 (E. coli numbering). A third 
cysteinyl residue was present close to the active site. Such a thiol could form disulfide 
intermolecular bonds, as reported for Dictyosteliwn discoidewn thioredoxin (Wetterauer et al., 
1992). The thioredoxin from A. nidulans could not serve as a substrate for E. coli thioredoxin 
reductase, nor could it activate fructose-1,6-bisphosphatase, but it could activate com NADP-
malate dehydrogenase. 
eDNA clones for three different thioredoxins have been isolated from D. discoidewn and 
multiple genes were identified on cross-hybridisation of eDNA with oligonucleotide probes 
(Wetterauer et al., 1992). The three different D. discoidewn thioredoxins showed 80% mutual 
identity. D. discoidewn is a cellular slime mould and its life cycle can be divided into two 
phases, a vegetative growth phase and a developmental phase. The expression of the mRNA 
coding for the three thioredoxins was coregulated during development and maximal mRNA 
levels were seen in the phase of the life cycle when growth was arrested. This is of interest as 
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many of the known functions of thioredoxin, for example ribonucleotide reduction or sulfur 
assimilation are linked to growth. Since the expression of D. discoidewn thioredoxin does not 
fit this pattern the authors decided to compare the enzymatic capacity of the D. discoideum . 
thioredoxin to other thioredoxins that have been studied (Wetterauer eta/., 1992). 
The D. discoidewn thioredoxin TRX 1 was found to be most similar to the cytoplasmic 
vertebrate thioredoxin (43% identity), whilst it was equally distant (30% identity) from E. coli, 
yeast and chloroplast f and m thioredoxins. The protein was found to be heat stable, like other 
thioredoxins but on a reverse-phase HPLC column, irrespective of its redox state, TRX1 
separated into two peaks. This was unlike E. coli TRX which migrated as a homogeneous 
sample. The authors proposed that this was due to an additional cysteine residue at the N-
terminus. The D. discoidewn TRX1 was unable to substitute for E. coli TRX during 
filamentous phage assembly and was found to be a 100-fold less reactive with the E. coli 
thioredoxin reductase than the E. coli TRX. However, it was highly reactive with insulin, 
chloroplast NADPH-malate dehydrogenase and fructose-1,6-bisphosphatase (FBP-ase). This is 
unusual as apart from chloroplast thioredoxin f, most thioredoxins interact poorly with FBP-ase. 
A comparison of amino acid sequences of D. discoideum thioredoxin, thioredoxin f and human 
thioredoxin, revealed that most changes between D. discoidewn thioredoxin and human · 
thioredoxin occurred in the C-terminal region, rendering the human thioredoxin more basic. 
The discovery that conversion of Asp-61 to Asn increased the reactivity of E. coli thioredoxin 
with FBP-ase supported the theory that more acidic residues are important for interaction with 
FBP-ase (de Lamotte-Guery eta/., '1991). Thus D. discoidewn thioredoxin appeared to be a 
promiscuous protein, reacting with a variety of substrates and reductants, and it was not possible 
to group it with human cytoplasmic thioredoxin or E. coli thioredoxin (Wetterauer eta/., 1992). 
1.2.10 Thioredoxins of Yeast 
Characterization of thioredoxin deletion mutants of Saccharomyces cerevisiae (Muller, 1991) 
revealed that the two thioredoxin genes, TRXJ and TRX2, were interchangeable and loss of 
either one alone had no effect on cell growth. However, deletion of both thioredoxin genes 
prolonged S phase, the period of DNA synthesis, by 3-fold and lead to a 33% increase in cell 
generation time. Since thioredoxin is a hydrogen donor for ribonucleotide synthesis (Laurent et 
al., 1964), the inhibition of DNA synthesis was predicted to be caused by a reduction in the 
deoxyribonucleotide pools. However, the levels of dNTPs were either unchanged or slightly · 
greater in the thioredoxin mutant (Muller, 1994). Thioredoxin mutants C30S and C33S were 
also unable to sustain normal rates of DNA synthesis, indicating that the redox capacity of 
thioredoxin was required for DNA synthesis (Muller, 1995). Muller proposed two alternative 
models incorporating these results. · In one model it was suggested that thioredoxin reduces a 
multiprotein complex channeling nucleotides to the replication apparatus. In the second model 
it was proposed that thioredoxin regulates the tempo of DNA replication directly by activation 
of a component of the replication machinery. 
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A 25 kDa antioxidant enzyme that provided protection against oxidation systems capable of 
generating reactive oxygen and sulfur species was identified in yeast (Kim eta/., 1989) and rat 
brain (Kim et a/., 1988). The antioxidant enzyme was later shown to be a peroxidase that 
reduced hydrogen peroxide and alkyl hydroperoxides with the use of hydrogens provided by 
thioredoxin, thioredoxin reductase and NADPH (Chae eta/., 1994). The antioxidant enzyme 
was therefore named thioredoxin peroxidase. Thioredoxin peroxidase existed as a dimer of 
identical 25 kDa subunits that contained two cysteine residues, Cys-47 and Cys-170. Reduced 
Cys-47 appeared to be the site of oxidation by peroxides, and the oxidized Cys-47 probably 
reacted with reduced Cys-170 of the other subunit to fonn an intennolecular disulfide. Mutants 
lacking either Cys residue did not exhibit thioredoxin-coupled peroxidase activity. 
1.2.11 Thioredoxin in Plants and Cyanobacteria 
In plants light acts as a switch, changing metabolism from oxidative in the dark to 
photosynthetic in the light by modulating the catalytic activity of selective enzymes of 
degradative and biosynthetic pathways. Thioredoxin mediates the activation of some of these 
enzymes (Wolosuik & Buchanan, 1977). In the light, electrons are transferred from chlorophyll 
to ferredoxin (F d)• a strongly reducing iron-sulfur protein. and then via the enzyme ferredoxin-
thioredoxin reductase to thioroooxin. Reduced thioredoxin can activate many enzymes. These 
include FBP-ase (Schtirmann et al .• 1981). sedoheptulose-1,7-bisphosphatase (Nishizawa & 
Buchanan. 1981). NADP-malate dehydrogenase. phenylalanine ammonia lyase. ribulose 
bisphosphate carboxylase. and NADPH-glyceraldehyde-3-phosphate dehydrogenase and 
phosphoribulokinase of the pentose phosphate pathway (Jacquot et al.. 1978). The 
cyanobacteria are the simplest organisms with an oxygen-evolving photosynthetic system like 
that of plants. As in eukaryotic algae and higher plants. these prokaryotes contain chlorophyll a 
and use water as a source of electrons for photosynthetic electron transport. and are able to fix 
carbon dioxide via the Calvin cycle with ribulose-1.5-bisphosphate carboxylase serving as the 
key carboxylating enzyme. 
In plant chloroplasts and cyanobacteria there appear to be two types of thioredoxins. Those 
capable of activating fructose-! ,6-bisphosphatase and certain other key enzymes of carbon 
dioxide assimilation are called f-type thioredoxins, while those preferentially activating NADP-
dependent malate dehydrogenase are termed m-type thioredoxins. Unlike cyanobacteria, 
thioredoxins f and m of plants appeared to have signal peptides that allowed import into 
chloroplasts (Kamo et a/., 1989; Wedel et a/., 1992). A third type of thioredoxin which was 
found in the cytoplasm of plants but not cyanobacteria and which was specifically reduced by a 
NADP/thioredoxin system was called the h-type thioredoxin (Florencio eta/., 1988). 
The type-f thioredoxins appear to be highly divergent in activity and amino acid sequence. 
unlike most thioredoxins which are highly conserved. Their only similarity appears to be the 
ability to activate fructose-1,6-bisphosphatase. Comparison of numerous thioredoxin amino 
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acid sequences showed that apart from the conserved active site thioredoxin f of plants was not 
very similar to other thioredoxins (Hodges et al., 1994). This was shown directly by the fact 
that pea thioredoxin f antibodies did not recognise any of the other thioredoxins tested (Hodges 
et al., 1994). Similarly antibodies to T-2 thioredoxin of Anabaena PCC 7120 (f-type 
thioredoxin) did not cross react with Anabaena PCC 7120 T-1, E. coli or spinach m 
thioredoxins, but did react with T4 phage, Synechocystis sp. strain 6803 and Synechococcus sp. 
strain R2 thioredoxins (Gleason, 1992). Thioredoxin T f from Anabaena PCC 7119 was found 
to have a molecular weight of 25 kpa, which is much higher than most other thioredoxins. In 
addition it was not a general protein disulfide reductase and could not act as a reductant for 
ribonuleotide reductase (Whittaker & Gleason, 1984). However, thioredoxin T-2 of Anabaena 
PCC 7120 was able to reduce both E. coli and Anabaena ribonucleotide reductases and insulin 
(Alam et al., 1989). T-2 could also be reduced by glutathione, like the glutaredoxins (Gleason, 
1992). The T-2 thioredoxin gene did not complement the TrxA mutation in E. coli (Alam et al., 
1989). Transformed E. coli cells were not able to use methionine sulfoxide as a methionine 
source or support replication of T7 phage or the filamentous phages. 
Thioredoxin m of plants and cyanobacteria and thioredoxin Ch-2 of Chlamydomonas reinhardtii 
had considerable sequence homology and shared a similar spectrum of activities with the E. coli 
thioredoxin (Tsugita et al., 1983; Yee et al., 1981; Gleason & Holmgren, 1981; Alam et al., 
1989; Gleason, 1992; Decottignies et al., 1990). Thioredoxin T-1 of Anabaena PCC 7120 (m-
type thioredoxin) was found to be essential for photosynthetic growth (Muller & Buchanan, 
1989). Thioredoxin T m of Anabaena PCC 7119 complemented the E. coli TrxA- phenotype in 
every respect except T7 phage replication (Lim et al., 1986). In plants NADP-malate 
dehydrogenase undergoes reductive activation in the light This process was mediated by 
thioredoxin and involved the reduction of a N-terminal and a C-terminal disulfide (lssakidis et 
al., 1992). Spinach thioredoxin m could exist as one of two very similar isomers mb and me; 
the only difference was an additional N-terminallysine residue in mb (Schtirmann et al., 1981). 
Both Synechococcus and Anabaena cylindrica have also been found to contain two thioredoxin 
species. Immunocytochemical techniques indicated the presence of one thioredoxin species 
predominantly in the nucleoplasm and a second species in the vicinity of the thylakoid 
membranes (chromatoplasm) of vegetative cells of A. cylindrica (Cossar et al., 1985). A 
thioredoxin of MW 11.68 kDa and high sequence similarity to the m-type thioredoxins had 
previously been isolated from A. cylindrica (lp et al., 1984). The cyanobacteria, therefore, seem . 
to resemble chloroplasts in containing more than one species of thioredoxin. Thus, it appears 
that most photosynthetic organisms contain two dissimilar thioredoxins, suggesting that the 
unusual thioredoxin (f-type) plays a specific role in photoautotrophic metabolism (Gleason, 
1992). 
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The other thioredoxin system (thioredoxin h) found in plants, the NADP/thioredoxin reductase 
system, was found in the mitochondria, endoplasmic reticulum and cytosol (Kobrehel et al., 
1992). The seed was the only tissue for which thioredoxin h has been ascribed physiological 
activity. Thioredoxin h reduced members of several different soluble seed proteins; thionins, a-
amylase and trypsin inhibitors (Johnsori eta/., 1987; Kobrehel eta/., 1991). It also reductively 
activated PPi fructose-6-P,1-phosphotransferase (PFP) an enzyme of the carbohydrate 
metabolism (Kiss eta/., 1991). Thioredoxin his thought to function as a signal in germination 
to enhance metabolic processes, such as the mobilization of storage proteins and activation of 
enzymes (Kobrehel eta/., 1992). Recently thioredoxin h was found to be one of the major 
proteins in rice phloem sap (Ishiwatari et a/., 1995). The authors proposed that the thioredoxin 
identified in this study may participate in maintenance of the sieve-tube proteins, such as 
A TPases, carriers, and transporters. Immunoblotting and Southern hybridization analysis 
suggested that rice plants contain another form of thioredoxin h as well as the cloned 
thioredoxin. A cytosolic h-type thioredoxin (Ch1) was also isolated from C. reinhardtii (Stein 
et a/., 1995) and two forms of thioredoxin h have been identified in spinach and tobacco 
(Florencio eta/., 1988; Brugidou eta/., 1993). 
1.2.12 Thioredoxin in Mammalian cells 
Thioredoxin has been purified from rats (Luthman & Holmgren, 1982), calves (Engstrom eta/., 
1974), rabbits (Hopper & Iurlano, 1983) and humans (Wollman et a/., 1988). All these 
mammalian cells appeared to contain a classical thioredoxin system with one thioredoxin and a 
NADPH-thioredoxin reductase. The thioredoxins had a molecular weight of approximately 12 
k.Da and the same highly conserved thioredoxin active site as E. coli. They were also able to 
reduce E. coli ribonucleotide reductase and, apart from rabbit bone marrow thioredoxin, their 
own ribonucleotide reductases. Mammalian thioredoxins had, in addition to the active site 
disulfide, two additional structural half-cysteine residues in the C-terminal half of the molecule 
(Ren eta/., 1993). Mutation of the half-cysteinyl residues to serine indicated that Cys-72 was 
critical for the potential regulation of activity of thioredoxin via the formation of intra- or 
intermolecular disulfides, which caused aggregation or dimerization and inactivation of 
thioredoxin (Wollman eta/., 1988). High levels of thioredoxin mRNA were detected in actively 
dividing cell lines, but very low levels were found in resting cells. The coding region of human 
thioredoxin spanned over 13 kb and was organised into five exons separated by four introns. 
The transcription start point, located 22 base pairs downstream of a TA TA box, defined a 5' 
untranslated region of 74 base pairs (Kaghad et a/., 1994). The promoter contained many 
possible regulatory elements compatible with both basal, constitutive expression and regulated, 
inducible expression, especially by cytokines such as interleukin-6 and interferons. Using 
Southern hybridization only one active gene encoding human thioredoxin was detected (Kaghad 
eta/., 1994). 
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Antisera prepared against pure rat liver thioredoxin and thioredoxin reductase, were used in 
immunohistochemical studies of adult rats to show that these two proteins to be widely 
distributed in tissues and organs (Rozell eta/., 1985). However, variations were seen between 
cell types; epithelial cells, neuronal cells and secretory cells (exocrine and endocrine) showed 
high immunoreactivity whereas mesenchymal cells showed low activity. Surface epithelial cells 
and keratinizing cells showed high activity. Thioredoxin was localised in the cytoplasm of cells 
with higher levels in the plasma membrane or subplasma membrane zone (Rozell et a/., 1985). 
High levels of thioredoxin and thioredoxin reductase were found in the endoplasmic reticulum 
which was consistent with its func.tion in protein processing, secretion and the formation of 
nascent protein disulfides (Rozell eta/., 1988). 
Thioredoxin was found to be secreted by normal and transformed cells despite its lack of a 
signal sequence (Rubartelli et a/., 1992). It was not secreted by the normal endoplasmic 
reticulum-Golgi route, but shared several features with the alternative pathway described for 
interleukin-1 b, such as the slow kinetics of secretion, the enhancing effect on secretion of 
several unrelated drugs and the sensitivity to methylamine (Rubartelli eta/., 1992). 
However, not all cells that synthesized thioredoxin secreted it, even within the same lineage. 
Whether this was due to some form of regulation or the absence of some components of 
machinery for secretion was not known (Rubartelli eta/., 1992). 
Thioredoxin has been found to regenerate proteins inactivated by oxidative stress in endothelial 
cells (Fernando et a/., 1992). Bjt>mstedt et a/. (1994), found that NADPH, thioredoxin 
reductase and thioredoxin were efficient electron donors for human plasma peroxidase. Human 
plasma glutathione peroxidase is a member of the selenium-dependent peroxidases, which are 
usually very specific for glutathione as an electron donor. However, the plasma level of 
glutathione is very low, suggesting that the peroxidase is dependent on other electron donors. 
Glutaredoxin was also able to act as an electron donor for the peroxidase. 
A soluble growth factor isolated from the supernatants of certain leukemic T cells, named acute 
T cell leukemia-derived growth factor (Tagaya et a/., 1989), and a factor which seemed to 
promote the growth of Epstein-Barr virus-immortalized lymphocytes (Wakasugi eta/., 1990), 
was shown to be identical to human thioredoxin (Wollman et aJ., 1988). This factor has been 
shown to up-regulate the expression of the IL-2 receptor and might be involved in autocrine 
control of certain transformed T and B cells (Rubartelli et al., 1992). Later Biguet et al. ( 1994 ), . 
discovered that thioredoxin increased the proliferation of a B-cell line via the activation of 
protein kinase C through its translocation to the membrane. The authors suggested that 
enhanced phosphoinositide-specific phospholipase C activity induced by the dithiol form of 
thioredoxin was associated with protein kinase activation, and thus played a role in the 
permanent growth of Epstein-Barr virus-infected B cells. 
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Human thioredoxin was also found to be capable of stimulating cellular proliferation and DNA 
synthesis of murine fibroblasts (Oblong et al., 1994). The mitogenic effect of thioredoxin was 
dependent on the active site or structural features of thioredoxin imparted by the active site 
cysteines since mutants C32S, C35S and C32S/C35S were not able to stimulate cell 
proliferation. The ability of thioredoxin to stimulate cellular proliferation could not be 
duplicated by either dithiothreitol or glutathione (Oblong et al., 1994). Added I 125_thioredoxin 
was taken up by cells in culture and therefore could have an intracellular action (Powis et al., 
1994 ). In addition, competitive inhibitors of thioredoxin reductase were shown to inhibit 
thioredoxin-dependent cell proliferation, supporting the theory that thioredoxin can stimulate 
proliferation of a variety of normal and tumor cell lines (Powis eta/., 1994). 
Another function of thioredoxin and ~hioredoxin reductase is the redox regulation of gene 
expression through the interaction with transcription factors. For example thioredoxin was 
proposed to stimulate DNA-binding of transcription factor NF-KB, by reduction of a disulfide 
bond involving the cysteine 62 residue of the p50 subunit of NF-KB (Matthews et al., 1992). 
Similar observations of redox control by thioredoxin have been made with the transcription 
factors TFIIIC (Cromlish & Roeder, 1989), BZLF (Bannister eta/., 1991) and AP-1 (Abate et 
al., 1990). 
Similarly thioredoxin is involved in the activation of glucocorticoid receptor to a steroid binding 
state (Grippo et al., 1985), and in the activation of rat brain cytosolic 3,5,3'-triiodo-L-thyronine-
binding protein (CCTBP) (Lennon, 1992). Thyroid hormones regulate a number of biological 
responses through the binding of CCTBP to a nuclear protein acceptor and subsequent 
transcriptional regulation of target genes (Oppenheimer & Samuels, 1986). 
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Thioredoxin derived from activated macrophages was found to be a potent neurotrophic factor 
for central cholinergic neurons (Endoh et al., 1993). 
Loss of sensitivity to growth inhibitory polypeptides is thought to be one of the events that leads 
to tumor formation and might be caused by inactivation or loss of genetic elements that 
transduce the extracellular signals (Deiss & Kimchi, 1991 ). One of these genetic elements was 
isolated by random inactivation of genes with an anti-sense complementary DNA expression 
library followed by direct selection for growth in the presence of an inhibitory peptide. Thus a 
gene whose inactivation conveyed growth resistance to interferon-y was isolated. Sequence 
analysis showed this factor, implicated in the interferon-y-mediated growth arrest of HeLa cells, 
to be thioredoxin (Deiss & Kimchi, 1991 ). Both normal liver cells and hepatocarcinoma cell 
line HepG2 synthesize thioredoxin. Only the former, however, secrete abundant thioredoxin 
extracellularly. Under mild reducing conditions, HepG2 cells but not normal hepatocytes 
increased the rate of thioredoxin secretion and underwent growth inhibition accompanied by 
morphological changes (Rubartelli et a/., 1995). Recombinant thioredoxin was also found to 
36 
inhibit proliferation of HepG2 cells. This was in contrast to the previous examples of 
thioredoxin stimulating proliferation of leukemic T -cells, Epstein Barr virus lymphocyctes and 
murine fibroblasts, indicating that different cell types respond differently to variations in the 
extracellular redox potential (Rubartelli eta/., 1995). 
Thioredoxin has been identified as the key component of the early pregnancy factor system. A 
system of components present in pregnancy sera which express a lymphocyte modifying activity 
in an assay known as the rosette inhibition assay (Tonissen eta/., 1993). Conversion of the two 
active site cysteine residues (Cys-32 and Cys-35) to serine, results in a protein devoid of · 
classical redox activity; however this protein was still able to express lymphocyte modifying 
activity in the rosette inhibition assay. Further study revealed that lymphocyte modifying 
activity was solely dependent on Cys-74 of thioredoxin. 
1.3 Glutathione 
This ubiquitous tripeptide (y-Glutamyl-L-cysteinylglycine), usually the most prevalent 
intracellular thiol, plays a pivotal role in the control of redox status, the storage of reduced 
sulfur and cysteine, the reduction of protein thiol groups, the synthesis of DNA, and the removal 
of reactive oxygen species and free radicals (Meister, 1983; Arrick et al., 1982; Williamson et 
a/., 1982). In E. coli 25% of the sulfur is found in glutathione (Kosower, E. M. & Kosower, N. 
S., 1969). 
Biosynthesis of glutathione takes place in two steps. In the first step the enzyme y-
glutamylcysteine synthetase, catalyzes the formation of y-glutamylcysteine from glutamate and · 
L-cysteine. In the second step, glycine is added to yield glutathione; this reaction is catalyzed 
by glutathione synthetase. Both reactions require ATP. The first reaction is usually the rate-
limiting step in glutathione synthesis, and is feed-back inhibited by glutathione. 
L-Glu + L-Cys + ATP ~ L-y-Glu-L-Cys + ADP +Pi 
L-"(-Glu-L-Cys + Gly + A TP ~ L-y-Glu-L-Cys-Gly + ADP + Pi 
Much less is known about glutathione metabolism in bacteria and plants than in mammalian 
systems. Observations on human diseases associated with glutathione deficiency indicated that 
glutathione was essential for normal health (Meister & Anderson, 1983). However, a number of 
bacteria, including certain anaerobes, do not contain glutathione (Fahey et a/., 1978), and at 
least one organism (E. coli) does not require glutathione for growth. The metabolism of 
glutathione in mammalian cells has been studied extensively. I shall therefore give an overview 
of the metabolism of glutathione in mammalian cells. 
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1.3.1 Metabolism of glutathione in mammalian cells 
Meister & Anderson (1983) summarized glutathione metabolism in mammals in the cycle 
shown in Fig. 1.2. Glutathione is synthesized intracellularly by the consecutive actions of y-
glutamylcysteine synthetase (Reaction 1) and glutathione synthetase (Reaction 2). The 
breakdown of glutathione (and also of oxidized glutathione and S-substituted glutathione) is 
catalyzed by y-glutamyl transpeptidase, which catalyzes transfer of the y-glutamyl moiety to 
acceptors - amino acids (cysteine, glutamine and methionine), certain dipeptides, water and 
glutathione itself- (Reaction 3). Glutathione occurs mainly intracellularly and a major fraction 
of the transpeptidase is on the external surface of the cell membrane. Glutathione transported 
across cell membranes interacts with y-glutamyl transpeptidase. y-Glutamyl amino acids 
formed by y-glutamyl transpeptidase are transported into cells. Intracellular y-glutamyl amino 
acids are substrates of y-glutamyl cyclotransferase (Reaction 4), which converts these 
compounds into the corresponding amino acids and 5-oxo-L-proline. The A TP-dependent 
conversion of 5-oxo-L-proline to L-glutamate is catalyzed by the intracellular enzyme 5-oxo-
prolinase (Reaction 5). The cysteinylglycine formed in the transpeptidase reaction is split by 
dipeptidase (Reaction 6). These six reactions constitute the y-glutamyl cycle, which thus 
accounts for the synthesis and degradation of glutathione. Two enzymes of the cycle also 
function in the metabolism of S-substituted glutathione derivatives, which may be formed non-
enzymatically by reaction of glutathione with certain electrophilic compounds or by glutathione 
S-transferases (Reaction 7). The y-glutamyl moiety of such conjugates is removed by the action 
of y-glutamyl transpeptidase (Reaction 3), a reaction facilitated by y-glutamyl amino acid 
formation. The resulting S-substituted cysteinylglycines are cleaved by dipeptidase (Reaction 
6a) to yield the corresponding S-substituted cysteines, which may undergo N-acylation 
(Reaction 8) or an additional transpeptidation reaction to form the corresponding y-glutamyl 
derivative (Reaction 3a). 
Intracellular glutathione is converted to oxidized glutathione by selenium-containing glutathione 
peroxidase, which catalyzes the reduction of H202 and other peroxides (Reaction 9); there is 
evidence that certain glutathione S-transferases can also catalyze such reactions. Glutathione is 
also converted to oxidized glutathione by transhydrogenation (Reaction 10). Reduction of 
glutathione to oxidized glutathione is mediated by the widely distributed enzyme oxidized 
glutathione reductase which uses NAD.PH (Reaction 11). Extracellular conversion of GSH to 
GSSG has also been reported; the overall reaction requires 0 2 and leads to the formation of 
H202 (Reaction 12). GSSGis also formed by the reaction of GSH with free radicals. 
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Fig. 1.2 Summary of glutathione metabolism in mammals. 
1.3.2 Some functions of glutathione 
As indicated in the above section glutathione is involved in the transport of amino acids, . 
especially cysteine (via y-glutamyl transpeptidase). The activities of many enzymes are 
influenced by glutathione and by other thiols (e.g. thioredoxin), and glutathione may therefore 
be involved in the regulation of these enzymes. There are also several reactions in which 
glutathione participates as a coenzyme. 
Characterization of viable mutants of E. coli lacking thioredoxin, resulted in the discovery of 
glutaredoxin and glutathione as a hydrogen donor for NADPH-dependent ribonucleotide 
reduction (Holmgren, 1979). In this mutant glutaredoxin, glutathione and glutathione reductase 
functioned in the reduction of ribonucleotide reductase (Holmgren, 1976). In addition to 
ribonucleotide reduction, glutaredoxin also catalyzed the glutathione-dependent reduction of 
small disulfide containing compounds like hydroxyethyl disulfide (HED); i.e. it exhibits 
glutathione disulfide transhydrogenase activity (Holmgren, 1979). As discussed above 
thioredoxin and/or glutaredoxin have been assumed to be required as hydrogen donors for 
ribonucleotide reductase which is essential for DNA synthesis, yet an E. coli double mutant 
lacking thioredoxin and glutaredoxin (Grxl) could be constructed (Russel eta/., 1990). This . 
implied the presence of a third hydrogen donor. Aslund eta/. (1994), reponed the purification 
of two proteins (Grx2 and Grx3), with glutaredoxin activity from an E. coli mutant lacking Trx 
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and Grxl. Their evidence indicated that Grx3 is likely to substitute for Trx and Grxl in the 
double mutant. 
Glutathione has been proposed to protect cells from oxidative damage and ionizing radiation 
(Meister & Anderson, 1983). Studies have shown that cells can maintain and even increase 
cellular glutathione content in response to sublethal oxidative stress. Shi eta/. (1994) were able 
to show that quinone-induced oxidative stress increased the rate of transcription of the gene for 
y-glutamylcysteine synthetase in rat lung cells. Induction of the y-glutamylcysteine synthetase 
heavy subunit gene transcription in rat cells did not appear to require an electrophile-glutathione 
conjugate. as 2,3-dimethoxy-1,4-naphthoquinone (DMNQ) was able to induce y-
glutamylcysteine synthetase transcription, but unlike simpler quinones, could not form a 
glutathione conjugate (Shi et a/., 1994). More recently Mulcahy & Gipp (1995). identified a 
possible antioxidant response element (ARE) in the 5'-flanking region of the human y-
glutamylcysteine synthetase heavy subunit gene, suggesting that y-glutamylcysteine synthetase 
expression in human cells may be reg.ulated in response to oxidative challenge via an ARE. 
Depletion of cellular glutathione or inhibition of y-glutamylcysteine synthetase enhanced the 
sensitivity of S. cerevisiae to hydrogen peroxide, suggesting that glutathione plays an important 
role in the adaptive response of S. cerevisiae to oxidative damage (lzawa et a/., 1995). 
Glutathione synthesis and the transport of glutathione metabolites also seemed to be responsive 
to heat shock (Kondo eta/., 1993), indicating that glutathione may play a role in the defense 
system of cells against several different stresses. 
In humans, glutathione peroxidases catalyze the glutathione-dependent reduction of HP2> and 
are important enzymes in the detoxification of hydrogen peroxide, lipid peroxides and organic 
hydroperoxides (Bjt>mstedt et al., 1994). However, human plasma glutathione peroxidase uses 
extracellular thioredoxin reductase, thioredoxin or glutaredoxin as reductants rather than 
glutathione, as plasma levels of glutathione are very low (Bjt>mstedt eta/., 1994). 
Conflicting results have been obtained as to whether glutathione protects E. coli cells from 
oxidative damage or not. Greenberg et. a/. (1986) showed that E. coli deficient in glutathione 
had normal resistance to H20 2, cumene hydroperoxide, heat and ionizing radiation. However, 
this E. coli gshA mutant was hypersensitive to thiol-specific reagents and highly resistant to 
toxic agents thought to require thiols for their activation. This data indicated that glutathione 
may not protect E. coli from oxidative damage. In contrast. an E. coli gshA mutant was found to 
be sensitive to 8-hydroxyquinoline, unless glutathione was provided in the media or the mutant 
was transformed with a y-glutamylcysteine synthetase gene able to complement the gshA 
mutation (May & Leaver. 1994). E. coli apparently lacks the enzyme glutathione peroxidase, 
which catalyzes the reduction of hydrogen peroxide and other peroxides (Smith & Schriff, 
1979). 
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The role of glutathione in the prevention of oxygen toxicity is closely related to phenomena 
associated with highly reactive oxygen species formed as a result of radiation. There are 
indications that diminished levels of glutathione render mammalian cells more sensitive to 
radiation (Bump et al., 1982; Edgren et al., 1981). However, in other experiments glutathione 
depletion had no effect on mammalian cells (Clark et al., 1984). A strain of E. coli enriched in 
its content of y-glutamylcysteine synthetase and glutathione synthetase activities by DNA 
recombination techniques was found to be more resistant to the lethal effects of gamma-
radiation than the corresponding wild type strain (Moore et al., 1989). The observed 
radioresistance appeared to be associated with the increased capacity of the gene-enriched E . . 
coli strain to synthesize glutathione, rather than the actual cellular levels of glutathione, as 
buthionine sulfoximine (an inhibitor of y-glutamylcysteine synthetase) abolished resistance, 
although glutathione levels remained constant. 
Reduction of glutathione concentrations can sensitize drug-resistant tumour cells in vivo as well 
as in vitro, suggesting that elevated levels of glutathione may play a prominent role in drug 
resistant phenotypes (Suzukake et al., 1982; Ono et al., 1986; Ozols et al., 1987). One of the 
most common biochemical changes detected in tumor cells resistant to the cytotoxic effects of 
alkylating or platinating agents or anthracyclines, such as doxorubicin, was a significant 
increase in the intracellular concentration of glutathione (Wolf et al., 1987). In yeast, the yAP-1 
transcriptional regulatory protein, has been found to cause profound alterations in cellular drug 
and metal resistance. The y-glutamylcysteine synthetase gene of yeast appears to be one of 
several genes that are transcriptionally regulated by yAP-1 and influence drug resistance (Wu & 
Moye-Rowley, 1994). Tumor cells depleted of glutathione by treatment with buthionine 
sulfoximine also exhibited increased susceptibility to cytolysis by reactive oxygen intermediates · 
(Arrick et al., 1982). These findings indicated, as suggested by Griffith & Meister (1979), that 
buthionine sulfoximine, because it inhibits y-glutamylcysteine synthetase, may be an important 
adjuvant in a wide range of chemo- and radiation therapies (Meister & Anderson, 1983). 
Administration of certain carcinogens increases the levels of glutathione and of y-glutamyl 
transpeptidase. Most chemical carcinogens are electrophiles and thus good candidates for 
detoxification by reactions catalyzed by glutathione-S-transferases. A substantial regression of 
aflatoxin-induced liver tumors in rats treated with large oral doses of glutathione, was noted by 
Novi (1981). Trypanosomes which lack catalase and have high intracellular HP2 levels, are 
more susceptible to the effects of glutathione depletion than are most cells. Treatment of mice 
infected with trypanosomes with buthionine sulfoximine, which inhibits glutathione synthesis, 
led to prolonged survival of the mice, indicating death of the trypanosomes (Arrick et al., 1981). 
These studies have provided significant evidence for the proposed functions of glutathione in 
destroying free radicals, and in the reduction of reactive oxygen intermediates. 
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Glutathione-S-transferases catalyze the nucleophilic conjugation of glutathione with a very large 
number and variety of foreign compounds to form glutathione conjugates (Habig, et al., 1974). 
Initial degradation of the glutathione conjugate proceeds via y-glutamyltranspeptidase to the 
cysteinylglycine conjugate and then is hydrolysed by a carboxypeptidase to the cysteine 
conjugate (Zablotowicz et al., 1995). Glutathione conjugation is a major mechanism of 
detoxification in mammals (Habig et al., 1974) and is involved in detoxification of at least six 
major herbicides in plants (Lamoureux & Rusness, 1989). It is postulated that glutathione 
transferase also plays a role in the detoxification of xenobiotics in rhizosphere bacteria 
(Zablotowicz et al., 1995). A cruci~l role for glutathione has thus been proposed in the 
detoxification of air pollutants such as sulfur dioxide and ozone (Sen-Gupta et al., 1991), in the 
removal of xenobiotics such as herbicides (Zablotowicz et al., 1995) and heavy metals (Jackson 
et al., 1987), and in the adaptation of plants to drought (Dhindsa & Matowe, 1981) and extremes 
of temperature (Nieto-Sotelo & Ho, 1986). 
The metabolism of glutathione in plant and bacteria has not been studied as extensively as in 
mammalian systems. However, various functions of glutathione in plants and bacteria have 
been identified. Interestingly both microorganisms and plants (Meister, 1980; Rennenberg, 
1982) seem to expon glutathione, at least in a few instances thus far studied. As stated above, 
glutathione-S-transferase activity was identified in 36 species of rhizosphere bacteria in 
detoxification of xenobiotics (Zablotowicz et al., 1995). E. coli accumulates the novel 
compound glutathionyl-spermidine (Tabor & Tabor, 1972), and homoglutathione (y-glutamyl-
cysteinyl-(3-alanine) has been found in mung beans (Buchanan, 1983). Thioredoxin, and 
possibly glutathione, function in photosynthesis (Buchanan, 1983). Plants also contain 
glutathione S-transferases (Lamoureux. & Rusness, 1989). Thus, further investigation of the 
metabolism of glutathione in plants and bacteria may reveal further similarities to that of 
mammals. 
y-Glutamylcysteine and bis-y-glutamylcysteine reductase in halobacteria were found to function 
in an analagous fashion to glutathione and glutathione reductase in other cells (Sundquist & 
Fahey, 1989). All species of halobacteria examined produced millimolar levels of y-
glutamylcysteine, whilst glutathione was not detected. Under halophilic conditions, y-
glutamylcysteine is as least as stable as glutathione, which may indicate why halobacteria are 
able to utilize y-glutamylcysteine rather than glutathione (Sundquist & Fahey, 1989). 
1.4 y-Glutamylcysteine synthetases from different organisms 
y-Glutamylcysteine synthetase has been purified from rat kidney (Orlowski & Meister, 1971), 
bovine lens (Wendel et al., 1972), human erythrocytes (Majerus et al., 1971), tobacco (Hell & 
Bergmann, 1990), Arabidopsis thaliana (May & Leaver, 1994), Candida biodinii (Dennda & 
Kula, 1986), Saccharomyces cerevisiae (Ohtake & Yabuuchi, 1991 ), Escherichia coli 
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(Apontoweil & Berends, 1975) and Proteus mirabilis (Kumagai et al., 1982). The different y-
glutamylcysteine synthetase enzymes vary widely in primary structure but all appear to follow 
the same reaction mechanism. 
1.4.1 Mammalian y-glutamylcysteine synthetases 
The enzyme purified from rat kidney has been studied the most and has 89% amino acid identity 
to that of humans. Rat kidney y-glutamylcysteine synthetase will be discussed as an example of 
mammalian y-glutamylcysteine synthetase. Rat kidney y-glutamylcysteine synthetase is 
composed of two subunits (~ 73 kDa and 27.7 kDa), which can be dissociated by native 
electrophoresis after treatment with DTT (Seelig et al., 1984). Partial reassociation occurs after 
DTT removal, suggesting that this phenomenon is associated with reformation of disulfide 
linkages between subunits. The heavy subunit exhibited all the structural requirements for 
enzyme activity and feedback inhibition by glutathione (Richman & Meister, 1975). The light 
subunit was recently shown to have a physiologically important regulatory function (Huang et 
al., 1993). The light chain also lowered the Km for glutathione and increased feedback 
inhibition by glutathione of the heavy catalytic subunit. Feedback inhibition by glutathione 
appeared to involve reduction of the enzyme (Huang et al., 1993). 
The acceptor amino acid specificity of the enzyme is rather broad, and it can interact with 
several glutamate analogs, including ~-aminoglutarate and a-aminomethylglutarate (Sekura & 
Meister, 1977). Evidence has also been obtained that y-methylene-D-glutamate, which . 
inactivates the enzyme, binds in the glutamate-binding site of the active center and forms a 
covalent linkage with the active site thiol through a Michael-type addition reaction (Simondsen 
& Meister, 1986). 
Feedback inhibition by glutathione was thought to be "non-allosteric" as inhibition by glutamate 
was competitive (Richman & Meister, 1975). However, only glutathione, and not y-glutamyl-a-
aminobutyrylglycine, inhibited y-glutamylcysteine synthetase. This suggested that glutathione 
binds not only at the glutamate binding site of the active center but also at another site that 
interacts with the thiol moiety of glutathione (Huang et al., 1988), as the thiol group of 
glutathione is replaced by a methyl group in y-glutamyl-a-aminobutrylglycine. 
y-Glutamylcysteine synthetase was strongly inactivated by cystamine. However, the 
inactivation could be reversed by treatment with DTT, suggesting that cystamine forms a mixed 
disulfide with an enzyme thiol (Seelig & Meister, 1984 ). Treatment of the enzyme with 
cystamine prevented interaction with the sulfoximines. Titration of the enzyme with 
5,5'dithiobis(2-nitrobenzoate) revealed that the enzyme had a single exposed thiol that reacted 
with this reagent without affecting activity (Seelig & Meister, 1982). Thus cystamine must 
interact with another enzyme thiol group. 
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y-Glutamylcysteine synthetase bound covalently to cystamine-Sepharose, an interaction that was 
facilitated by ATP and inhibited by Mg2+ plus glutamate (Seelig & Meister, 1982). A large 
fraction of the enzyme applied to such columns apparently bound by forming a disulfide bond 
between cystamine-Sepharose and a sulfhydryl group at or near the active site. The enzyme 
could be released by treatment with dithiothreitol. The enzyme did not bind to columns of S-(S-
methyl)cysteamine-Sepharose, but S-(S-methyl)cysteamine was a potent inhibitor of y-
glutamylcysteine synthetase. A cysteamine-S-disulfide moiety derived from the external 
cysteamine residue of cystamine-Sepharose, seemed to be the critical group recognized by the 
enzyme. Studies with a number of cystamine analogs supported this conclusion and led to the 
further conclusion that a disulfide (or.diselenide) moiety and a single free amino group are 
required for inhibition (Seelig & Meister, 1984). 
The enzyme was also inactivated by S-sulfocysteine and S-sulfohomocysteine; these 
inactivators were tightly but noncovalently bound and their interaction with the enzyme was 
postulated to involve effects of the active site thiol (Moore eta/., 1987). 
The heavy subunit was inactivated by incubation with L-2-amino-4-oxo-chloropentanoate. 
Studies with the 14C-labelled chloroketone showed that it bound stoichiometrically to the 
enzyme, and it bound exclusively to the heavy subunit (Sekura & Meister, 1977). Inhibition by 
the chloroketone was competitive with L-glutamate. Like cystamine the chloroketones are 
thought to interact with a thiol group at the active site. A low concentration of divalent metal 
ions was required for inhibition by the chloroketones. The authors suggested that a divalent ion 
such as Mg2+ may be involved in the binding or reaction, or both, of the chloroketone, and 
possibly also of the natural substrate, glutamate. It must be noted that while L-glutamate 
protected the enzyme against inactivation by the chloroketone, D-glutamate did not. Although 
the enzyme was inactivated by incubation with the less specific alkylating agent, iodoacetamide, 
higher concentrations of the latter reagent were required for inhibition and L-glutamate did not 
protect the enzyme against such inhibition as effectively as it did against the chloroketone 
(Sekura & Meister, 1977). 
Meister (1974) proposed that the reaction catalysed by y-glutamylcysteine synthetase proceeds 
via an enzyme-bound y-glutamylphosphate intermediate, which interacts with the amino group 
of cysteine. Kinetic investigations were consistent with this possibility, but did not demonstrate 
y-glutamyl phosphate as a discreet covalent complex (Yip & Rudolph, 1976). 
Methionine sulfoximine was an effective, irreversible inhibitor of y-glutamylcysteine synthetase 
and, in the presence of Mg2+ and ATP, was converted to methionine sulfoximine phosphate, 
which bound tightly to the enzyme (Richman et a/., 1973). Under certain conditions the 
methionine sulfoximine could be released with the restoration of catalytic activity. These 
findings are consistent with the formation of an enzyme-bound glutamyl phosphate 
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intermediate, since phosphorylation of methionine sulfoximine seems to reflect phosphorylation 
of glutamate in the normal reaction (Richman eta/., 1973). Buthionine sulfoximine was a more 
potent inhibitor of y-glutamylcysteine synthetase (Griffith & Meister, 1979), and was also 
phosphorylated at the active site of y-glutamylcysteine synthetase (Griffith, 1982). It is thought 
that the S-alkyl moiety of the sulfoximines binds at the enzyme site that normally binds the 
acceptor amino acid (Griffith & Meister, 1979). 
1.4.2 Yeast 
Dennda & Kula (1986), purified the y-glutamylcysteine synthetase enzyme from Candida 
boidinii. Their studies indicated that the yeast enzyme was very similar to the mammalian y-
glutamylcysteine synthetase. Both seem to be regulated by feedback inhibition. They exhibited 
similar temperature and pH optima and seemed to possess SH groups essential for maintenance 
of enzymatic activity, as reagents reacting with sulfhydryl groups such as N-ethylmaleimide 
(NEM), p-chloromercuribenzoate (PCMB) and iodoacetamide (IAA) had a strong inhibitory 
effect on the yeast enzyme. However, the mammalian enzyme was inactivated by treatment 
with DTE, while DTE was used in the extraction of the yeast enzyme and did not appear to 
affect the activity of the enzyme. The yeast enzyme also differed from the mammalian enzyme 
in the size of its subunits. The native yeast enzyme had a molecular weight of approximately 
124 kDa, and appeared to be composed of two 60 kDa subunits, whereas the mammalian 
enzyme was formed from 73 kDa and 27 kDa subunits. Therefore, -the main differences _ 
between the two enzymes appeared to be the sizes of the subunits and the effect of DTE on 
enzyme activity. 
The y-glutamylcysteine synthetase gene of Saccharomyces cerevisiae was cloned and 
sequenced. The deduced amino acid sequence was reported to have 45% identity to that of rat 
kidney and only 26% identity to that of E. coli (Ohtake & Yabuuchi, 1991). 
1.4.3 Plants 
1.4.3.1 Higher Plants 
y-Glutamylcysteine synthetase activity was analyzed from partially purified cell extracts of 
Nicotiana tabacum (Hell & Bergmann, 1990). The enzyme had a relative molecular mass of 60 
kDa and exhibited maximal activity at pH 8 and an absolute requirement for Mg2+. Treatment 
with DTE led to a heavy loss of activity and to dissociation into subunits (Mr 34 kDa). The 
enzyme was completely inhibited by glutathione and the inhibition was competitive with respect 
to L-glutamate. 
Buthionine sulfoximine and L-methionine sulfoximine were effective inhibitors of the plant 
enzyme, indicating that the reaction may proceed via a y-glutamylphosphate intermediate (Hell 
& Bergmann, 1990). 
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y-Glutamylcysteine synthetase activity was found both in the cytoplasm and the chloroplasts. 
Hell & Bergmann (1990) proposed that the rate of glutathione synthesis could be linked to light, 
from the following observations. When chloroplasts are illuminated the stroma pH is shifted 
from pH 7.0 to pH 8.0 and at the same time the stromal Mg2+ concentration increases to about 
2mM. The alkalinization of the stroma and the increase in Mg2+ concentration are in a range 
where they can effectively influence the rate of y-glutamylcysteine synthesis and the rate of 
glutathione synthesis in the chloroplasts, as glutathione synthetase also shows 50% of its 
maximal activity at pH 7.0 and a broad pH optimum between pH 8.0 and pH 9.0 (Hell & 
Bergmann, 1988). Such an increase in the rate of glutathione synthesis during illumination 
could be involved in the light-dependent diurnal fluctuations of glutathione concentrations 
observed in leaves (Koike & Patterson, 1988; Schupp & Rennenberg, 1988). 
1.4.3.2 Arabidopsis thaliana 
The A. thaliana y-glutamylcysteine synthetase gene was cloned by complementation of an E. 
coli gshA mutant for growth on 8-hydroxyquinoline (May & Leaver, 1994). The E. coli gshA 
mutant was unable to synthesize glutathione and in the absence of glutathione was sensitive to 
8-hydroxyquinoline. The derived amino acid sequence of the A. thaliana y-glutamylcysteine 
synthetase gene constituted a polypeptide of 59.9 kDa. The predicted amino acid sequence had 
only 15-19% identity to other y-glutamylcysteine synthetase genes. To determine the extent of 
sequence conservation among higher plants, the authors carried out Southern hybridization, 
using eDNA derived from the A. thaliana y-glutamylcysteine synthetase gene as a probe. 
Surprisingly, this probe did not hybridize to tobacco DNA and only a weak signal was detected 
against maize DNA. This suggested that plant y-glutamylcysteine synthetase molecules are 
structurally highly divergent. Differences in kinetic properties of the recombinant A. thaliana y-
glutamylcysteine synthetase (May & Leaver, 1994), maize y-glutamylcysteine synthetase 
(Ruegsegger & Brunold, 1993) and that of tobacco (Hell & Bergmann, 1990), were also found. 
In direct contrast to tobacco and mammals the A. thaliana y-glutamylcysteine synthetase activity 
was stable upon storage and was not inactivated by reductants (May & Leaver, 1994). The 
tobacco enzyme was found to be dimeric, while A. thaliana enzyme activity suggested it was 
monomeric since it was not susceptible to dissociation and subsequent inactivation by 
reductants. However, the maize enzyme was active in the presence of DTT and, therefore, may 
be more similar to the A. thaliana enzyme, as indicated by the weak hybridization of A. thaliana 
y-glutamylcysteine synthetase eDNA to maize genomic DNA (May & Leaver, 1994). 
As with all the other y-glutamylcysteine synthetase enzymes studies so far, the A. thaliana y-
glutamylcysteine synthetase enzyme was feedback inhibited by glutathione in a nonallosteric 
manner, and inhibited by sulfoximine analogs of y-glutamylphosphate. 
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1.4.4 Prokaryotes 
1.4.4.1 Escherichia coli 
The E. coli y-glutamylcysteine synthetase enzyme had a molecular weight of 56 k.Da and was 
found to be homogenous on polyacrylamide gel electrophoresis in the presence or absence of 
SDS (Huang eta/., 1988). The enzyme had a pH optima of 8.5 and was stable after storage at-
20°C for two months (Apontoweil & Berends, 1975). 
The catalytic properties of the y-glutamylcysteine synthetase from E. coli and rat kidney were 
very similar. This was evident from the similarities in turnover number, substrate specificity 
and apparent Km values. Furthermore both enzymes were inactivated to the same extent by 
buthionine sulfoximine in the presence of A TP. In contrast to the mammalian enzyme, the E. 
coli enzyme was insensitive to cystamine, y-methylene glutamate and S-sulfo amino acids, 
indicating that it did not have an active site thiol (Huang et al., 1988). It seems from these 
results that although the rat kidney and E. coli enzymes catalyze the same overall reaction, their 
catalytic functions may be performed by use of different active site structures. The antigenic . 
determinants of the rat kidney and E. coli enzymes were also different; polyclonal antibodies 
obtained from rabbits immunized against the one or other of the purified enzymes did not cross-
react on Ouchterlony plates (Huang et al., 1988). Thus the quaternary structures of the two 
enzymes must differ. The E. coli enzyme appeared to consist of a single 56 k.Da subunit, whilst 
the mammalian enzyme has been found to be composed of two subunits differing in size and 
activity. 
1.4.4.2 Proteus mirabilis 
A y-glutamylcysteine synthetase enzyme isolated from Proteus mirabilis (Kumagai et al., 1982) 
had similar properties to the rat kidney and E. coli enzymes in optimum pH and Km values for 
substrates, but it showed a sigmoidal dependence of the reaction rate on L-cysteine which has 
not been observed in other y-glutamylcysteine synthetases. The molecular weight of the enzyme 
was determined by ultracentrifugation and gel filtration to be between 62 and 64 k.Da, and a 
single band at 62 k.Da was obtained on SDS polyacrylamide gel electrophoresis, after cross-
linking with dimethylsuberimidate. However, several bands were obtained on SDS (without · 
cross-linking) and disc polyacrylamide gel electrophoresis. 
1.5 Motivation for the isolation and characterisation of the thioredoxin 
and y-glutamylcysteine synthetase genes. 
The redox potentials in the environment of an iron-oxidising bacterium such as T. ferrooxidans 
is a function of the Fe3+fFe2+ ratio. When ferrous iron is oxidised to ferric iron the redox 
potential of the surrounding medium increases correspondingly and bacteria which grow in such 
an environment require the ability to maintain their cytoplasmic redox potential within certain 
limits. Iron-oxidising bacteria like T. ferrooxidans might, therefore, be expected to have a 
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greater capacity for controlling their internal redox potential than most bacteria. This study was 
undertaken to investigate intracellular systems that are likely to play a role in the ability ofT. 
ferrooxidans to cope with large changes in its redox potential. The thioredoxin and y-
glutamylcysteine synthetase genes were chosen for investigation, as thioredoxin and glutathione 
are two molecules that play a role in the control of redox potential within a cell. 
The isolation and analysis of these genes was also of interest in terms of increasing the 
knowledge of the genetics and physiology of T.ferrooxidans. 
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CHAPTER2 
THE ISOLATION AND CHARACTERIZATION OF THE T. FERROOXIDANS 
THIOREDOXIN GENE 
2.0 Summary 
The T. ferrooxidans thioredoxin gene was isolated by complementation of the E. coli trxA 
mutant strains BH5262 and BH2012. The source of the thioredoxin complementing DNA was 
confirmed by Southern hybridisation as originating from the T. ferrooxidans A TCC 33020 
chromosome. The nucleotide sequence of a l.lkbp HindiiJ.-Pstl T. ferrooxidans chromosomal 
DNA fragment was determined from both sttands. An open reading frame (ORF) corresponding 
to the thioredoxin gene and part of an ORF corresponding to theN-terminal region of the rho 
gene were identified. Synthesis of a 14 kDa protein corresponding to the predicted size of the T. 
ferrooxidans thioredoxin was confirmed using an E. coli-derived in vitro transcription-
translation system. 
DNA:RNA hybridisation was carried out on RNA transcripts prepared from E. coli BH5262 
trxA (deletion mutant), E. coli BH5262 containing the cloned trxA gene and T. ferrooxidans 
cells. The T. ferrooxidans trxA gene was found to be transcribed independently of the 
downstream rho gene. Primer extension analysis was used to determine the transcriptional start 
sites of the trxA gene in T. ferrooxidans and that of the cloned gene in E. coli. Three 
transcription start sites were identified with RNA prepared from T. ferrooxidans. Using RNA 
derived from the cloned gene in E. coli, two transcription start sites were identified that were 
identical to those of T.ferrooxidans-derived RNA. 
The cloned T. ferrooxidans thioredoxin gene was able to support T7 phage growth in the E. coli 
trxA mutant, BH2012. A growth curve of phage T7 was determined in E. coli host strains 
MC1061, BH2012 and BH2012(pTRX6). The T. ferrooxidans thioredoxin was also tested for 
the ability to support filamentous phage assembly, however, it was not able to satisfy the 
thioredoxin requirement of M13 phage. 
Crude extracts of E. coli trxA mutants with and without the T. ferrooxidans trxA gene were 
compared for the ability to reduce insulin. Crude extracts of the E. coli trxA mutant, containing 
the cloned T.ferrooxidans trxA gene were able to reduce insulin far more rapidly than those that 




As discussed in Chapter 1 thioredo~in has many different functions, and the role it plays in T. 
ferrooxidans is unclear. There are numerous possible functions thioredoxin may have in 
relation to the unusual habitat occupied by T.ferrooxidans. These may include the maintenance 
of redox potential in the cell, enzyme regulation or acting as a cofactor to specific enzymes. 
When growing in arsenopyrite ores T. ferrooxidans is able to tolerate high concentrations of 
arsenic. In other arsenic resistant bacteria thioredoxin is required for the maintenance of the 
cysteine residues of arsenate reductase (ArsC) in the reduced state (Ji & Silver, 1992). Neither 
glutaredoxin nor glutathione were able to replace thioredoxin in this reaction. A similar 
mechanism of arsenic resistance may operate in T. ferrooxidans to that of ArsC but this has not 
been elucidated yet. In addition reduced thioredoxin may react directly and irreversibly with 
arsonous acid to form very stable dithioesters thus removing the highly toxic arsonous acid from 
the cell (Knowles & Benson, 1983). 
Despite T. ferrooxidans being an ac~dophilic, obligate chemoautolithotroph, and E. coli being a 
heterotrophic bacterium, E. coli and T. jerrooxidans share a remarkable amount of similartiy at 
the genetic level. A number of T.jerrooxidans genes have been isolated by complementation of 
E. coli mutants (Rawlings & Kusano, 1994). Thioredoxin genes from oth.er bacteria have also 
been isolated by complementation of E. coli trxA mutants, as stated in Chapter 1. The ability of 
T. jerrooxidans genetic material to be expressed, and the proteins to function in E. coli enabled 
the isolation of the thioredoxin gene from T.ferrooxidans. 
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2.2 Materials and Methods 
2.2.1 Bacterial strains and media 
The strains and plasmids used in this study are described in Appendix A. Complex medium 
used for growth of E. coli was Luria-Bertani medium (LB), and M9 minimal medium was used 
for growth of E. coli on selective medium (Sambrook et al., 1989). When required, antibiotics 
were added at the following concentrations: ampicillin 100 Jlg/ml and chloramphenicol 30 
Jlg/ml. T. ferrooxidans was grown on tetrathionate medium for DNA and RNA extractions. 
Tetrathionate medium was made from mineral salts solution (gil); (NH,V2S04, 3.0; KCl, 0.1; 
K2HP04, 0.5; and Ca(N03)2, 0.01, adjusted to pH 2.5 with H2S04 and autoclaved. Trace 
elements solution (mg/1); FeCl3.6H20, 11.0; CuS04.5H20, 0.5; HB03, 2.0; Na2Mo04.2H20, 
0.8; CoCl2.6H20, 0.6 and ZnS04.?H20, 0.6, was filter sterilized. One ml of trace elements 
solution was added to 100 ml mineral salts solution and to this was added 50 mM sterile 
K2S406 and the pH adjusted such that the final pH was 2.5. 
2.2.2 Preparation of DNA 
The alkaline lysis method (Ish-Horowicz & Burke, 1981; Birnboim & Doly, 1979) was used for 
both small and large scale preparations of E. coli DNA. Chromosomal DNA was prepared from 
T.ferrooxidans ATCC 33020 grown on tetrathionate medium by the DNA extraction method as 
outlined below. Cells from a 1 litre culture were harvested, concentrated down to 1.5 ml and 
pelleted by centrifugation in an Eppendorf microfuge tube for 1 min. The pellet was 
resuspended in 0.5 ml of a 25% sucrose, 2 mM EDTA, 50 mM Tris-Cl buffer (pH 8.0) and 
frozen at -20°C for 1h. Proteinase K was added to the frozen cells (0.1 mg/ml final 
concentration) and the samples shaken at ambient temperature until they thawed. Sodium 
dodecyl sulphate (SDS) was added to a final concentration of 0.5 %, and the samples held on ice 
for 15 min, followed by RNase (50 Jlg/ml) digestion for 20 min at 37°C. The viscous, opaque 
samples were dialysed at room temperature for 24-60 h against numerous changes of TE buffer 
(pH 8.0) until they became translucent. Protein was removed from the samples by three phenol-
chloroform-isoamyl alcohol (25:24: 1) extractions, followed by two diethyl-ether extractions. 
The DNA purification procedure was completed by an overnight dialysis against TE buffer at 
room temperature. 
Construction of the gene bank of T. ferrooxidans ATCC 33020 DNA in the cosmid vector 
pHC79 was carried out by Raj Ramesar (Ramesar, R. PhD Thesis, University of Cape Town, 
South Africa, 1988). 
2.2.3 DNA manipulations 
Standard methods (Sambrook et al., 1989; Ausubel et al., 1993) were used for restriction 
digests, gel electrophoresis, purification of DNA fragments from agarose gels and ligations. All 
enzymes and buffers were used according to the manufacturer's specifications. E. coli cells 
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were made competent by the standard rubidium chloride method described by Sambrook et a/. 
(1989). 
2.2.4 Transduction of E. coli cells 
The T.ferrooxidans pHC79 cosmid gene bank was stored as a phage lysate above chloroform at 
4°C. Recipient E. coli cells were grown overnight in 25 ml LB medium containing 0.25% (w/v) 
maltose. A sample of 1 ml was sedimented by centrifugation in an Eppendorf microfuge, 
resuspended in 10 mM MgS04. and placed at room temperature for 1 h. A 10 Jll sample of an 
appropriate dilution (routinely w-7 or 10-6 in SM buffer; Sambrook et al., 1989) of the cosmid 
gene bank phage lysate was mixed with 200 Jll of cells. The sample was incubated at 37°C for 
30 min, followed by addition of 1 ml of LB and a further 60 min incubation at 37°C. Samples · 
of 100 Jll were plated onto the appropriate agar plates. 
2.2.5 Screening for the T. ferrooxidans trxA gene by complementation of E. coli trxA 
mutants 
The T. ferrooxidans A TCC 33020 cosmid library was transducect into the E. coli trxA gshA 
mutant BH5262. The expression mixes were washed with 0.8% sodium chloride before plating 
onto M9 minimal medium containing 20 Jlg/ml arginine and 100 Jlg/ml ampicillin. Possible 
thioredoxin positive clones were identified by their abilitiy to grow on M9 minimal medium 
lacking in glutathione. Positive clones were then miniprepped and retransformed into E. coli 
BH2012 competent cells and plated on minimal medium containing methionine sulfoxide, 
isoleucine, valine and leucine (20 Jlg/ml of each) plus ampicillin (100 Jlg/ml). Positive colonies 
were identified by their ability to convert methionine sulfoxide to methionine. Methionine 
sulfoxide reductase specifically requires thioredoxin as a reductant for this reaction (Gonzalez 
Porque et al., 1970). 
2.2.6 Subcloning of cosmid 32 
Cosmid 32 DNA was digested with Psti and ligated into the vector pBluescriptSK (Psti). The 
ligation mixes were transformed inJo E. coli BH5262 and expressed in M9 minimal medium. 
The transformants were selected for complementation of the trxA phenotype. Subclone 
pTRX32A was isolated. A restriction map of pTRX32A was constructed (Fig. 2.1 ). All 
subclones are shown in Fig. 2.1. Plasmid pTRX32 was constructed from pTRX32A by cloning 
a 1.6 kb Sacii-Psti fragment into pBluescriptSK. A 850 bp Sful-Psti fragment from pTRX32 
was cloned into pBluescriptSK to produce pTRX6. Plasmid pTRX13A is the result of an 
insertion of a 960 bp Sacii-Saci fragment from pTRX32 into pBluescriptSK. Plasmid 
pTRX14A was a Sad deletion of pTRX32. Plasmid pTRX9 was constructed by cloning a 682 
bp H indiii fragment into pBluescriptSK, whilst pTRX24 is the result of inserting a 192 bp 
Hindiii-Sful fragment from pTRX32 into pBluescriptSK. 
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All subclones of plasmid pTRX32A shown in Fig. 2.1 were tested for the ability to complement 
E. coli strains BH2012 and BH5262 as described above. 
2.2.7 DNA hybridisation 
In order to confirm the ongm of the cloned thioredoxin-complementing DNA, DNA 
hybridisation was performed. T. ferrooxid.ans chromosomal DNA (15-20~g), cosmid 32 
(800ng), plasmid pTRX32 (20ng) and plasmid pTRX6 (20ng) were digested with restriction 
enzymes Kpni-Saci and Hind.III and electrophoresed together with lambda DNA digested with 
Psti, as a marker, on a 0.8% agarose gel. Blotting was carried out according to the method 
recommended by Amersham for Hybond N+ membranes. A 517 bp Kpni-Saci fragment from 
pTRX32 was used as a probe. Labelling of the probe, hybridisation and detection were carried 
out according to the dioxygenin-dUTP non-radioactive DNA labelling and detection kit 
(Boehringer-Mannheim). 
2.2.8 Nucleotide sequencing 
Recombinant plasmids generated by subcloning were sequenced by the dideoxy chain 
termination method (Sanger et al., 19Ti), using the Sequenase kit (version 2.0) from the United 
States Biochemical Corp. The sequence of the 1.05 kbp Hind.III-Pstl fragment from pTRX32 
(Fig. 2.3) was determined from both strands. The Genetic Computer Group Inc. (GCG) 
sequence analysis software package (version 7.1) was used for sequence analysis (Devereux et 
al., 1984). 
2.2.9/n vitro synthesis of thioredoxin 
The in vitro synthesis of polypeptides was determined using the prokaryotic DNA-directed 
transcription kit, E. coli S30 system of the Promega Corp., Madison USA. Reactions were 
performed according to the manufacturer's specifications. The proteins were separated by SDS 
polyacrylamide gel electrophoresis using a 10 to 20% gradient gel. The gel was poured using a 
standard gradient pourer, and SDS polyacrylamide gel electrophoresis carried out according to 
the method outlined by Promega. 
2.2.10 Phage growth 
A growth curve of phage T7 was determined in E. coli host strains MC1061, BH2012 and 
BH2012(pTRX6). Overnight cultures of the host strains grown in Luria-Bertani medium were 
diluted to an 00600 = 0.6 in a 20 ml volume. This was done to ensure that each culture had 
approximately the same number of cells per ml of culture. Each 20ml culture was inoculated 
with 100J..Ll T7 phage (1010 pfu/ml). At different time intervals 10J..Ll samples were taken and the 
appropriate dilutions made. Ten microlitres of the diluted sample was added to 4 ml of sloppy 
agar (40°C) plus 100~1 plating cells and poured onto Luria agar plates. The plates were 
incubated at 37°C for 8 hours and the plaques counted. Plating cells consisted of an overnight 
culture of E. coli MC1061 diluted to an OD6ooof0.6 in Luria-Bertani medium. 
54 
The growth of T7 phage was also monitored using different E. coli host strains; MC1061, 
BH2012 and BH2012(pTRX6), as plating bacterium. 
It was not possible to determine a growth curve of M 13 phage in E. coli host strains JF510 and 
JF510(pTRX6), as M13 phage showed no increase in titre over the 4 hour interval studied. 
Cultures of E. coli strains 71/18, JF510 and JF510(pTRX6) were, therefore, innoculated with 
M13 phage to 5 x 108 pfu/ml and ~own overnight with vigorous aeration at 37°C. Titres were 
taken at the time of inoculation and 20 hours later using E. coli 71/18 as a plating bacterium. 
2.2.11 Insulin Assay 
The insulin assay of Holmgren ( 1979), was used to measure the rate of disulfide reduction, by 
recording the rate of precipitation at 650nm. Crude extracts were prepared as follows. Midlog 
bacterial cells were harvested from 100ml M9 minimal medium and resuspended in 1ml assay 
buffer (lOOmM potassium phosphate pH 7.5, 1mM EDTA, 1mM DIT and 1mM Pefabloc). 
Pefabloc [4-(2-aminoethyl)benzoylsulfonyl-fluoride, hydrochloride] was obtained from 
Boehringer Mannheim. After sonication, lysed cells were precipitated and the supernatant 
heated to 85°C for 5 minutes. Most thioredoxins are heat stable and are, therefore, not 
denatured. Denatured proteins were removed by centrifugation and the supernatant used in the 
assay. Insulin was added to 900~1 crude extract (final concentration 1mg/ml), and the reaction 
initiated by adding 3~ 100mM DIT. The rate of precipitation of the insulin B chain was 
monitored by measuring the increas~ in turbidity at 650nm. Crude extract prepared from E. coli 
trxA mutant BH2012 was compared to that prepared from E. coli BH2012(pTRX6), which 
contained the cloned T. ferrooxidans thioredoxin gene,. 
2.2.12 The preparation of glassware, perspex and chemicals for RNA extraction and 
analysis. 
All chemicals used for RNA extraction procedures were treated with 0.01% DEPC (diethyl 
pyrocarbonate) for 2 hours at 37°C, and autoclaved prior to use. Tris-based buffers were not 
treated with DEPC; rather they were made up with deionized water which had been pre-treated 
with 0.01% DEPC, and subsequently autoclaved prior to adding Tris. Perspex electrophoretic 
buffer tanks, and glass gel supports were soaked in 10% sodium hypochlorite for 24 hours prior 
to use, and thoroughly rinsed with DEPC-treated de-ionized water. Glassware and metal 
utensils were baked at 200°C for 8 hours prior to use. These precautions were taken to 
eliminate any possibility of contaminating RNases. 
2.2.13 Preparation of RNA 
T. ferrooxidans total RNA was prepared from cultures grown on tetrathionate medium (see 
2.2.1), and E. coli total RNA from cultures grown on M9 minimal medium, by the method of 
Aiba et al. (1981 ). 
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2.2.14 DNA:RNA hybridisation 
The HindiTI fragment of pTRX9labelled with (a-32p)CfP (3000 Ci/mmol) using the Random 
Primed DNA labelling kit from Boehringer Mannheim, was used as a probe for RNA 
hybridisation. Total RNA from E. coli BH5262, E. coli BH5262(pTRX6) and T. ferrooxidans 
was separated on a 1.5% agarose gel containing 6% formaldehyde. The RNA was transferred to 
an Amersham Hybond N+ membrane and hybridisation carried out. RNA separation, blotting 
and hybridisation were carried out according to the Amersham Hybond N+ protocol. 
2.2.15 Primer extension analysis 
Transcript start sites of the thioredoxin mRNA from T. ferrooxidans and the cloned gene in E. 
coli BH5262 were determined by primer extension analysis. A synthetic 18 mer oligonucleotide 
primer GACACATAAAGAATGGCG was designed to anneal 8 bp from the start of the trxA 
gene. The primer was end-labelled with y-32p using polynucleotide kinase according to the 
method of Ausubel et al. (1993). Primer extension was carried out using total RNA derived 
from E. coli BH5262(pTRX6) and total RNA from T. jerrooxidans according to the method of 
Ausubel et al. (1993). The resulting eDNA and a sequencing ladder generated from pTRX6 
primed with the above 18 mer primer were analysed on a 6% polyacrylamide/urea sequencing 
gel. The length of the eDNA and, therefore, the transcription start site was estimated by 
comparison to the pTRX6 sequencing ladder. 
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2.3 Results 
2.3.1 Screening for the T. ferrooxidans trxA gene by complementation of E. coU trxA 
mutants. 
Transduction of the T. ferrooxidans genome cosmid library into E. coli BH5262 resulted in 
approximately 100 colonies that were able to grow on minimal media lacking glutathione. DNA 
was prepared from 16 of these colonies. These cosmids could be divided into two groups that 
had several restriction fragments in common and appeared to contain overlapping pieces of two 
regions of the T. ferrooxidans chromosome. On transforming into E. coli BH2012 only one of 
the groups of cosmids enabled cells to grow on minimal media plus methionine sulfoxide. One 
cosmid from this group (cosmid 32) was chosen for further study. 
All subclones of cosmid 32 were tested for complementation of E. coli mutant BH2012 for 
growth on methionine sulfoxide and E. coli mutant BH5262 for growth on minimal medium 
lacking glutathione. Plasmids pTRX32A, pTRX32 and pTRX6 complemented the E. coli trxA 
mutants, while plasmids pTRX13A; pTRX14A, pTRX9 and pTRX24 did not (Fig. 2.1). This 
indicated that the thioredoxin-complementing DNA was located between the Sfui and Pstl sites 
ofpTRX32. 
Plasmid 
Pstl Sa ell 
TRX32A 
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Pstl 










Fig. 2.1 Restriction endonuclease map of plasmid pTRX32A and derivatives. The trxA gene 
and the start of the rho gene are indicated by arrows. The dotted line indicates the region of 
DNA sequenced from both strands. TrxA +activity indicates that the transformed plasmid was 
able to complement the thioredoxin mutant E. coli BH2012 for growth on methionine sulfoxide. 
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2.3.2 DNA hybridisation 
The source of the cloned thioredoxin-complementing DNA was confirmed by hybridisation of 
the labelled Saci-Kpni fragment from pTRX32 toT. ferrooxidans ATCC 33020 chromosomal 
DNA, cosmid 32, pTRX32 and pTRX6 digested with Hindlll (Fig. 2.2lanes 1-4) and Saci-Kpni 
(Fig. 2.2 lanes 6-9). The 685bp Hindiii fragment that is internal to the cloned T. ferrooxidans 
chromosomal DNA present on pTRX32 corresponded exactly to the Hindlll fragment present 
on the T.ferrooxidans chromosome, cosmid 32 and pTRX32. The hybridisation signals at 1.8kb 
(Fig. 2.2, lanes 1 and 2) represented the adjacent Hindiii fragmen~ which contain~d part of the 
trxA and rho genes and was present in the chromosome and cosmid 32 only. The hybridisation 
signal at approximately 3.0 kb in the Hindiii digest of pTRX32 (Fig. 2.2, lane 3) corresponded 
to the region flanking the 685bp H indiii fragment and included the vector. Plasmid pTRX6 has 
a single HindiiT site and, therefore, gave a single hybridisation signal at 3.9kb (Fig. 2.2, lane 4) 
when probed with the Saci-Kpni fragment. Similarly, when the T. ferrooxidans chromosomal 
DNA was digested with both Sac! and Kpni, a single hybridisation signal at 530bp, also present 
on cosmid 32, pTRX32 and pTRX6 was detected. 






Fig. 2.2 Hybridisation of the labelled 517 bp Kpnl-Sacl fragment of pTRX32 to Hindlll 
digests (lanes 1 to 4) and Kpni-Saci digests (lanes 6 to 9) of: lane 1, T. ferrooxidans 
chromosomal DNA; lane 2, cosmid 32; lane 3, plasmid pTRX32; lane 4, plasmid pTRX6; lane 
5, blank; lane 6, T. ferrooxidans chromosomal DNA; lane 7, cosmid 32; lane 8, plasmid 
pTRX32; lane 9, plasmid pTRX6. 
The faint upper bands in lanes 2, 7, 8 and 9 (Fig. 2.2), were due to a low concentration of vector 
DNA which remained in the incompletely purified Saci-Kpni probe. Overexposure of the 
autoradiogram (not shown) failed to indicate any additional chromosomal bands. This indicated 
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that there was one copy of the thioredoxin gene per genome and that the cloned thioredoxin-
complementing DNA originated from T.ferrooxidans ATICC 33020. 
2.3.3 Nucleotide and amino acid sequence of the T. ferrooxidans trxA gene and flanking 
regions 
The nucleotide sequence of the 1.05 kbp Hindlll-Pstl fragment of pTRX32 is shown in Fig. 2.3. 
Analysis of the sequence data revealed one complete ORF. Data base searches, using the 
BLASTNCBI package revealed significant amino acid homology of the ORF to known 
thioredoxin genes of other organisms (data not shown). 
1 AAGCTTTGCCAAACGCAGATGTTTACCATACGCCAAGCCCCGAACGGCGACTATA 










start of trxA gene -7 M S 
441 GACGCCATTCTTTATGTGTCTGATGACAGTTTTGAAACGGATGTATTGAAGTCCT 
D A I L Y V S D D S F E T D V L K S 
496 CCAAACCGGTATTGGTCGATTTCTGGGCCGAATGGTGCGGACCTTGCAAGATGAT 
S K P V L V D F W A E W C G P C K M I 
551 CGCCCCCATTCTGGAAGAGATCGCTGATGAATATGCCGATCGCCTGCGGGTTGCC 
A P I L E E I A D E Y A D R L R V A 
606 AAATTCAACATCGACGAAAATCCCAATACTCCCCCTCAGTACGCGATTCGCGGTA 
K F N I D E N P N T P P Q Y A I R G 
661 TTCCCACACTGCTCCTTTTCAAGGCTGGCAAGCTTGAAGCGACCAAAGTGGGTGC 
I P T L L L F K A G K L E A T K V G A 
716 CCTGAGCAAAGCCCAGCTGACCGCATTCCTGGATAGCCAACTTTGAATACGTCCC 
L S K A Q L T A F L D S Q L * 
771 GCCACCGCCGTAAACCCCCCCGGACAGCCCAAGTCCTTTCCCAACGAAGATATTC 
826 TGGTAGACGAAGACGAGAACGCGCTTTGTCCGTCACCTGGCGCTGCGGCGATGAA 
start of rho gene -7 M N 
881 TCTGACCGACCTCAAACGCAAAACGGCCGCTGATCTGGCGGTGATCTGCCAGGAC 
L T D L K R K T A A D L A V I C Q D 
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936 ATGGGGTTGGAGGGTACCGCCCGTCAGAAGAAACAGGAAATCATTTTCAATATCC 
M G L E G T A R Q K K Q E I I F N I 
991 TCAACGCACGCGCGCAATGCGACGCCATTTACGGTGAGGGGGTGCTGGAAATTCT 
L N A R A Q C D A I Y G E G V L E I L 
1046 GCAG 
Q 
Fig. 2.3 Nucleotide and deduced amino acid sequence of the HindliT-Psti fragment of 
pTRX32A, containing the trxA gene and the N-terminal region of the rho gene. A putative 
ribosome binding site is indicated in bold and -10 and -35 regions of a cr70-1ike promoter are 
underlined. 5' transcription start sites are indicated by arrows. 
2.3.3.1 Codon usage in the T. ferrooxidans trxA gene. 
The table in Appendix C details the codon usage pattern of the trxA gene. As can be seen from 
the table the codon usage of the trxA gene is very similar to that in Tfchrom.cod, with a bias 
• 
towards the G orCin the "wobble" position. 
The UWGCG CODONPREFERENCE application ultilizes a codon usage data file to analyze 
all 6 reading frames of a DNA sequence, to identify open reading frames (ORFs) that have a 
similar codon usage to that provided in the data file. Figure 2.4 shows the 
CODONPREFERENCE analysis of the 1.05kbp HindliT-Psti fragment of pTRX32 using the T. 
ferrooxidans codon usage file (Tfchrom.cod). The latter file was compiled from 14 previously 
sequenced T. ferrooxidans genes, nam~ly; ginA (Rawlings et al., 1987), nifHDK (Pretorius et 
al., 1987; Rawlings, 1988), recA (Ramesar et al., 1989), ntrA (Berger, 1990), ORF1 (Berger, 
1990) and the 7 ATPase genes (Brown et al., 1994). 
The central ORF seen in Fig, 2.4, frame 1, was found to code for the tr.tA gene, and the 
incomplete ORF at the 3' end of the 1.05kb fragment, for the N-terminal region of the rho gene. 
Both genes show a codonpreference and absence of rare codons which correlates with the 
Tfchrom.cod codon usage data file. The GC composition of the trxA gene was 50.92%. 
The codon usage data was analysed using the UWGCG CORRESPOND subroutine. The 
program CORRESPOND is designed to identify similar patterns of codon usage by comparing 
codon frequency, which is calculated by dividing the number of incidents of the codon in 
question by the total number of codons specifying the amino acid or terminator in each table. 
The lower the statistic (D), the more similar the patterns of codon usage. The codon frequency 
table of the T. ferrooxidans trxA gene was compared to the composite codon frequency table of 
T. ferrooxidans (Tfchrom.cod) as well as the codon frequency tables for highly expressed 
(UWGCG dataf:tle "Ecohigh.cod") and the weakly expressed (UWGCG datafile "Ecolow.cod") 
E. coli genes. The results are shown in Table 2.1. 
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Fig. 2.4 CODONPREFERENCE analysis of the Hindlll-Pstl fragment of pTRX32A. The 
predicted protein-coding open reading frames, trxA and rho, are shown as open boxes. The 
vertical axis shows the CODONPREFERENCE plots of all of the three forward frames, with 
ORFs and the positions of rare codons (defmed as those codons which appear in the 
Tfchrom.cod codon usage datafile at a frequency less than 10%) drawn below as open boxes 
and vertical bars, respectively. Any plot above the dotted line in any of the three reading frames 
identifies a protein-coding sequence with a similar codon usage to the Tfchrom.cod datafile. 
Table 2.1. Comparison of codon usage of the T. ferrooxidans trxA gene with that of T. 
ferrooxidans and E. g:li genes using the UWGCG program CORRESPONDa. Numbers 
represent the statistic D as described in the text. 
a 
Tfchrom.cod Ecohigh.cod Eclow.cod 
trxA.cod 1.34 3.33 1.11 
Tfchrom.cod is a composite codon usage frequency table of 14 T. ferrooxidans genes as 
stated earlier. Ecohigh.cod and Ecolow.cod refer to the codon usage frequency tables of 
E. coli weakly and E. coli highly expressed genes respectively. trxA.cod refers to the 
codon usage frequency table of the T.ferrooxidans tr.xA gene. 
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The codon usage of the T.jerrooxidans tr.xA gene is most similar to that of the weakly expressed 
E. coli genes and the T.ferrooxidans genes. 
2.3.3.2 Amino acid similarity between· T. ferrooxidans TrxA and other TrxA proteins 
The amino acid sequence of the trxA ORF was aligned with other TrxA proteins using the 
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Fig. 2.5. Alignment of deduced amino acid sequence of the T. ferrooxidans TrxA with other 
TrxA proteins. Amino acids conserved in all seven TrxA proteins are shaded in black. Ectrx = 
E. coli TrxA (GenBank M87049), Tftrx = T. ferrooxidans TrxA, Rstrx = R. sphaeroides TrxA 
(GenBank M33806), Bstrx = B. subtilis (GenBank 103294), Hstrx = H. sapiens (GenBank 
X54540), Sctrx = S. cerevisiae (Trxl)(GenBank M62647), Nttrx = Nicotiana tabacum 
(GenBank Z11803). 
To give a comparison of thioredoxins across a broad range of different organisms 
representatives were chosen from plants (Nfcotiana tabacum), mammals (Homo sapiens), fungi 
(Saccharomyces cerevisiae), Gram-positive bacteria (Bacillus subtilis), Gram-negative bacteria 
(E. coil) and Rhodobacter sphaeroides. Thioredoxins are usually highly conserved proteins, and 
their comparison is thus thought to be of evolutionary significance. The high degree of 
conservation among thioredoxins is cle;rrly illustrated in Fig. 2.5., All the proteins studied here 
have the highly conserved active site sequence -W-C-G-P-C-. There are also a number of other 
highly conserved residues which are indicated by shading. 
The T. ferrooxidans TrxA shows highest identity to those of E. coli (10.6%) and Salmonella 
typhimurium (GenBank Ml0424) (70.6%), followed by Chromatium vinosum (GenBank 
P09857) (69.2%). It has lowest identity to the Eubacterium acidaminophilum TrxA (GenBank 
L04500) (29.4 %), followed by that of N. tabacum (29.9 %). 
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2.3.3.3 Identification of the downstream rho ORF 
An incomplete ORF, 126 bp downstream of the thioredoxin gene was identified (Fig. 2.6). The 
predicted amino acid sequence showed homology to the rho transcriptional termination protein 
of other prokaryotes. A multiple sequence alignment of the first 58 amino acids of the T. 
ferrooxidans rho gene with those of E. coli (GenBank 101673), S. typhimurium (GenBank 
D 100 15), Neisseria gonorrhoeae (GenBank Z21790), Pseudomonas fluorescens (GenBank 
L27278) and C. vinosum (GenBank L27275) was dUTied out using the UWGCG PILEUP 
application (Fig. 2.6). The first 58 amino acids of the T. ferrooxidans rho protein were not as 
homologous as the rho proteins of E. coli, S. typhimurium and N. gonorrhoeae were to each 
other (T. ferrooxidans 53.6% identity to E. coli). Opperman & Richardson (1994) carried out a 
phylogenetic analysis of possible rho genes in a range of bacterium. Their results indicated that 
the rho gene can be split into three regions; the first region, stretching from amino acids 1 to 116 
was denoted the RNA-binding domain. This region was found to be the most divergent. 
However, their analysis revealed a region of higher similarity within the RNA-binding domain 
from amino acids 51 to 141. Although the region is very short, T. ferrooxidans shows increased 
homology to the other rho proteins from amino acid 51 onwards (Fig. 2.6), consistant with this 
analysis. From these sequence data and its position downstream of the trxA gene (similar to E. 
coli) this incomplete ORF appears to code for the rho transcriptional terminator protein. 
T.f. MNLTDLKRKTAADLAVICQDMGLEGTARQKKQEIIFNILNARAQ.CDAIYGEGVLEILQ 
II II . II .. I II II II . II · I II · I · I · I · 11111111 
E.c. MNLTELKNTPVSELITLGENMGLENLARMRKQDIIFAILKQHA.SGEDIFGDGVLEILQ 
1111111111111111111 1111111111111111 1 111111 111111111111111 
S.t. MNLTELKNTPVSELITLGESMGLENLARMRKQDIIFAILKQHAKSGEDIFGDGVLEILQ 
111111111111111111111111111111111111 1 11111111111111111 . II II 
N.g. MNLTELKNTPVSELITLGESMGLENLARMRKQDIIFAILKQHAKSGEDIFGDGVVEILQ 
1111111 . I . .. I . I . I II . II II II II . II ·. II II Ill . I II II · II II 
P . f. MNLTELKQKPITDLLQLAEEMGIENMARSRKQDVIFSLLKKHA.SGEEISGDGVLEILQ 
1111111 I . I . II I II . 111111 · II · . II · I II . I 111111 · 
C.v. MNLTELKKMPVPNLVALAQSMDIEGVGRSRKQDLIFAILKAQAK.GEDIYGDGVLEKIL 
Fig. 2.6. Comparison of the N-terminal amino acid sequence of T. ferrooxidans rho protein 
(T.f) to that of E. coli (E.c) GenBank 101673, S. typhimurium (S.t) GenBank D10015, N. 
gonorrheae (N.g) GenBank Z21790, Pseudomonas jlourescens (P.f) GenBank L27278 and C. 
vinosum (C.v) GenBank L27275. 
2.3.4 In vitro protein synthesis 
To establish a correlation between the predicted ORF, derived from sequence analysis, and the 
polypeptide produced, protein products from cosmid 32 and various subclones were examined. 
A protein of approximately 14 kDa was produced from cosmid 32 and plasmids pTRX32 and 
pTRX6, but not by plasmid pTRX14A or the vector pBluescriptSK (Fig. 2.7). A slightly larger 
protein was synthesized from plasmid pTRX9 (Fig. 2.7, lane 5). However, this construct lacked 
the stop codon of the thioredoxin gene and the larger protein was probably the result of 
transcriptional and translational read-through. These results strongly support the contention that 
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Fig. 2.7. SDS PAGE analysis of proteins expressed from cosmid 32 and subclones using an E. 
coli-derived in vitro transcription-translation system. Lanes: 1, cosmid 32; 2, pTRX32; 3, 
pTRX6; 4, pTRX14A; 5, pTRX9; 6, pBluescriptSK. 
2.3.5 Phage Growth 
The ability of thioredoxin expressed from pTRX6 in E. coli BH2012 to support T7 phage 
replication was compared to the thioredoxin expressed from the chromosome of E. coli parental 
strain MC1061 (Fig. 2.8). As can be seen from Fig. 2.8 titres of phage T7 reached almost the 
same level when the T. ferrooxidans thioredoxin was provided, as the titres obtained with the E. 
coli chromosomal thioredoxin gene. When E. coli BH2012(pTRX6) was used as a plating 
bacterium the T7 plaques were more variable in size and slightly smaller that when strain 
MC1061 was used (Fig. 2.9). No plaques were formed when E. ~oli BH2012 was used as 
plating bacterium. The cloned T.ferrooxidans trxA gene was clearly able to complement the E. 
coli trxA mutant to support growth of T7 phage, although with slightly reduced efficiency. The 
T. ferrooxidans thioredoxin, therefore, appears to be able to form a functional association with 
the gene 5 protein of the phage T7 DNA polymerase complex. 
The ability of the T. ferrooxidans thioredoxin to support the growth of M13 phage is shown in 
Table 2.2. Although there was a slight increase in titre of phage M13 in E. coli JF510(pTRX6) 
relative to the E. coli JF510 control when grown in liquid media no plaques were detected on 
solid media, when E. coli JF510(pTRX6) was used as a plating bacterium. The T.ferrooxidans 
thioredoxin, therefore, does not appear to be able to satisfy the thioredoxin requirement of the 
filamentous phage. 
64 
/"' _..._ 10.5 _ ..... - --/ ' ' -
10.0 




0 9.0 I 
I 
I 
8.5 • / 
/ 
8.0 
0 20 40 60 80 100 120 140 160 180 
Time (min) 
Fig. 2.8. Growth of 17 Phage on E. coli cells. E. coli hosts: MC1061 - - ~- -
BH2012(pTRX6) • ;BH2012 A . The data represent the 
means of three experiments. 
Fig. 2.9. A comparison of the size and number of plaques formed when 17 phage is grown on 
E. coli cells. E. coli hosts: A MC1061; B BH2012(pTRX6); C BH2012. 
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Table 2.2. Growth of M13 phage in different E. c~li hosts. Values are expressed in plaque 
forming units per ml. The data represent the mean of three experiments. Standard deviations 
are shown in brackets. 




2.3.6 Insulin reduction 
Time (h.) 
0 
1.69(0.13) X 108 
1.55(0.39) X 108 
1.52(0.45) X 108 
20 
1.71(0.51) x 1011 
2.63(1.38) X 108 
1.45(1.03) X 108 
Thioredoxin has been shown to catalyze the reduction of the insulin disulfide bridge by 
dithiothreitol (Holmgren, 1979). This reduction resulted in the precipitation of the insulin B 
chain which could be readily measured as an increase in turbidity. 
2.0.-----------------------------------------~ 
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Fig. 2.10. Reduction of disulfide bonds of insulin by DTT and crude extracts of E. coli cells 
containing the cloned T.ferrooxidans thioredoxin gene. E. coli BH2012(pTRX6), 
.t. E. coli BH2012 • . The data represent the means of three assays. 
We compared crude extracts of E. coli rrxA mutants with and witl\out the cloned T.ferrooxidans 
trxA gene for the ability to reduce insulin (Fig. 2.10). Extracts prepared from E. coli 
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BH2012(pTRX6) cells were able to reduce insulin at a greatly enhanced rate compared to 
extracts from E. coli BH2012 cells. This clearly indicated that the thioredoxin from the cloned 
T.ferrooxidans trxA gene was active in E. coli. 
2.3.7 Transcript analysis 
To determine whether the T. ferrooxidans trxA gene was independently transcribed, or 
cotranscribed with an unidentified upstream gene or with the downstream rho gene, RNA:DNA 
hybridisation analysis was carried out on RNA transcripts prepared from E. coli BH5262 trxA 
mutants, E. coli BH5262(pTRX6) and T. ferrooxidans cells, probed with the Hindill.-Hindiii 
fragment from pTRX9 (Fig. 2.11). A single transcript of about 0.5kb was obtained for RNA 
from T.ferrooxidans cells (Fig. 2.11, lanes 3 and 4), which corresponded to the predicted size of 
the thioredoxin gene and indicated that the T. jerrooxidans trxA gene was transcribed on its 
own. Several transcripts were prod~ced from E. coli BH5262(pTRX6) cells (Fig. 2.11, lane 2) 
and one of these corresponded exactly in size to the 0.5 kb signal from T.ferrooxidans while the 
other transcripts were much larger (approximate sizes 1.35, 1.40, 1.60 and 1,80 kb). These 
presumably represented transcription products that originated from the lacZ promoter of the 
vector. A very weak signal at about 0.45 kb was produced from RNA isolated from E. coli 
BH5262 cells which was smaller than the T. jerrooxidans trxA transcript and may represent a 





1 2 3 4 
Fig. 2.11. Hybridisation of labelled Hindill fragment of pTRX9 to total RNA prepared from: 
lane 1, E. coli BH5262 (-20 J.Lg); lane 2, E. coli BH5262(pTRX6) (-40 J.lg); lane 3, T. 
ferrooxidans (-25 J.lg); lane 4, T. ferrooxidans (-5 J.lg). 
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Primer extension analysis was used to compare the transcriptional start sites of the T. 
ferrooxidans trxA gene in its natural host with those of the gene cloned in E. coli. RNA 
prepared from T. ferrooxidans gave three possible transcriptional start sites, at positions 274, 
298 and 345 (Fig. 2.12, lane 2). In the case of RNA derived from E. coli BH5262(pTRX6), only 
two transcription start sites were detected which were identical to those of T. ferrooxidans, at 
positions 298 and 345 (Fig.2.12, lane 1). 
2AACGT 
Fig. 2.12. Primer extension analysis of the 5' transcription start sites of the tr.xA gene cloned in 
E. coli and in T. ferrooxidans. The letters above each lane indicate the dideoxynucleotide used 
to terminate the sequencing reaction. Lane 1, extension products from E. coli BH5262(pTRX6) 
RNA and lane 2, extension products from T. ferrooxidans RNA. The first two transcription start 
sites of the gene in T. ferrooxidans are indicated by black arrows next to the text. 
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2.4 Discussion 
In spite of the differences in physiology between T. ferrooxidans and E. coli, the two bacteria 
share a remarkable amount of similarity at the genetic level (Rawlings & Kusano, 1994). 
Analysis of the trxA gene and its flanking regions is an illustration of this. The trxA genes of 
both bacteria are independently transcribed (Wallace & Kushner, 1984), present in a single copy 
and have a rho gene located immediately downstream. Furthermore, two of the 3 transcriptional 
start sites detected in T. ferrooxidans were also functional in E. coli. A minor difference is that 
in E. coli approximately 10% of the rho gene mRNA occurs as a 2.1 kbp transcript (Matsumoto 
eta/., 1986), which is a result of transcriptional read-through from the trxA gene. This does not 
appear to be the case in T.ferrooxidans. The T.ferrooxidans thioredoxin was clearly functional 
in E. coli as it enabled growth of the E. coli BH5262 gshA trxA mutant on minimal medium 
lacking glutathione and the E. coli BH2012 trxA met mutant on minimal medium containing 
methionine sulfoxide. Thus the T. ferrooxidans thioredoxin was able to serve as a cofactor for 
methionine sulfoxide reductase in E. coli. 
A more illustrative representation of the relatedness .of the TrxA proteins is shown in the 
phylogram (Fig. 2.13). As thioredoxins are usually approximately 100 amino acids in length, 
they are too small to predict phylogenetic relatedness between sequences, however it is of 
interest to compare the relatedness of thioredoxins to each other. This analysis shows the T. 
ferrooxidans thioredoxin to be most closely related to the thioredoxins of E. coli and S. 
typhimuriwn. The TrxA proteins analysed in Figure 2.13 form four clusters. The prokaryotes 
and the eubacteria form one cluster. The two Gram-positive bacteria, B. subtilis and S. 
clavuligerus, are loosely clustered with the prokaryotes and eubacteria. A. nidulans, Anabaena 
PCC 7119, C. reinhardtii (Ch2), P. yezoensis and C. caldarium form a second cluster. A third 
cluster is fonned by E. coli, S. typhimurium, T.ferrooxidans, C. vinosum andR. rubrwn. Lastly, 
C. bacterium, C. nephridii and S. aureofaciens form a fourth cluster, to which the thioredoxin of 
R. capsulatus is also very loosely clustered. 
As stated earlier, E. coli and T. ferrooxidans show a remarkable amount of similarity at the · 
genetic level, and thus it is not surprising that the two thioredoxins show a high degree of 
relatedness. The thioredoxins of C. vinosum and R. rubrum are probably clustered together as 
both are photosynthetic, purple, non-sulfur bacteria. Unlike the thioredoxins of other 
photosynthetic organisms, such as cyanobacteria and plants, their thioredoxins are reduced by 
NADPH and thioredoxin reductase rather than ferredoxin-thioredoxin reductase. T. 
ferrooxidans is also an autotrophic bacterium and, like the TrxAs of C. vinosum and R. rubrum, 
the T. ferrooxidans TrxA appears to be reduced by NADP-thioredoxin reductase, as it is 
functional in E. coli. In addition, T. ferrooxidans and C. vinosum both utilize ATP-driven 
reverse electron transport to reduce electronegative acceptors such as NAD+ (Eo= -320m V) and 
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possibly ferredoxin. Reduction via NADP is therefore energetically less costly to these bacteria 
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Fig. 2.13. A phylogram based on thioredoxin amino acid sequences. The GCG software 
packages Pileup and GrowTree were used to calculate and draw the phylogram, using the 
neighbour-joining method (Swofford & Olsen, 1990). The GenBank accession numbers of the 
sequences used were as follows: C. psittaci L3982; C. trachomatis lA0369; P. chrysogenum 
X76120; S. cerevisiae M62647; H. sapiens X54540; D. discoideum M91384; N. tabacum 
Zl1803; E. acidaminophilum L04500; B. subtilis 103294; S. clavuligerus Z21946; A. nidulans 
M14736; C. reinhardtii X62335; P. yezoensis X76612; C. caldarium X21723; E. coli M87049; 
S. typhimurium M10424; C. vinosum P09857; R. rubrum P10473; C. bacterium P00275; C. 
nephridii 102801; S. aureofaciens P33791 and R. sphaeroides M33806. 
The amino acids forming the flat, hydrophobic surface around the active site of thioredoxin that 
is thought to interact with other proteins are highly conserved. These amino acids include Asp-
26, Ala-29, Trp-31, Cys-32, Gly-33, Pro-34, Cys-35, Asp-61, Pro-76 and Gly-92 (Eklund eta/., 
1991). Pro-40 provides a kink in the alpha~2 helix, ensuring the proper position of the active 
site at the amino end of this helix, whilst Pro-7 6 appears to be important in maintaining the 
native structure of the molecule. In addition, residues Phe-12, Val-25 and Phe-27 which form 
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the internal contact surfaces between the secondary structural elements are generally unchanged 
(Eklund et al., 1991). These amino acids are all conserved in the T.ferrooxidans thioredoxin. 
The ability of the T. ferrooxidans thioredoxin in E. coli to support growth of phage T7 but not 
the filamentous phage M 13 is different to that which was found for the thioredoxin of Anabaena 
PCC 7119. No growth of wild type phage T7 occurred in the presence of the Anabaena 
thioredoxin and the protein was unable to form an active protein with the DNA polymerase gene 
5 protein in vitro (Lim et al., 1986). However, the Anabaena thioredoxin was able to support 
filamentous phage assembly. It has been suggested that the regions around amino acids 74 to 77 
and 91 to 93 of the E. coli protein are critical for the interaction of thioredoxin with the gene 5 
protein (Huber et al., 1986). Amino acid Gly-74 of the E. coli thioredoxin has been found to be 
essential for the formation of an active T7 DNA polymerase complex. T. ferrooxidans, E. coli 
(Mark & Richardson, 1976) and R. sphaeroides (Pille et al., 1990) all possess a glycine residue 
at position 74 and are all able to s~pport T7 phage replication. However, in the C. nephridii 
(Lim et al., 1987) and Anabaena (Lim et al., 1986) thioredoxins, which are both unable to 
support T7 replication, Gly-7 4 is replaced by a serine residue. 
71 
CHAPTER THREE 
THE ISOLATION AND· CHARACTERIZATION OF THE 
y-GLUTAMYLCYSTEINE SYNTHETASE GENE OFT. 
FERROOXIDANS AND THE UPSTREAM 
CHROMOSOMAL DNA. 
3.1 Summary ............................................... 74 
3.2 Introduction ................................... ,, ......... 76 
3.3 Materials and Methods ....................................... 77 
3.3.1 Bacterial strains, plasmids and media ........................... 77 
3.3.2 Preparation of DNA ...................................... 77 
3.3.3 DNA manipulations ...................................... 77 
3.3.4 Isolation of the y-glutamylcysteine synthetase gene 
by complementation of an E. coli gshA trxA mutant ................... 77 
3.3.5 Subcloning of cosmid 5.1 .................................. 77 
3.3.6 Subcloning of pTHIOD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78 
3.3. 7 Exonuclease shortening and cloning of shortened 
fragments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78 
3.3.8 Subcloning the upstream region ........................ : ...... 80 
3.3.9 Southern hybridisation of plasmid pTHI07 to 
T.ferrooxid.ans chromosomal DNA ............................ 80 
3.3.10 Nucleotide sequencing ................................... 81 
3.3.11 In vitro protein synthesis of the entire 
cloned region . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81 
3.3.12 Complementation of the gltA phenotype ......................... 81 
3.3.13 Complementation of the pyruvate dehydrogenase 
complex ............................................ 81 
3.3.14 Preparation of RNA ..................................... 82 
3.3.15 DNA:RNA hybridisation .................................. 82 
3.3.16 Assay for glutathione .................................... 82 
3.3.17 Cloning, expression and purification of 
maltose-binding protein fusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83 
3.3.18 Assay for y-glutamylcysteine synthetase activity ................... 84 
3.3.19 Dabsylation and HPLC analysis of DABS-amino acids ................ 85 
3.4 Results ................................................ 87 
3.4.1 Isolation of the gshA gene by complementation 
of the E. coli gshA trxA mutant . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87 
3.4.2 DNA hybridisation of gshA ................................. 87 
3.4.3 DNA hybridisation of the upstream region ........................ 88 
72 
3.4.4 Nucleotide Sequence Analysis ............................... 89 
3.4.4.1 Analysis of partial, single-stranded sequence 
obtained upstream of the g ItA gene . . . . . . . . . . . . . . . . . . . . . . . . 100 
3.4.5 In vitro synthesis of gltA, gshA and possible 
pyruvate dehydrogenase genes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105 
3.4.6 Complementation of the gshA phenotype ......................... 106 
3.4.7 Complementation of the gltA phenotype ......................... .106 
3.4.8 Complementation of the pyruvate dehydrogenase 
complex ............................................ 107 
3.4.9 Transcript analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108 
3.4.10 Glutathione assay . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110 
3.4.11 Cloning, expression and purification of the 
MBP-fusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111 
3.4.12 Assay for y-glutamylcysteine synthetase activity ................... 112 
3.4.13 HPLC analysis of Dabsylated products ......................... .113 




THE ISOLATION AND CHARACTERIZATION OF THE 
y-GLUTAMYLCYSTEINE SYNTHETASE GENE OFT. 
FERROOXIDANS AND THE UPSTREAM 
CHROMOSOMAL DNA. 
3.1. Summary 
The y-glutamylcysteine synthetase gene of T.ferrooxidans was isolated by complementation of 
the E. coli gshA tr.xA double mutant, strain BH5262. An 8 kbp region of chromosomal DNA 
lying upstream of the y-glutamylcysteine synthetase-complementing DNA was also cloned. It 
was confirmed by Southern hybridisation that the source of the cloned DNA was T. 
ferrooxidans ATCC 33020 chromosomal DNA and that the cloned DNA was contiguous on the 
chromosome. The nucleotide sequence of a 2.3 kbp Clai-BamHI T. ferrooxidans chromosomal 
DNA fragment was determined from both strands. Two ORFs, separated by 9 bp, 
corresponding to a citrate synthase gene and a y-glutamylcysteine synthetase gene were 
identified on the 2.3 kbp Clai-BamHI fragment. Partial sequencing and analysis of the cloned 
chromosomal DNA upstream of the Clai site indicated regions ofhomology to the genes of the 
pyruvate dehydrogenase complex. 
Synthesis of proteins corresponding to the T. ferrooxidans citrate synthase (43 kDa) and y-
glutamylcysteine synthetase (49 kDa) enzymes were confirmed using an E. coli-derived in vitro 
transcription-translation system. The identity of the proposed citrate synthase gene was also 
demonstrated by complementation of an E. coli gltA- mutant. Similarly, the DNA upstream of 
the citrate synthase gene, was found to complement an E. coli mutant for the pyruvate 
dehydrogenase complex, confirming that this region contained the T. ferrooxidans pyruvate 
dehydrogenase complex, as predicted from the sequence analysis. 
RNA:DNA hybridisation was carried out on RNA transcripts prepared from E. coli JM109, E. 
coli JM109(cosmid 5.1) and T.ferrooxidans. The transcripts were probed with probes specific 
to the gshA gene, the gltA gene and the aceF gene. All three probes gave transcripts of 9 kbp 
and a number of smaller transcripts. The 9 kbp transcripts indicate transcriptional linkage of the 
y-glutamylcysteine synthetase gene, the citrate synthase gene and the genes of the pyruvate 
dehydrogenase complex. 
The T. ferrooxidans y-glutamylcysteine synthetase gene had very low homology to previously 
cloned genes. The predicted amino acid sequence of the T. ferrooxidans gshA gene had only 18 
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%identity to those of E. coli, A. thaliana, and S. cerevisiae; and 15 %identity to that of human 
and 16 % identity to that of rat. The identity of the gene product was, therefore, confirmed by 
determining the levels of glutathione in crude extracts of the gshA mutant (E. coli BH5262), the 
gshA mutant containing the cloned T.ferrooxidans y-glutamylcysteine synthetase gene (E. coli 
BH5262(pTHI07)) and a parental strain (E. coli MC1061). Crude extracts prepared from E. 
coli BH5262(pTHI07) contained far higher levels of glutathione than crude extracts prepared 
from E. coli BH5262, indicating that the gene from T. ferrooxidans encoded a protein with y-
glutamylcysteine synthetase activity. 
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3.2. Introduction 
As discussed in Chapter 2 a group of cosmids was isolated that was able to complement the E. 
coli trxA gshA double mutant, strain BH5262, but was unable to complement the E. coli rrxA 
mutant, strain BH2012. It was, therefore, thought possible that these cosmids might encode a 
gshA gene or some other gene from T. ferrooxidans, which enabled growth of the E. coli trxA 
gshA mutant on minimal medium lacking glutathione. 
The gshA gene encodes the enzyme y-glutamylcysteine synthetase which catalyses the first step 
in the synthesis of the tripeptide thiol glutathione. Glutathione plays a pivotal role in the 
metabolism of a cell. It has previously been proposed that y-glutamylcysteine synthetase has 
evolved independently in different organisms, and yet functionally similar active centers have 
been achieved (May & Leaver, 1994). Functionally, y-glutamylcysteine synthetase enzymes 
from all organisms catalyse the same reaction and exhibit the same substrate specificity and 
apparent Km values; all enzymes are feedback inhibited in a nonallosteric manner by GSH 
(May & Leaver, 1994; Hell & Bergmann, 1990; Meister, 1983; Huang et al., 1988) and all are 
inhibited by sulfoximine analogs of y-glutamyl phosphate (May & Leaver, 1994; Hell & 
Bergmann, 1990; Griffith & Meister, 1979). However, sequence analysis suggests that the five 
gshA genes sequenced to date are structurally dissimilar. It was, therefore, of interest to 
compare the gshA gene of T.ferrooxida'ns to the other gshA genes studied. 
This is only the second gshA gene to be sequenced from a bacterium, and the first gshA gene 
found to be transcriptionally linked to the citrate synthase gene. 
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3.3. Materials & Methods 
3.3.1. Bacterial strains, plasmids and media 
The bacterial strains and plasmids used in this study are described in Appendix A. Complex 
media used for growth of E. coli was Luria-Bertani medium (LB), and M9 minimal medium was · 
used for growth of E. coli on selective medium (Sambrook eta/., 1989). T. ferrooxidans was 
grown on tetrathionate medium (see Chapter 2). When required antibiotics were added at the 
following concentrations; ampicillin 100jlg/ml and chloramphenicol 30jlg/ml. 
3.3.2. Preparation of DNA 
The alkaline lysis method (Birnboim & Doly, 1979; Ish-Horowicz & Burke, 1981) was used for 
both small and large scale plasmid preparations. Chromosomal DNA was prepared from T. 
ferrooxidans ATCC 33020 by the DNA extraction method outlined in Chapter 2. Construction 
of the gene bank ofT. ferrooxidans ATCC 33020 DNA in the cos mid vector pHC79 was carried 
out by Ramesar ( 1988). 
3.3.3. DNA manipulations 
Standard methods were used for restriction digests, gel electrophoresis, purification of DNA 
fragments from agarose gels and ligations (Sambrook eta/., 1989; Ausubel eta/., 1993). All 
enzymes and buffers were used according to the manufacturer's specifications. E. coli cells · 
were made competent by the standard rubidium chloride method described by Sambrook et a/. 
(1989). Transduction of E. coli cells with the T.ferrooxidans cosmid gene bank was carried out 
according to the method outlined in Chapter 2. 
3.3.4. Isolation of the g-glutamylcysteine synthetase gene by complementation of an E. coli 
gshA trxA mutant. 
The T. ferrooxidans A TCC 33020 cosmid library was transduced into E. coli BH5262, a gshA. 
trxA double mutant. The expression mixes were washed with 0.8% NaCI before plating onto 
M9 minimal medium containing 20 jlg/ml arginine and 100 jlg/ml ampicillin. Possible positive 
y-glutamylcysteine synthetase clones were identified by their ability to grow on M9 minimal 
medium lacking glutathione. E. coli strain BH5262 is unable to grow on minimal medium 
lacking glutathione whereas TrxA + or GshA + colonies can (Lim et a/., 1986). The positive 
clones were miniprepped and retransformed into E. coli BH5262 to confirm the GshA + or 
TrxA +complementation. 
3.3.5. Subcloning of cosmid 5.1 
Cosmid 5.1 DNA was restriction digested with BamHl and ligated with the vector 
pBluescriptSK (digested with B~HI). The ligation mixes were transformed into E. coli 
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BH5262 competent cells and expressed in M9 minimal media plus 20 J.!.g/ml arginine. The 
expression mixes were then plated on M9 minimal medium and transformants selected for 
complementation of the GshA + or TrxA + phenotype. The subclone cosmid 4.1, a BamHI 
deletion of cosmid 5.1, was isolated. A 5 kbp Hind.III-Hind.III fragment from cosmid 4.1 was 
further subcloned into the vector pUCBM21 (digested with Hind.III) to give the subclone 
pTHIOD. 
3.3.6. Subcloning of pTHIOD 
All subclones are shown in Fig. 3.1. A 4.6 kbp Hindiii-Saci fragment from pTHIOD was 
cloned into pUCBM21 to form plasmid pTHI06. Plasmid pTHI05 was constructed by 
cloning of a 2.6 kbp Hind.III-Ciai fragment from pTHIOD into pBluescriptSK (Hind.III-Ciai). 
Plasmid pTHI07 was constructed by cloning of a 1.9 kbp HindliT-Bgfli fragment from pTHIOD 
into pBluescriptSK (Hindlii-BamHI). A 1.8 kbp Smai-EcoRV fragment from pTHIOD was 
cloned into the Smai and EcoRV sites of pBluescript to produce pTIII028. As both Smal and 
EcoRV are blunt-ended restriction sites the 1.8 kbp fragment could ligate to the vector in either 
orientation. It was found that the Smal site of the insert had ligated with the EcoRV site of the 
vector and vice versa. Plasmid pTHI082 was constructed by cloning the same Smai-EcoRV 
fragment in the opposite orientation with respect to the lac promoter. A 1.3 kbp EcoRV 
fragment from pTHIOD was cloned into the EcoRV site ofpBluescriptSK to produce pTill015. 
Plasmid pTill09 was constructed by insertion of a 1.1 kbp Hind.III-San fragment from pTIIIOD 
into pBluescriptSK (Hindlil-Safl). A 0.4 kbp EcoRI-Ciai fragment from pTHI07 was cloned 
into pBluescriptSK (EcoRI-Cial) to produce pTHI08. Plasmid pTHI013 was constructed from 
a 1.3 kbp Xbai-EcoRI fragment of pTI-1107 cloned into pBluescriptSK (Xbai-EcoRO. Plasmid 
pTHI04 was constructed from a 0.8 kbp Sa/I-Xbal fragment of pTHI07 cloned into 
pBluescriptSK (Sa/1-Xbal). A 0.6 kbp BamHI-EcoRV fragment from pTHIOD was cloned into 
pBluescriptSK (BamHI-EcoRV) to produce pTHI021. Plasmid pTHI012 was constructed from 
a 1.9 kbp Kpni-Sacl fragment of pTHI07 cloned into pUCBM21 (Kpnl-Sacl). A 0.5 kbp Bgfll 
fragment from pTHIOD was cloned into pUCBM21 to form pTI-11036. Plasmid pTII1014 was 
constructed from a 0.9 kbp Clal fragment of pTHIOD cloned into pBluescriptSK. A 3.0 kbp 
Hindlii-BamHI fragment from pTHIOD was cloned into pBluescriptSK to produce pTHI017. 
All subclones were tested for the ability to complement the E. coli tr.xA gsM double mutant, 
BH5262. 
3.3.7. Exonuclease shortening and cloning of shortened fragments 
Plasmid pTHI07 was digested with Hindiil-Apai to generate a template for unidirectional 
Exonuclease III digestion by the method of Henikoff ( 1987). This enabled shortening from the 
Bg/II end of pTHI07. Plasmid pTHI012 was digested with Kpnl-Sacl to enable shortening 
with Exonuclease III from the Hindiii end of pTHI07. All subclones generated by Exonuclease 
shortening are shown in Fig. 3.2. 
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Fig. 3.1 Restriction endonuclease. map of plasmid pTHIOD and derivatives. The gshA, gltA and possible aceE, aceF and lpd genes are indicated by 
arrows. The solid line represents the region of DNA sequenced from both strands. The arrows with dotted lines indicate regions of single stranded 
sequence. Numbers proceeding restriction enzyme sites indicate the distance from the BamHI (0.0) site in kbp. 
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Fig. 3.2 Restriction endonuclease map of subclones generated by exonuclease ill shortening of 
pTill07. Cross-hatched line indicates cosmid vector pHC79, numbers indicate distance from 
BamHI (0.0) site in kbp. 
3.3.8. Subcloning the upstream region 
. All subclones are shown in Figure 3.1. A 3.4 kbp Sad fragment from cosmid 5.1 was 
subcloned into pBluescriptSK (Sad) to produce pTill051. Plasmids pTin0510, pTill052, 
pTin0525, pTill0516 and pTHI0533 were Clai, Apai, Psti, EcoRV and Smai deletions of 
pTin051, respectively. Plasmid pTill061 was constructed from a 6.0 kbp EcoRI-Psti 
fragment of cosmid 5.1 cloned into pUCBM21 (EcoRI-Pstn. A 3.8 kbp SaciT-Psti fragment 
from pTill061 and a 3.3 kbp Psti-Bgill fragment from cosmid 4.1 were ligated and cloned into 
pBluescriptSK (SaciT-BamHI) to form pTill081. Plasmids pTHI0171, pTillOlll, pTill0191 
and pTill0351 were Hindiii, Psti, Apai and EcoRV deletions of pTin081, respectively. 
Plasmid pTill0361 was constructed from a 1.3 kbp Kpni fragment of cosmid 5.1 cloned into 
pUCBM21 (Kpni). A 1.6 kbp HindiiiiClai fragment from pTinOD was cloned into 
pBluescriptSK to produce pTin025. 
3.3.9. Southern hybridisation of plasmid pTHI07 to T. fe"ooxidans chromosomal DNA 
In order to confirm the origin of the cloned y-glutamylcysteine synthetase-complementing DNA 
and the region cloned upstream, DNA hybridisation was performed. T. ferrooxidans 
chromosomal DNA, cosmid DNA and plasmid DNA were digested with restriction enzymes 
and electrophoresed together with lambda DNA (Psti) as a molecular weight marker, on a 0.8% 
80 
agarose gel. Blotting was carried out according to the method recommended by Amersham for 
Hybond N+ membranes. Hybridisation and detection were carried out according to the 
dioxygenin-dUTP non-radioactive DNA labelling and detection kit (Boehringer Mannheim). 
3.3.10. Nucleotide sequencing 
Recombinant plasmids generated from Exonuclease III shortening (Fig. 3.2), or from subcloning 
(Fig. 3.1), were sequenced by the dideoxy chain terminating method (Sanger eta/., 1977), using 
the Sequenase kit (version 2.0) from United States Biochemical Corp. The sequence of a 2.4 
kbp C/ai-BamHI fragment was determined from both strands. Regions of single and double-
stranded sequence were determined upstream of the Clai restriction site (Fig. 3.1). The Genetic 
Computer Group Inc. (GCG) sequence analysis software package (version 7.1) was used for 
sequence analysis (Devereux eta/., 1984). Multiple sequence alignments and phylogenetic trees 
were calculated using the software package Clustal W (Thompson eta/., 1994). The software 
package Tree View was utilised to draw the phylogenetic tree (Page, 1995). 
3.3.11./n vitro protein synthesis from the entire cloned region 
The in vitro syntheis of polypeptides from cosmid 5.1, plasmids, pTHI081, pTHI0191, 
pTHI051, pTHIOD, pTHI028, pTHI07 and pBluescriptSK was determined using the 
prokaryotic DNA-directed transcription kit, E. coli S30 system of Promega Corp., Madison 
USA. Reactions were performed according to the manufacturer's specifications. The proteins 
were separated by SDS-PAGE using a 5-20% gradient gel. 
3.3.12. Complementation of the gltA phenotype 
The plasmids pMW264, pBluescriptSK, pTHI06, pTHI028 and pTHI082 were transformed 
into the£. coli gltA mutan't, strain MOB150. The transformants were plated onto Luria-Bertani 
agar containing 100 Jlg/ml ampicillin and placed at 37°C until colonies were visible 
(approximately 36 hours). Individual colonies were then streaked onto both M9 minimal media 
plates containing no amino acids and M9 minimal media plates containing 20 j.l.g/ml glutamate. 
Possible citrate synthase positive clones were identified by their ability to grow on M9 minimal 
medium lacking glutamate. E. coli MOB150 is unable to grow on minimal medium lacking 
glutamate, whereas GltA +colonies can (Wood eta/., 1987). Positive clones were selected, and 
the DNA isolated, retransformed and tested for the ability to complement E. coli MOB150, as 
above, to confirm the GltA + phenotype. 
3.3.13. Complementation of the pyruvate dehydrogenase complex 
Constructs to be tested were transformed into E. coli JRG1342, the aroP-aceEF-lpd deletion 
mutant. The expression mixes were plated on Luria-Bertani agar plates and the appropriate 
antibiotics and placed at 37°C for approximately 36 hours or until colonies were visible. 
Individual colonies from each plate were then streaked out onto M9 minimal media agar plates, 
with glucose ( 10 mM), potassium succinate (50 mM) or potassium acetate (50 mM) as carbon 
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sources and supplements of acetate (2 mM and 4 mM for glucose and succinate carbon sources 
respectively), succinate (2 mM), and L-methionine (20 ~g/ml) (see Table 3.5). 
3.3.14. Preparation of RNA 
All glassware, apparati and chemicals .used for RNA extraction and analysis were treated as 
outlined in Chapter 2. T. ferrooxidans total RNA was prepared from cultures grown on 
tetrathionate medium, and E. coli total RNA from cultures grown on M9 minimal medium by 
the method of Aiba et al. (1981). 
3.3.15. DNA:RNA hybridisation 
All DNA probes were labelled with [32p]CfP (3000Ci/mmol) using the Random Primed DNA 
labelling kit from Boehringer Mannheim. Total RNA from T. ferrooxidans, E. coli 
JM105(cosmid 5.1) and E. coli JM105 was separated on a 1.5% agarose gel containing 6% 
formaldehyde (Amersham Hybond N+ protocol). The RNA was transferred to an Amersham 
Hybond N+ membrane and hybridisation and washes were carried out according to the 
manufacturer's specifications. 
Three different DNA:RNA hybridisations were carried out. In the first, the RNA was probed 
with a 900 bp Sali-BamHI 32P-labelled fragment from pTHI07. The second probe was derived 
from a 1.1 kbp BamHI-Smai fragment of pTHI028 and the third probe from a 900 bp Hindiii-
Apai fragment from pTHI052. 
3.3.16. Assay for glutathione 
A modification of the fluorometric assay described by Hissin & Hilf (1976) was used to 
measure the endogenous GSH content of the bacteria. Overnight cultures of the strains were 
grown in M9 minimal medium plus the appropriate amino acids and antibiotics. The cultures 
were pelleted (5000rpm for 10 minutes), and resuspended to an approximate concentration of 1g 
wet cells per 5 ml of minimal medium. The bacterial suspensions were sonicated for 8 X 30s at 
0°C, centrifuged for 10 minutes at 12 000 rpm and the resulting supernatant fractions used 
immediately or stored at -70°C for up to a month. 
Fifteen ~of 25% trichloroacetic acid were added to 100 ~I of bacterial extract, and the extract 
centrifuged to remove precipitated protein. Forty ~I of the supernatant were added to 960 ~ of 
fresh phosphate-EDTA buffer (O.lM potassium phosphate pH 8, 0.005M EDTA). The final 
reaction mixture contained 0.1 ml of the diluted extract, 1.8 ml of phosphate-EDT A buffer and 
0.1 ml of o-ophthalaldehyde (OPT) solution (1 mg/ml o-opthalaldehyde in absolute methanol, 
made up fresh). After thorough mixing and incubation at room temperature for 15 minutes, the 
solution was transferred to a quartz cuvette, and the fluorescence at 420nm was determined with 
activation at 350nm. 
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A standard curve was plotted using known concentrations of glutathione (Appendix B). To 
account for background interference due to the reaction of o-opthalaldehyde with compounds 
other than GSH in the bacterial extract, 4 !J.l of undiluted bacterial extract (treated with 
trichloroacetic acid), derived from the negative control E. coli BH5262, was added to the 
standards. 
3.3.17. Cloning, expression and purification of maltose-binding protein fusion 
The maltose-binding protein (MBP) vectors allow the expression and purification of a protein 
encoded by a cloned gene, by fusing it to the MBP, encoded by the malE gene of E. coli. This 
method uses the strong, inducible tac promoter and the malE translation initiation signals to give 
high levels of expression of the cloned gene, followed by affinity purification for the MBP to 
facilitate isolation of the fusion protein (Kellerman & Ferenci, 1982). 
As there were no restriction sites available for cloning the target gene in frame with the malE 
gene of the vector pMal-c2, the target gene was cloned by PCR. A synthetic oligonucleotide 
primer was designed containing a Pvull restriction site for in frame cloning into the Stul site of 
the pMal vector, followed by the nucleotide sequence corresponding to the 5' end of the target 




The oligonucleotide primer was synthesized by the Dept. of Biochemistry, University of Cape · 
Town, using an Autogen 6500 DNA synthesizer and it was purified by a reverse phenyl 
cartridge purification processs. 
The second primer used for PCR, was the T7 sequencing primer, which annealed to the 
pBluescriptSK vector of plasmid pTHI07, at the 3' end of the target gene (Hindlll end). The 
reaction mix for PCR was constituted as follows: 
0.5 J.Lg pTHI07 DNA or h~ss 
10 X PCR/Taq buffer 
10 X MgCl2 (25mM) 
0.25 J.LM of each primer 
2.0 mM each mixed dNTPs (final cone. 
200 J.LM each) 












The reaction mix was overlayed with 100 J..Ll of mineral oil and placed in the PCR machine. The 
PCR regime was as follows; 
1. 60s at 94 °C 
2. 30s at 94 °C 
3. 30s at 50°C 
4. 90s at 72°C 
5. 120s at 72°c 
6. 60s at 20°C 
Steps 2 to 4 were repeated for 30 cycles. 
A 10 J..Ll aliquot was removed and electrophoresed on a 0.8 % agarose gel to check that a PCR 
product of the predicted size had been produced. The aqueous phase of the PCR reaction mix 
was then removed, precipitated and resuspended in 50 J..Ll Tris/EDT A buffer (Sam brook et al., 
1989). The PCR product was digested with the restriction enzymes Pvull!BamHl and the pMal 
vector with Stui/BaniHI and the two fragments ligated. The ligation mix was transformed into 
E. coli TBI competent cells and the DNA isolated from the transformants mapped with 
restriction enzymes. 
The MBP-fusion protein was then purified according to the method of Ausubel et al. (1993). A 
pilot experiment indicated that the fusion protein was located in the crude extract and not in the 
osmotic shock fluid, so the standard purification procedure was followed. Maltose was removed 
from the extract after Factor Xa cleavage by dialysis in 2 litres of column buffer for 24 hours 
(with replacement of the buffer every 5 hours). The dialysed cleavage products were passed 
through the amylose resin column to remove the MBP. The purified protein was concentrated 
to 1.0 mg/ml using a Diaflo PMlO membrane (Amicon) and an Amicon filtration apparatus. 
3.3.18. Assay for y-glutamylcysteine synthetase activity 
The standard assay for determination of gshA activity contained; lOOmM Tris-HCl at pH 8.2, 
lOmM L-glutamate, lOmM L-a-aminobutyrate, 40mM MgCl2, 5mM ATP and the enzyme 
extract to a final volume of 50 J..Ll. The reaction mix was incubated at 30°C for 15 minutes. Ten 
J..Ll 25% trichloroacetic acid was added and the precipitated proteins removed by centrifugation. 
As a negative control enzyme storage buffer was used in place of the enzyme extract. The 
amount of inorganic phosphate in the supernatant was measured according to the method of 
Lanzetta et al. (1979). The following stock solutions were made: 
A. 0.045% malachite green hydrochloride 
B. 4.2% ammonium molybdate in 4N HCl 
C. 34% sodium citrate.2H20 (w/v) 
D. lOOJ..Ll Triton N in 20ml deionized water 
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E. 10mM K2HP04 (initially dried overnight at 100°C), from which appropriate dilutions were 
made to give inorganic phosphate concentrations of 1-10 nm for standard curve determinations. 
The colorimetric reagent was made with a 3:1 mix of A: B. This solution was stirred for 20 
minutes, and was then filtered through a 0.45 Jlm Millipore membrane fllter. Solution D was 
added at a concentration of 300J.1V5ml filtrate, and the solution stirred for 30 minutes at room 
temperature. 
The amount of inorganic phosphate released by the enzyme reaction mix was measured by 
adding 50jll of the terminated mix to 800jll of the colorimetric reagent in 1ml disposable 
spectrophotometric cuvettes. After 1 min, the reaction was quenched by adding lOOJ.1l of 
solution C. The contents of the tubes were briefly vortexed and left at ambient temperature for 
30 minutes. The OD660 was read. To account for background interference, the absorbance 
reading obtained for the negative control was substracted from that obtained for each sample. 
The amount of inorganic phosphate released was determined by reference to a standard curve, · 
obtained using Pi prepared from solution D, containing 1, 2, 5, 8, and lOnm Pi and 5% 
trichloroacetic acid. Five percent trichloroacetic acid was added as it was found to affect the 
absorbance reading of the samples and therefore had to be added to the standards also. 
3.3.19 Dabsylation and HPLC analysis of DABS-amino acids 
The following samples were prepared for HPLC analysis: (i) the standard assay mixture for 
determination of gshA activity, as in section 3.3.19. (ii) the standard assay mixture with enzyme 
storage buffer instead of enzyme extract, (iii) the standard assay mixture without the substrates. 
The samples were placed at 30°C for 30 minutes. Proteins and contaminants were removed 
from the samples prior to HPLC analysis using Sep-pak C18 columns, according to the 
manufacturer's specifications (Millipore). The above samples and the standards L-glutamate, a-
aminobutyrate, GSH and water were dabsylated according to the following procedure: the 
samples were hydrolysed by freeze drying and dissolved in 25 J.l.l of 50mM sodium bicarbonate 
(pH 9.0). Next, 50 J.l.l DABS-Cl solution (4 mM in acetonitrile; freshly prepared) was added to 
each sample. The samples were sealed and heated at 70°C for 12 minutes (the mixture becomes . 
completely soluble after heating). After dabsylation, the samples were diluted with 125 J.l.l of 
diluting solution (50 mM sodium phosphate pH 7.0/ethanol, 1:1 v/v) and approximately 50 J.l.l 
injected directly for HPLC analysis. 
The dabsylated samples and standards were separated on a reverse phase C-18 column (4.6mm 
x 15 em, TSK-gel ODS-80Tm, manufactured by TosoHaas), using as eluting solvents 38 mM 
potassium phosphate, pH 6.5 (solvent A) and 80 % acetonitrile (solvent B) at a flow rate of 1 
mVminute. Both solvents were degased prior to use. The detector wavelength used was 436nm. 
Following injection the column was eluted as follows: 
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Time (mins) %Solvent A %Solvent B 
0 100 0 
15 50 50 
30 20 80 
32 20 80 
38 100 0 
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3.4. Results 
3.4.1. Isolation of the gshA gene by complementation of the E. coli gshA trxA mutant. 
As described in Chapter 2, transduction of the T. ferrooxidans genome cosmid library into E. 
coli BH5262 resulted in approximately 100 colonies that were able to grow on minimal medium 
lacking glutathione. DNA was prepared from 16 of these colonies and restriction endonuclease 
mapping carried out. These cosmids could be divided into two groups that had several 
fragments in common and appeared to contain overlapping pieces of two regions of the T. 
ferrooxidans chromosome. Only one of the groups of cosmids, on transforming into E. coli 
BH2012, enabled cells to grow on minimal medium plus methionine sulfoxide. This group of 
cosmids was found to contain the thioredoxin gene. A representative of the second group of 
cosmids, that were unable to complement E. coli BH2012, cosmid 5.1, was chosen for further 
study. 
3.4.2. DNA hybridisation of gshA. 
The source of y-glutamylcysteine synthetase-complementing DNA was confirmed by the 
hybridisation of labelled pTIII07 (linearised with Hindill), to T. ferrooxidans A TCC 33020 
chromosomal DNA, cosmid 5.1, cosmid 4.1 and plasmids pTHIOD and pTIII07 digested with 





1 2 3 4 5 6 
Fig. 3.3 Hybridisation of labelled plasmid pTHI07 to: Smal digests of lane 1, plasmid pTHI07; lane 2, plasmid pTHIOD; lane 3, cosmid 4.1; lane 4, cos mid 5.1 and lane 6, T. ferrooxidans ATCC 33020 chromosomal DNA, and a BamHI digest of cosmid 5.l,lane 5. 
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The 3.0 kbp Smal fragment that is internal to the cloned T. ferrooxidans chromosomal DNA 
present on pTHIOD corresponded exactly to the Smal fragment present on the T. ferrooxidans 
chromosome, cos mid 5.1, cosmid 4.1 and pTHIOD. Similarly the 1.8 kbp BamHl fragment 
present on cosmid 5.1, corresponded to the size predicted from restriction endonuclease 
analysis. This indicated that the cloned genes originated from T. ferrooxidans ATCC 33020, 
and that no rearrangements had occurred in the region between the Smal (3.0) and BamHI (1.0) 
sites during cloning. The hybridisation signal at 4.8 kbp (Fig. 3.3, lane 1) of pTHI07 
corrresponded to the linearised plasmid, as pTHI07 only contains a single Smal site. The 
hybridisation signals above the 3.0 kbp Smal signal, for cosmids 4.1 (lane 3) and 5.1 (lane 4) 
corresponded to hybridisation of the Smai-BamHI flanking region and vector DNA. Digestion 
of pTHIOD with Smal gives a doublet at approximately 3.0 kbp and single fragments at 1.8 kbp 
and 0.4 kbp. The probe hybridised to both the internal 3.0 kbp Smal fragment and the 3.0 kbp 
vector-Smai-BamHI fragment. 
3.4.3. DNA hybridisation of the upstream region 
It was confirmed that the subclones pTHI061, pTHI081 and pTHI051 were composed of 
contiguous pieces of DNA, by comparison of hybridisation signals of the plasmids to those of 
the T. ferrooxidans A TCC 33020 chromosome and cos mid 5.1, probed with linearised plasmid 
pTHI051 (Fig. 3.4). The 3.4 kbp Sacl fragment that was cloned into pTHI051 corresponded 
exactly to the fragment present on the T.ferrooxidans chromosome (lane 1 ), cosmid 5.1 (lane 2) 
and plasmids pTHI081 (lane 4) and pTHI051 (lane 10). The digest of plasmid pTHI051 was 
included to check that the probe was labelled correctly. Plasmid pTHI061 contains a single 
Saci restriction site and therefore gave a hybridisation signal at 9.0 kbp corresponding to the 
linearised plasmid (Fig. 3.4 lane 3). Additional hybridisation signals at approximately 14.0 kbp 
(cosmid 5.1, lane 2), 5.4 kbp (pTHI081, lane 4) and 2.9 kbp (pTHI051, lane 10), corresponded 
to the hybridisation of vector DNA. When the T.ferrooxidans chromosomal DNA was digested 
with Sacll a strong hybridisation signal at 5.1 kbp and a weaker one at 0.8 kbp, which were also 
present on cos mid 5.1 and plasmid pTHI081, were detected (Fig. 3.4, lanes 6, 7 and 9). 
Plasmid pTHI061 contains a single Sacll restriction site and therefore gave a single 
hybridisation signal at 9.0 kbp (Fig. 3.4 lane 8). The hybridisation signal at 14.0 kbp in the 
Sac II digest of cosmid 5.1 (Fig. 3.4 lane 7) and at 5.1 kbp in the Sacll digest of pTHI081 (Fig. 
3.4 lane 9) corresponded to the hybridisation of vector DNA. Digestion of pTHI081 with Sacll 
gave a doublet at 5.1 kbp and a single fragment at 0.8 kbp. Thus the probe (pTHI051) 
hybridised to both fragments of the pTHI081 (Sacll) doublet. These results indicated that the 
cloned DNA originated from T. ferrooxidans A TCC 33020, and that no rearrangements had 
occurred between the Sacll (9.3) and Sac II (3.5) sites. 
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Fig. 3.4 Hybridisation of labelled plasmid pTHI051 to: Sac! digests of lane 1, T.ferrooxidans 
ATCC 33020 chromosomal DNA; lane 2, cosmid 5.1; lane 3, plasmid pTHI061; lane 4, 
plasmid pTHI081; lane 10, plasmid pTHI051; and Sacll digests of lane 6, T. ferrooxidans 
ATCC 33020 chromosomal DNA; lane 7, cosmid 5.1; lane 8, plasmid pTHI061 and lane 9 
plasmid pTHI081. 
3.4.4. Nucleotide Sequence Analysis 
The nucleotide sequence from 154 bp upstream of the Clal (2.4) site to the BamHI (0.0) site is 
shown in Fig. 3.5. 
1 t AGTGCCCCAAGGGGAGGCTGACGGCCTCCCTTTTATTTTACGGGCAGGTTATGATGAT 
59 CCGGCGGCTTGTCGTCCGGACGCCTTCGTGCAGGACGCTGCCCGTGAGCAGTGCCCCG 
117 ACTGGCCGACCGCCGAAGGTCCGGGCAGTCAAACACCAGAATGATTAAAGGAGTTCTG 
start of gltA gene ~ 
175 TATGGCGGAACCGAACTTTGCGCCAGGTCTGGAGGGTGTGGCTGCAACCCAGTCCAGC 
M A E P N F A P G L E G V A A T Q S S 
233 ATTTCCAACATCGATGGCGCTGCCGGCCTGCTGAGTTACCGTGGTTTTGCCATTGCGG 
I S N I D G A A G L L S Y R G F A I A 
291 ATCTTGCGGCGCACAGCAGTTTCGAGGAGGTGGCGCTCTTGCTGCTGGATGGTGTCCT 
D L A A H S S F E E V A L L L L D G V L 
349 GCCCGGCGCCGCAGATCTGGAACGGTTCGACCACGGTCTGCGTGCGCACCGCCAAGTC 
P G A A D L E R F D H G L R A H R Q V 
89 
407 AAATATAATGTCCGGGAAATCATGAAGTTCATGCCCGTGACCGGACACCCCATGGATA 
K Y N V R E I M K F M P V T G H P M D 
465 TGCTGCACTGTGCCGTGGCCAGTCTGGGCATGTTCTACCCGCAGCAGGAGCTTTCCGA 
M L H C A V A S L G M F Y P Q Q E L S D 
523 TGCCGAACGCGGAAATACGCTCCATTTGGACGCCATGGCGATGCGGATTATCGCGCGC 
A E R G N T L H L D A M A M R I I A R 
581 ATGCCCACCATTGTCGCGATGTGGGAGCAGATGCGTTTCGGCAATGATCCTATTTCAC 
M P T I V A M W E Q M R F G N D P I S 
639 CTCGCCCGGATCTCAGCCATGCGGCCAACTTTCTCTATATGCTGTCGGGTCGCGAACC 
P R P D L S H A A N F L Y M L S G R E P 
697 TGATCCGGCCCATACCAAAATCCTCGACTCCTGCCTGATTCTGCATGCCGAGCACACC 
D P A H T K I L D S C L I L H A E H T 
755 ATCAATGCCAGTACCTTCTCGGTACTGGTGACCGGATCCACCCTGACCAATCCTTACC 
I N A S T F S V L V T G S T L T N P Y 
813 ATGTCATCGGGGGGGCGATCGGAACCCTGGCCGGCCCGTTGCATGGTGGTGCCAATCA 
H V I G G A I G T L A G P L H G G A N Q 
871 GAAGGTGGTGGAAATGCTGGAAGAAATCAGCTCCGTCCAGCAGGTGGGTGCCTATCTC 
K V V E M L E E I S S V Q Q V G A Y L 
929 GACAGGAAGATGGCCAACAAGGAGAAGATCTGGGGTTTCGGGCATCGCATCTACAAAA 
D R K M A N K E K I W G F G H R I Y K 
987 CCCGCGATCCGCGTGCAGTGATTCTCAAGGGGATGATGGAGGATATGGCCAGTCATGG 
T R D P R A V I L K G M M E D M A S H G 
1045 AAATCTGCGGCATAGCAGCCTCTTTGAAATTGCCATCGAAGTGGAACGCCAGGCTACG 
N L R H S S L F E I A I E V E R Q A T 
1103 GAGCGGCTCGGTGCCCAAGGGATTCACGCCAATGTGGATTTCTATTCGGGCGTGCTGT 
E R L G A Q G I H A N V D F Y S G V L 
1161 ATCACGAGATGGGCATCAAAGCGGACCTTTTTACGCCTATTTTTGCTATGGCTCGTTC 
Y H E M G I K A D L F T P I F A M A R S 
1219 TGCGGGCTGGCTGGCTCACTGGCGGGAGCAACTGGCGGATAACCGGATCTTCCGGCCT 
A G W L A H W R E Q L A D N R I F R P 
1277 ACGCAGGTGTATACAGGGGAACAGGATCGACGCTATGTGCCTGTGGCCCAACGTACTT 
T Q V Y T G E Q D R R Y V P V A Q R T 
start of gshA gene 
1335 AGGAAAGACGCATGACGGAAGTGATACGGGATATTCCTTTCCTGGCCACGGATCGGGT 
* M T E V I R D I P F L A T D R V 
1393 GGAGGCTCTGCTGGATATCGAGCGCCACCTGATCGTCGAGCAATCCACGATTGAGCGC 
E A L L D I E R H L I V E Q S T I E R 
1451 TGGTTTCGGGGACAATGGCAACGGACGCCACCGCCTTTCTATGCCTCTGTGGACTTGC 
W F R G Q W Q R T P P P F Y A S V D L 
1509 GCAATGCCGGTTTCAAGTTGGCGCCCGTGGACACCAATCTGTTTTCGGCGGGCTTTAA 
R N A G F K L A P V D T N L F S A G F N 
90 
1567 TAACCTCAATCCGGAGTTTTCGGCGGTCTATGTTTCGGCTATTCAGCATTATCTGAAC 
N L N P E F S A L Y V S A I Q H Y L N 
1625 CAGTACCATCCAGGTCTGGAGCGGGTACTGCTGATTCCTGAAAACCACACGCGTAACC 
Q Y H P G L E R V L L I P E N H T R N 
1683 TTTTTTATCTGGAGAGCGTGGCACGATTGCGTGAGTTGTTGGAACTCGCCGGATTGGA 
L F Y L E S V A R L R E L L E L A G L D 
1741 CGTGCGAGTGGGCTCCCTGATTCTGGAAGACCGTACGGTCTATGATCTGCCTTCAGGT 
V R V G S L I L E D R T V Y D L P S G 
1799 GGCCAGTTGCTGCTGGAACCACTGTGTCGCGACGACGGGCGGCTGTCGACGAGGGGTT 
G Q L L L E P L C R D D G R L S T R G 
1857 TTGATGCACAACTGATCTTACTGAACAATGATTTATCTGGTGGTGTGCCGGAAATATT 
F D A Q L I L L N N D L D G G V P E I L 
1915 GGCAGGCCTGGAGCAACCTATTCTGCCCCCCCTCGCGGCAGGTT~GCGTAACCGGCGT 
A G L E Q P I L P P L A A G W R N R R 
1973 AAATCCCAGCACTTCACCCATTACCGTGCGGTGGCACAGGAGCTGGCGGAGGTGATTG 
K S Q H F T H Y R A V A Q E L A E V I 
2031 GCATCGATCCCTGGCTGATTGACCCCGTTTTTCGGCGTTGTCAGGGCATTGACTTCAT 
G I D P W L I D P V F R R C Q G I D F M 
2089 GCGCTCCGAAGGCCGCGAGTGCCTGGTTGCGAACGTGGATGCCGTACTGGAGATCACC 
R S E G R E C L V A N V D A V L E I T 
2147 CGCGAGCGTTATGCCCACTATGGTATTCATCAGCGTCCTTTTGTGATCGTCAAGGCGG 
R E R Y A H Y G I H Q R P F V I V K A 
2205 ATGCGGGTACTTACGGTATGGGTATTATGACCGCCTATTCGGGTGAGGAATTCCTTGA 
D A G T Y G M G I M T A Y S G E E F L D 
2263 CCTCAACCGTAAGGAACGCACCCGGATGGCGAAGAGTAAAGAGGGGTTGCCGGTCAGT 
L N R K E R. T R M A K S K E G L P V S 
2321 GACGTCTTTATTCAAGAGGGTGTATATACCTTCGAACAGACCGCGCAGGAGGCAGTCG 
D V F I Q E G V Y T F E Q T A Q E A V 
2379 CAGAGCCGGTGGTCTATATGATCGGTCAGCAGGTGCTGGGAGGGTTTTACCGGGTGCA 
A E P V V Y M I G Q Q V L G G F Y R V H 
2437 TACGGAGCGTGGACGGGATGAGAATCTCAACGCTCCGGGTGCGCATTTTGAGCCAATG 
T E R G R D E N L N A P G A H F E P M 
2495 GCCTTTGGCCAGACCTGCGTGCTCCCTTGCCGGAAGTCGCCACCGGATGCGCCGGCCA 
A F G Q T C V L P C R K S P P D A P A 
2553 ATCGTTACTATGCCTATGGCGTCATCGCGCGCCTCACTCTGGTGGCGGCGGCCCGGGA 
N R Y Y A Y G V I A R L T L V A A A R E 
2611 AATGGCAGACTGGCGGCGGCAAGGTACACTGGAGACAGGCCAATGAGTGCGCTCAAGG 
M A D W R R Q G T L E T G Q * 
Fig. 3.5 Nucleotide sequence from 154 bp upstream of Clal site (2.4) to Bamm site (0.0) and 
the deduced citrate synthase and y-glutamylcysteine synthetase amino acid sequences. Putative 
ribosome binding sites are indicated.in bold. 
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Fig. 3.6 shows the CODONPREFERENCE analysis of the sequence using a Tfchrom.cod codon 
usage data ftle generated from previously sequenced T. fe"ooxidans genes. Two ORFs can be 
clearly seen in the second reading frame. Both ORFs show a codon preference and absence of 
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Fig. 3.6 Codonpreference analysis of the amino acid sequence from 154 bp upstream of the 
Clai site (2.4) to the BamHI site (0.0). The vertical axis shows the CODONPREFERENCE 
plots of all of the three forward frames, with ORFs and the positions of rare codons (defmed as 
those codons which appear in the Tfchrom.cod codon usage data flle at a frequency of less than 
10%) drawn below as open boxes and vertical bars, respectively. Any plot above the dotted line 
in any of the three reading frames identifies a protein-coding sequence with a similar codon 
usage to the Tfchrom.cod data flle. 
Further evidence for the probability of the two ORFs coding for proteins was provided by 
analysis of the sequence data using the UWGCG application TESTCODE. TESTCODE 
produces a graph which predicts coding regions to a 95% level of confidence, represented by 
any plot above a level of 9.5 TESTCODE units. Fig. 3.7 shows the TESTCODE analysis in 
which both ORFs predicted from the CODONPREFERENCE application correspond to coding 
regions using the TESTCODE analysis. 
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Fig. 3.7 TESTCODE analysis of the amino acid sequence from 154 bp upstream of the Clal site · 
(2.4) to the Bamm site (0.0). The ORFs predicted from the nucleotide sequence are shown as 
open boxes. The vertical axis is in TESTCODE units, with two horizontal lines demarcating the 
three "windows" of probability for protein-coding sequences: < 7,5 units = low probability; 7.5-
9.5 units= intermediate probability; >9.5 units= 95% probability. 
The first ORF is preceeded by a strong ribosomal binding site and encodes a polypeptide of 386 
amino acids, corresponding to a protein of approximately 43 kDa. The second ORF encodes a 
polypeptide of 436 amino acids, corresponding to a protein of 49 kDa. The predicted amino 
acid sequences were analysed for homology to sequences in the GenBank data base using the 
program NCBI BLAST and the first ORF was found to be closely related to a number of citrate 
synthases (37% identity to that of E. coli GenBank accession no. J01619). The predicted amino 
acid sequence of the T. ferrooxidans citrate synthase gene (gltA) was aligned with previously 
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Fig. 3.8 Alignment of the deduced amino acid sequence of the T. jerrooxidans gltA gene with 
other gltA gene products. Aa = Acetobacter anitratum (GenBank: no. M33037), Pa = 
Pseudomonas aeruginosa (GenBank: no. M29728), Ec =E. coli (GenBank: no. V01501), Rt = 
Rhizobium tropici (GenBank: no. 2 34516), Cb =Coxiella burnetti (GenBank: no. M36338), Rp = 
Rickettsia prowazekii (GenBank: no. Ml7149), Cg =Corynebacterium glutamicum (GenBank 
no. X66112), Bs =Bacillus subtilis citZ gene (GenBank: no. U05257) , Bsi =B. subtilis citA gene 
(GenBank: no. U05256), Be= Bacillus coagulans (GenBank: no. M74818), Ms =Mycobacterium 
smegmatis (GenBank: no. X60513) and Ta = Thermoplasma acidophilum (GenBank: no. 
X55282). 
Regions of high sequence homology can be seen, identifying the ORF as a T. ferrooxidans 
citrate synthase gene. The key position of citrate synthase as the first enzyme of the Kreb's 
cycle, has lead to it being studied in a number of different organisms. These studies have 
identified two main types of citrate synthase: Gram-positive and eukaryotic organisms possess 
"small" dimeric citrate synthases (Mr 100 kDa), which are inhibited by ATP and isosterically 
. 
regulated, whereas Gram-negative bacteria in general have "large", hexameric forms (Mr 250
 
kDa) which are allosterically inhibited by NADH, and in facultative anaerobes, by a-
ketoglutarate. However, the subunits of both citrate synthase types are approximately the same
 
size (Mr 40-50 kDa) and display ·fairly high amino acid identity in some regions. Thus, 
although the T. ferrooxidans citrate synthase is clustered with Gram-positive bacteria such as 
the Bacilli, this may be due to similarity at the amino acid level only (Fig 3.9). Further analyses 
95 
would be required to determine whether the enzyme belongs to the "small", hexameric type 




















Corynebacterium gl utamicum 
Thio bacillus ferrooxidans 
Bacillu 
Thermoplasma acidophilum 
s subtilis (citZ) 
B acillus subtilis (citA) 
Mycobacterium smegmatis 
Bacillus coagulans 
Fig. 3.9 A phylogram based on citrate .synthase amino acid sequences. The software packages Clustal W and Tree View were used to calculate and draw the phylogram. Bootstraping values are indicated at the branch points (values are out of 1000). The scale of 0.1 indicates 10% amino acid divergence. The GenBank accession numbers are the same as those indicated in Fig. 3.8. 
The percentage similarity and identity of the T. ferrooxidans gltA gene product to other gltA 
gene products is shown in Table 3.1. 
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Table 3.1. Percentage identity and similarity of T. ferrooxidans gltA predicted amino acid · 
sequence to other gltA gene products. Values were determined using the UWGCG program 
GAP. 
Bacterium %Identity % Similarity 
B. subtilis citZ 42.59 60.11 
C. glutamicum 41.69 62.80 
R. prowazekii 39.37 59.58 
A. anitratum 38.03 59.57 
R. tropici 37.53 59.32 
M. smegmatis 37.50 57.34 
E. coli 37.23 59.04 
B. subtilis citA 36.91 58.36 
P. aeruginosa 36.74 58.00 
C. burnetti 36.55 58.23 
B. coagulans 35.95 60.27 
T. acidophilum 32.74 56.25 
S. cerevisiaea 25.73 52.26 
Porcineb 24.60 49.20 
a GenBank accession no. Z23259 
b GenBank accession no. M21197 
The second ORF showed no significant homology to any proteins in the GenBank data base 
using the program NCBI BLAST. Since the gene was known to complement an E. coli gshA 
trxA mutant, but not an E. coli trxA mutant, it was probable that the ORF was complementing 
the gshA mutation. The amino acid sequence was, therefore, compared to the amino acid 
sequence of the E. coli gshA gene, using the UWGCG application GAP (Fig. 3.10). · The ORF 
was found to have 47% amino acid similarity and 18% amino acid identity to the E. coli gshA 
gene. This low level of homology was considered significant as the gshA genes are not highly 
homologous. A comparison of the % amino acid identities and similarities of the gene product 
of the second ORF to those of several other organisms was carried out using the UWGCG 
application GAP (Table 3.2). The rat and human GshA proteins are highly homologous (89% 
identity), and the yeast protein is fairly homologous to the human and rat proteins (46 and 45% 
respectively). However, the A. tha/iana, E. coli and T.jerrooxidans proteins differ widely, with 
identities ranging between 15 and 18% to the othery-glutamylcysteine synthetase proteins. 
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T.f MTEVIRDIPFLATDRVEALLDIERHLIVEQSTIERWFRGQWQRTPPPFYASVDL 54 
: I I II I I I I I : I I I 
E.c LIPDVSQALAWLE.KHPQALKGIQRGL .. ERETLRVNADGTLATTGHP ..... EA 47 
T.f RNAGFKLAPVDTNLFSAGFNNLNP ..... EFSALYVSAIQHYLNQYHPGLERVL. 103 
: I I : I I I I II I 
E.c LGSALTHKWITTDFAEALLEFITPVDGDIEHMLTFMRDLHRYTAR.NMGDERMLP 101 
T.f ..... LIPENHTRNL .. FYLESVARLRELLELAGLDVRVGSLILEDRTVYDLPSG 151 
I I I I I II I I I I I 
E.c LSMPCYIAEGQDIELAQYGTSNTGRFKTLYR.EGLKNRYGALMQTISGVHYNFSL 155 
T.f GQLLLEPLCRD ...... DGRLSTRGFDA ..... QLILLNNDLSGGVPEILAGLEQ 195 
I I : I I I I I I I 
E.c PMAFWQAKCGDISGADAKEKISAGYFRVIRNYYRFGWVIPYLFGASPAICSSFLQ 210 
T.f PILPPLA ..................... AGWRNRRKSQHFTHYRAVAQELAEV .. 227 
I I I : I : I 
E.c GKPTSLPFEKTECGMYYLPYATSLRLSDLGYTNKSQSNLGITFNDLYEYVAGLKQ 265 
T.f ...•.•..... IGIDP ........•... WLIDPVFRRCQGIDFMRSEGREC ... L 256 
Ill: II I 
E.c AIKTPSEEYAKIGIEKDGKRLQINSNVLQIENELYAPIRPKRVTRSGESPSDALL 320 
T.f VANVD .. AVLEITRERYAHYGIHQRPFVIVKADAGTYGMGIMTAYSGEEF .. LDL 307 
I I : . I I 
E.c RGGIEYIEVRSLDINPFSPIGVDEQQVRFLDLFMVWCALADAPEMSSSELACTRV 374 
T.f NRKERTRMAKSKEGLPVSDVFIQEGVYTFEQTAQEAVAEPVVYMIGQQVLGGFYR 362 
I I I II I I 
E.c NW.NRVILEGRKPGLTL.GIGCETAQFPLPQVGKD ...... LFRDLKRVAQTLDS 422 
T.f VHTERGRDENLNAPGAHFEPMAFGQTC.VLPCRKSPPDA .. PANRYYAYGVIARL 414 
I I I I I : I 
E.c INGGEAYQKVCDELVACFDNPDLTFSARILRSMIDTGIGGTGKAFAEAYRNLLRE 476 
T.f TLVAAARE ... MADW .... RRQGTLETGQ ............ 436 
II 1: Ill I 
E.c EPLEILREEDFVAEREGFERRQQEMEAADTEPFAVWLEKHA 518 
Fig. 3.10 Comparision of the amino acid sequences of the T. ferrooxidans (T.f.) and £. coli 
(E.c.) (GenBank X03954) y-glutamylcysteine synthetase proteins. 
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Table 3.2 Amino acid identities and similarities between y-glutamylcysteine synthetases from 
different species. 
% Similarity 
Rat Human Yeast A. t. E. c. T.f. 
Rat 97 63 44 42 46 
-Human 94 65 44· 43 43 
P'o ld~ntitx Yeast 45 46 44 46 45 
A. t 15 17 17 - 45 45 
E. c 15 15 16 16 47 
T.f 16 15 18 18 18 
A. t = A. thaliana, E. c = E. coli, T. f = T. ferrooxidans. The GenBank numbers of the 
sequences used were as follows: Rat P19468, human M90656, S. cerevisiae D90220, A. 
thaliana Z29490 and E. coli X03954. 
The Table in Appendix C shows the codon usage pattern of the gshA gene, the gltA gene and 
that of Tfchrom.cod, a codon usage file composed from 14 previously sequenced T. 
jerrooxidans genes. The codon usage of the gshA and gltA genes are similar to that of the other 
T.ferrooxidans genes and show a bias towards aGora C in the "wobble" position. 
The UWGCG program CORRESPOND is designed to identify similar patterns of codon usage 
by comparing codon frequency tables. The frequency which is compared is calculated by 
dividing the number of incidents of the codon in question by the total number of codons 
specifying the amino acid or terminator in each table. The lower the statistic (D), the more 
similar the patterns of codon usage. 
Table 3.3. Comparison of the codon usage of the T. jerrooxidans gshA gene with that of T . . 
ferrooxidans and E. c~li genes, using the UWGCG program CORRESPONDa. Numbers 













TfgshA, Tfg/tA, Ecol.low and Eco.high refer to the codon frequency tables of T. 
ferrooxidans gshA, T. ferrooxidans g/tA, E. coli weakly expressed and E. coli highly 
expressed genes respectively. Tfchrom.cod is the composite codon usage frequency table 
ofT. jerrooxidans. 
The codon frequencies of the T.ferrooxidans gsM and gltA genes were compared to that of the 
composite codon frequency table forT. jerrooxidans (Tfchrom.cod) and to the codon frequency 
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tables for the highly expressed (UWGCG data file "eco.high") and weakly expressed (UWGCG 
data file "eco.low") E. coli genes. The codon usage of the T. ferrooxidans gshA gene was most 
similar to the T. ferrooxidans composite codon usage file (Tfchrom.cod) as would be expected 
(Table 3.3). The codon usage of the gltA gene, however, was most similar to that of the weakly 
expressed E. coli genes. 
Analysis of portions of single-stranded ·sequence derived from subclones upstream of the C/ai-
BamHl fragment (see Fig. 3.1) using the NCB! BLAST application revealed homology to a 
number of pyruvate dehydrogenase complexes. 
3.4.4.1. Analysis of partial, single-stranded sequence obtained upstream of the gltA gene. 
Portions of sequence obtained upstream of the C/ai (2.4) site (Fig. 3.1) were compared directly 
to the amino acid sequences of the pyruvate dehydrogenase complex genes of B. subtilis and E. 
coli. Pyruvate dehydrogenase complexes consist of three components: the pyruvate 
decarboxylase component (E1), the dihydrolipoyl transacetlyase component (E2) and the 
dihyrolipoamide dehydrogenase component (E3). The E2 component forms the structural core 
of the complex, to which the peripheral subunits E1 and E3 bind (Oliver & Reed, 1982). 
Pyruvate dehydrogenases from Gram-negative bacteria have a core of 24 E2 subunits arranged 
with octahedral symmetry, whereas those from Gram-positive bacteria and eukaryotes have a 
larger E2 core of 60 subunits arranged with icosahedral symmetrY (1\{attevi et a/., 1992). The 
E1 component can be one of two forms. In the octahedral complex (Gram-negative bacteria), 
El exists as a homodimer, a.:z, with a subunit molecular weight of approximately 100 kDa, 
whereas in the icosahedral complex it is found as a heterotetramer, a2fl2> with subunit 
molecular weights of approximately 41 and 36 kDa respectively. Partial T.ferrooxidans amino 
acid sequence obtained upstream of the Clai (2.4) site (Fig. 3.1) was compared to that of 
pyruvate dehydrogenase complexes from a Gram-positive bacterium, B. subtilis (Fig. 3.11) and 
a Gram-negative bacterium, E. coli (Fig. 3.12). Interestingly, preliminary sequence of the T. 
ferrooxidans El component showed homology to the heterotetramer El component found in 
Gram-positive bacteria (Fig. 3.lla) and eukaryotes and no homology to the El component of E. 
coli (Fig. 3.12a). The E2 component is well conserved amongst all pyruvate dehydrogenase 
complexes, and the E2 component of T.ferrooxidans shows homology to both that of B. subtilus 
(Fig. 3.llb) and of E. coli (Fig. 3.12b). The E3 component is also homologous to both B. 














. Fig. 3.lla(i) Amino acid sequence of the pyruvate decarboxylase gene (pdhA), Ela subunit, of the 













Fig. 3.11a(ii) Amino acid sequence of the pyruvate decarboxylase gene (pdh.B), Elj3 subunit, of 















Tf SSMP MPITITADHRVVNGAEAALFLNDLKQA 
Bs LNDPQLILMEA 
Tf IEKPENWLGSG 
Fig. 3.1lb Amino acid sequence of the dihydrolipoyl transacetylase gene (pdhC), subunit E2, of 
the B. subtilis pyruvate dehydrogenase complex. 
Bs MVVGDFPIETDTLVIGAGPGGYVAAIRAAQLGQKVTVVEKATLGGVCLNVGCIPSKALINAG 















Fig. 3.11c Amino acid sequence of the dihydrolipoamide dehydrogenase gene (pdhD), subunit E3, 

















Fig. 3.12a Amino acid sequence of the pyruvate decarboxylase gene (aceE), El subunit, of the E. 





















Tf SSMP MPITITADHRVVNGAEAALFNDLKQAI 
Ec .. LSDIRRLVM 
Tf EHPENWLGS 
Fig. 3.12b Amino acid sequence of the dihydrolipoyl transacetylase gene(aceF), subunit E2, of the 
E. coli pyruvate dehydrogenase complex 
Ec MMSTEIKTQVVVLGAGPAGYSAAFRCADLGLETVIVERYNTLGGVCLNVGCIPSKALLHVA 















Fig. 3.12c Amino acid sequence of the-lipoamide dehydrogenase gene (lpd), subunit E3, of the E. 
coli pyruvate dehydrogenase complex. 
104 
3.4.5. In vitro synthesis of gltA, gshA and possible pyruvate dehydrogenase genes. 
To establish the correlation between a predicted ORF, derived from sequence analysis, and the · 
polypeptide produced, protein products from various subclones of cosmid 5.1 were examined 
using an E. coli-derived in vitro transcription-translation system (Fig. 3.13). A protein of 
approximately 49 kDa, corresponding to the OshA protein, was produced from cosmid 5.1 and 
plasmids pTIIIOD and pTIII07 (Fig. 3.13 lanes 1, 5 and 7) and a protein of approximately 43 
kDa, corresponding to the GltA protein, was produced from cosmid 5.1 and plasmids pTIIIOD 
and pTIII028 (Fig. 3.13 lanes 1, 5 and 6). 





-43- - -----30- - ... --- ... -
14-
-
Fig. 3.13 SDS-PAGE analysis of proteins expressed from cosmid 5.1, plasmid pTIII081, pTHI051, pTHI0191, pTIIIOD, pTIU028, pTIII07 and pBluescriptSK (lanes 1 to 8 respectively) using an£. coli-derived in vitro transcription/translation system. 
Proteins of approximately 110 kDa, 80 kDa, 49 kDa, 43 kDa. 36 kDa, 34 kDa, 25 kDa, 22 kDa, 
19 kDa and about 6 proteins smaller than 14 kDa were produced by cosmid 5.1 (Fig. 3.13 lane 
1) and by the various plasmid subclones analysed, but not by cosmid vector pHC79 
(unpublished results). There is insufficient data to clearly identify the location of the genes 
encoding all these proteins. Howev~r. it is possible to identify the approximate location of some 
of the genes. The 110 kDa and 80 kDa proteins were produced by cosmid 5.1 and plasmid 
pTHI081, but not by plasmids pTHI051, pTIII0191, pTIIIOD, pTHI028, pTHI07, 
pBluescriptSK or pTIII061 (unpublished results). These results indicate that the starts of the 
genes encoding the 110 kDa and 80 kDa proteins probably lie between the Apal (6.7) and the 
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the Hind.III (4.9) sites (Fig. 3.1). The 80 kDa protein could be a degradation product of the 110 
kDa protein. A protein of approximat~ly 36 kDa was produced by cosmid 5.1 and plasmids 
pTHI081 and pTHI0191 only. The gene encoding this protein must, therefore, lie between the 
Sacii (9.3) and Apai (6.7) sites (Fig. 3.1), as this is the overlapping region of DNA between 
plasmids pTHI081 and pTHI0191. The 34 kDa protein was only produced by cosmid 5.1, 
plasmids pTHI081, pTHI051 and pTHI0191, thus the gene encoding this protein must lie 
between the Sad (7.6) and Apai (6.7) sites. Plasmid pTI-11051 also produced a protein of about 
69 kDa which may be a truncated form of either the 110 kDa or 80 kDa proteins or is encoded 
by a gene lying between the Sad (7.6) and Sad (4.2) sites (Fig. 3.13 lane 3). The 30 kDa 
protein produced by cosmid 5.1 and all the plasmids corresponds to the ~-lactamase protein. It 
is not possible to clearly identify the positions of the genes encoding the proteins smaller than 
30 kDa. Some of the proteins produced may be artefacts of the in vitro transcription/translation 
system. 
3.4.6. Complementation of the gshA phenotype. 
E. coli strain BH5262 is unable to grow on minimal medium lacking glutathione, whereas 
GshA + or TrxA + colonies can (Lim et a/., 1986). Plasm ids pTHIOD and pTHI07 
complemented the E. coli gsh.A trxA double mutant. In comparison plasmids pTHI01 and 
pTHI015 weakly complemented E. coli BH5262, whilst plasmids pTHI05, pTHI09, pH29 and 
the vectors pHC79 and pBluescriptSK were unable to complement the mutant. Plasmid 
pTHI01 (not shown in Fig. 3.1) is the same subclone as pTHI07, but the insert lies in the 
opposite orientation with respect to the lac promoter of the vector. This result together with the 
observation that pTHI05, which contains the entire gsh.A gene but lacks the start of the gltA, 
produced a GshA + phenotype is evidence that the gsh.A gene was operating off the lac promoter 
of the vector in the pTHI07 construct. 
3.4.7. Complementation of the gltA phenotype 
Various plasmids containing the T.ferrooxidans citrate synthase gene were tested for the ability 
to complement the gltA_ phenotype of E. coli strain MOB150. E. coli strain MOB150 is unable 
to grow on minimal medium lacking glutamate whereas GltA + colonies can (Wood et a/., 
1987). Plasmid pMW264, which contains the Rickettsia prowazekii citrate synthase gene, was 
used as a positive control. Plasmids pMW264, pTHI06, pTHI028 and pTHI082 were able to 
complement the E. coli gltA mutant, while the vector, pBluescriptSK, did not. Cosmid 5.1 
complemented the E. coli gltA mutant very weakly. As pTHI082 and pTI-11028 lie in opposite 
orientations with respect to the vector lac promoter, the gltA gene of T.ferrooxidans appears to 
be able to operate off its own promoter. Plasmids pMW264, pTHI06, pTHI028 and pTHI082 
were reisolated from E. coli MOB 150, and retransformed into fresh£ . coli MOB 150 competent 
cells, to ensure that the GltA + was not due to a mutation in the host strain. All four plasmids 
were able to complement £ . coli gltA mutant on retransformation, whilst the negative control 
pBluescriptSK was not. 
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3.4.8. Complementation of the pyruvate dehydrogenase complex 
The pyruvate dehydrogenase complex catalyses the following reaction: 
pyruvate + CoA + NAD ~ acetyl-CoA + NADH + C02 
Firstly, pyruvate decarboxylase converts pyruvate to hydroxyethylthiamine pyrophosphate. 
Then the transacetylase shifts the two-carbon fragment from thiamine pyrophosphate to lipoic 
acid and thence to coenzyme A, forming acetyl-coenzyme A. Lastly, the flavoprotein 
dihydrolipoamide dehydrogenase reoxidises the reduced form of lipoic acid. Citrate synthase 
then catalyses the Claisen condensation of oxalacetate and acetyl-CoA to form citrate (Rawn, 
1983). 
E. coli strain JRG1342 is an aceEF-lpd deletion mutant, and therefore lacks the pyruvate 
decarboxylase, dihydrolipoyl transacetylase and dihydrolipoamide dehydrogenase activities. It 
is thus unable to grow on minimal medium lacking acetate (Guest eta/., 1983; Guest & Lewis, 
1985). However, E. coli JRG 1342 transformants containing the pyruvate dehydrogenase 
complex can grow on minimal medium lacking acetate. In E. coli the product of the lpd gene, 
lipoamide dehydrogenase, also functions as the E3 component of the analogous a-ketoglutarate 
dehydrogenase multienzyme complex. This multienzyme complex catalyses the conversion of 
a-ketoglutarate to succinyl-coenzyme A. The Lpd+ phenotype confers succinate-independence 
(but not acetate-independence) on glucose minimal medium as E. coli JRG1342 Lpd+ colonies 
are able to form a functional a-ketoglutarate dehydrogenase multienzyme complex. The 
results of the complementation of the E. coli pdhR -lpd mutant JRG 1342 are shown in Table 3.4. 
Different carbon sources were used in the M9 minimal medium, as indicated. Plasmid pGS87 
contained the cloned E. coli pdhR-lpd region and was used as a positive control. The data in . 
Table 3.4, indicated that cosmid 5.1 and plasmid pTHI081 were able to complement the E. coli 
pdhR-lpd mutant (shown by the ability to utilise glucose as the sole carbon source), whereas 
plasmids pBluescriptSK and pTHI0251 were not. The T. ferrooxidans lpd gene product, 
lipoamide dehydrogenase, also appeared to be functional, as the E. coli pdhR-lpd mutant was 
able to grow in the absence of succinate. This indicated that the cloned T. ferrooxidans 
pyruvate dehydrogenase complex lies between the Sacii and Bg/II sites of cosmid 5.1, and is 
functional in E. coli. The orange pigmented colonies obtained on growing E. coli JRG 1342 
containing pGS87, cosmid 5.1 and pTHI081 on minimal media with succinate as the sole 
carbon source were not contaminants (tested for lysis by T4 phage). When the experiment was 
repeated twice, colonies with the same orange appearance grew on each occasion. 
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Table 3.4. Genetic complementation of E. coli pdhR-lpd mutant, JRG 1342. 
Carbon Source -
Plasmid G+A+S G+A G S+A s 
None ++++ ++++ - +++ -
pSK ++++ ++++ - + -
pGS87 ++++ ++++ ++++ +++ +++"' 
cosmidS.l ++++ ++++ +++ +++ +"' 
pTHIOSl ++++ ++++ +++ + +"' 
pTHI0251 +++ +++ - + -
G+A+S = lOmM glucose, 2mM acetate, 2mM succinate; G+A = lOmM glucose, 2mM 
acetate; G = lOmM glucose; A+S = 4 mM acetate, 50 mM succinate; S = 50 mM 
succinate; ++++ = normal growth; + = very poor growth; - = no growth; + * = growth of 
orange pigmented colonies after 6-7 days; +++ * = growth of orange pigmented colonies 
after 2 -3 days. 
3.4.9. Transcript analysis 
To determine whether the y-glutamylcysteine synthetase gene, the citrate synthase gene and the 
pyruvate dehydrogenase genes were part of an operon or were independently transcribed total 
RNA isolated from E. coli JM109, E. coli JM109(cosrnid 5.1) and T. ferrooxidans cells was 
examined by RNA:DNA hybridisation. The transcripts were probed with probes specific to the 
gshA gene, the gltA and the aceF gene (transacetylase gene of the pyruvate dehydrogenase 
complex). With all three probes a small quantity of transcript of about 9 kbp was obtained for 
RNA from T. ferrooxidans cells (lane 1 Figs 3.14, 3.15 and 3.16). RNA obtained from T. 
ferrooxidans cells probed with the gshA and gltA-specific probes also gave a transcript of about 
2.4 kbp. RNA derived from E. coli JM109(cosrnid 5.1) gave a SIJ1all quantity of transcript of 
about 4 kbp and a strong transcript of about 2.4 kbp for both probes (Fig. 3.14, lanes 2 and 4; 
Fig. 3.15 lanes 2 and 4). RNA derived from E. coli JM109(cosmid 5.1) probed with the aceF-
specific probe gave a transcript of approximately 4.0 kbp (Fig. 3.16 lane 4). Smaller RNA 
transcripts which probably resulted from degradation were detected with all three probes and 
with both sources of RNA. No transcripts were detected from RNA obtained from E. coli 
JM109, the negative control. The major transcript in both T. ferrooxidans and E. coli is about 
2.4 kbp. This transcipt size is sufficient to encompass both the gshA and gltA genes suggesting 
that they may be transcriptionally linked in both E. coli and T. ferrooxidans. The 9 kbp 
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transcript visible in the RNA preparation from T.ferrooxidans (lane 1, Figs 3.14, 3.15 and 3.16) 







1 2 3 4 







1 2 3 4 
Fig. 3.15 Hybridisation of labelled BamHI-Smai fragment of pTI-Il028 to total RNA prepared from: lane 1, T.ferrooxidans; lane 2, E. coli JM109(cosmid 5.1); lane 3, E. coli JM109; lane 4, 
E. coli JM109(cosmid 5.1). 
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Fig. 3.16 Hybridisation of labelled Hindiii-Apai fragment from pTIII052 to total RNA 
prepared from: lane 1, T.ferrooxidans; lane 2, E. coli JM109; lane 3, E. coli JM109; lane 4, E. 
coli JM109(cosmid 5.1). 
3.4.10. Glutathione assay 
GSH was shown to react specifically with o-opthalaldehyde at pH 8.0, yielding a highly 
fluorescent product that could be activated at 350nm with an emission peak at 420nm (Hissin & 
Hilf, 1976). Extracts from E. coli BH5262(p11ll07) were shown to contain GSH 
concentrations comparable to the wild type strain E. coli MC1061 and much higher 
concentrations than E. coli BH5262 (Table 3.5). These results indicate that the cloned T. 
ferrooxidans y-glutamylcysteine synthetase gene was able to complement the E. coli gshA 
mutant to produce glutathione at almost the same level as the E. coli chromosomal gshA gene 
(E. coli MC1061). 
Table 3.5. Cellular glutathione content of E. coli MC1061, E. coli BH5262 and E. coli 
BH5262(pTHI07). The results represent the means of three assays. Standard deviations are 
indicated in brackets. 
Bacterial cell extract 
E. coli MC1061 
E. coli BH5262 
E. coli BH5262(pTIII07) 
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3.4.11. Cloning, expression and purification of the MBP-fusion 
The pilot experiment indicated that the fusion protein (90 kDa) was largely in the cell extract 
(Fig. 3.17, lane 2), however some of the fusion protein was also found in the insoluble matter 
(Fig. 3.17, lane 3). This was probably due to binding of the fusion protein to the membrane 
fraction. As expected the fusion protein was found in the shocked cells (Fig. 3.17, lane 4), but 
not in the osmotic shock fluid (Fig. 3.17, lane 5). This indicates that the protein is not located in 
the periplasm. The partially purified fusion protein (Fig. 3.18, lane 1), and the products after 
cleavage with Factor Xa for 2, 4, 8 and 24 hours (Fig. 3.18, lanes 2, 3, 4 and 5, respectively) 
indicated that the fusion protein was cleaved as the 90 kDa protein band disappears. Protein 
bands corresponding in size to the target (GshA) protein ( 49 kDa) and the maltose-binding 






1 2 3 4 5 
90 kDa 
Fig. 3.17 SDS-PAGE analysis of proteins expressed from E. coli TBI cells containing the 
pMal-fusion protein. Lane 1, molecular weight markers; lane 2, cell free extract; lane 3, 
insoluble cell matter; lane 4, shocked cells and lane 5, osmotic shock fluid. 
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Fig. 3.18 SDS-PAGE analysis of the partially purified fusion protein (lane 1) and the partially 
purified fusion protein after cleavage with Factor X a for 2, 4, 8 and 24 hours (lanes 2, 3, 4 and 5 
respectively). Molecular weight markers (lane 6). 
3.4.12. Assay for y-glutamylcysteine synthetase activity. 
y-Glutamylcysteine synthetase catalyses the ATP-dependent formation of the dipeptide y-
glutamylcysteine from L-glutamate and L-cysteine, as indicated by the reaction below; 
L-Glu + L-Cys + A TP --? L-y-Glu-L-Cys + ADP +Pi 
y-Glutamylcysteine synthetase activity was determined by measuring the release of Pi from ATP 
in the presence of the substrates L-glutamate and L-a-aminobutyrate. While L-cysteine is the 
natural substrate for y-glutamylcysteine synthetase, it is convenient to replace it with L-a-
aminobutyrate, since the latter amino acid does not undergo spontaneous oxidation and is an 
effective substrate for the enzyme (Hell & Bergmann, 1990). Pi release was found to be 
approximately the same whether the substrates, glutamate or a-aminobutyrate, were omitted or 
added to the assay, indicating that the ligation of L-glutamate and L-a-aminobutyrate by the 
enzyme to form y-glutamylaminobutYI:ate, was not necessary for ATP degradation to occur. 
Fresh enzyme extracts were prepared to confrrm these results and the same results were 
obtained. Pi release was not detectable in assays in which enzyme extract or A TP were 
omitted. To try and obtain activity above the spurious background Pi release, the assays were 
also carried out at a range of pHs between 7.0 and 9.0. However, no increased level of Pi 
release was obtained. In addition L-cysteine was used in the reaction instead of L-a-
aminobutyrate to ensure that L-a-aminobutyrate was an effective substrate for the enzyme. The 
cleavage factor Xa was substituted for the enzyme extract in the standard assay to confrrm it 
had no ATPase activity. HPLC was used to analyse the reaction products, as measuring the 
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release of Pi in the assay above did not indicate whether small amounts of y-
glutamylcysteine/g-glutamylaminobutyrate were being formed. 
3.4.13. HPLC Analysis of Dabsylated products 
The samples and standards were dabsylated, as the undabsylated samples all had very low 
retention times on the reverse phase column and were thus difficult to separate. Dabsyl chloride 
is a large, hydrophobic group whic~ reacts with the amino group of amino acids making them 
more hydrophobic. More hydrophobic amino acids are eluted less rapidly on a reverse phase 
column and are thus easier to separate. Dabsylated standards of L-glutamate, L-a.-
aminobutyrate and glutathione were run to determine retention times on the reverse phase 
column, and to estimate the retention time of y-glutamylcysteine. A dabyslated standard of y-
glutamylcysteine was not run as it was not commercially available. No new peak at the 
predicted retention time for y-glutamylcysteine was observed, and there was no detectable 
decrease in the concentration of either the L-glutamate or the L-a.-aminobutyrate in the 
complete reaction mix analysed. These results indicate that no L-glutamate or L-a.-
aminobutyrate was being converted to y-glutamylcysteine by the enzyme in this reaction, and 





The organisation of the T. jerrooxidans pyruvate dehydrogenase, citrate synthase and r-
glutamylcysteine synthetase genes as a single transcript on a contiguous piece of chromosomal 
DNA has not been found before. The pyruvate dehydrogenase genes and citrate synthase genes 
of both E. coli and B. subtilis are widely separated on the chromosome (Fig 3.19). The E. coli 
y-glutamylcysteine synthetase gene is also located on a different portion of the E. coli 
chromosome. However, as discussed in section 3.4.8., pyruvate dehydrogenase provides the 
link between glycolysis and the Kreb's cycle, as it catalyses the oxidative decarboxylation of 
pyruvate to acetyl-SCoA. Citrate synthase catalyses the condensation of acetyl-SCoA with 
oxaloacetate to form citrate. Experiments have shown that citrate synthase binds to the 
dihydrolipoyl transacetylase core of the pyruvate dehydrogenase complex and to other 
components of the pyruvate dehydrogenase complex ( Siimegi & Alkonyi, 1983). As 
physiologically the two enzymes are linked it is likely that the genes would be contiguous. 
3 16 58 
E. coli 
aceE aceF lpd .gltA gshA 
91 129B 256 
B. subtilis 
citA pdhA pdhB pdhC pdhD citZ. 
T. ferrooxidans --.. ~-----.~ --... ~ _ _,.~---.~ 
aceF lpd gltA gshA 
Fig. 3.19 The location of the y-glutamylcysteine synthetase, citrate synthase and pyruvate 
dehydrogenase genes on the E. coli, B. subtilis and T. ferrooxidans chromosomes. The genes 
have the following nomenclature: pyruvate carboxylase, aceE in E. coli and T. ferrooxidans and 
pdhA (a. subunit) and pdhB (~ subunit) in B. subtilis; dihydrolipoyl transacetylase, aceF in E. 
coli and T. ferrooxidans and pdhC in B. subtilis; lipoamide dehydrogenase, lpd in E. coli and T. 
ferrooxidans and pdhD in B. subtilis; citrate synthase, gltA in E. coli and T. ferrooxidans and 
citA and citZ in B. subtilis; y-glutamylcysteine synthetase, gshA in E. coli and T. ferrooxidans. 
The arrows indicate the direction of transcription of the genes (where it is known) and the 
numbers indicate the location of ~he genes on the chromosome. 
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The Kreb's cycle has a two-fold metabolic function: (i) to oxidise metabolites and generate 
NADH, which on conversion to NAD+ may be coupled to ATP formation (ii) to generate 
metabolites required for biosynthesis, such as the amino acids glutamine, proline and arginine. 
T. ferrooxidans is a chemolithoautotroph, and therefore, would not require the Kreb's cycle for 
energy generation, but it would require portions of the cycle to generate certain metabolites 
required for biosynthesis. This would explain the presence of the pyruvate dehydrogenase and 
citrate synthase genes in T. ferrooxidans. 
There are three pieces of evidence indicating that the T. ferrooxidans gltA and gshA genes are 
transcriptionally linked, and that the cloned gltA and gshA genes are linked in E. coli. Firstly, 
the DNA:RNA hybridisation experiments (section 3.4.9) gave similar transcript signals when a 
probe from each of the genes was used. A similar result was achieved with an aceF probe, 
suggesting that the aceF, gltA and gshA are all linked in T. ferrooxidans. Secondly, the gshA 
gene does not appear to function off its own promoter in E. coli, as subclones in which the gshA 
gene is transcribed in the opposite orientation to the lac promoter were unable to complement 
the gshA mutation of E. coli BH5262. The citrate synthase gene, however, was able to 
complement gltA mutant E. coli MOB 150 irrespective of its orientation to the lac promoter. 
These results suggest that the gshA gene is transcribed from a promoter upstream of the citrate 
synthase gene. Thirdly, the two genes are separated by only 9 bp, the close proximity of genes 
is frequently a feature of genes that are transcriptionally coupled. Transcriptional linkage of the 
aceE, aceF, lpd and gltA genes is logical since, as discussed above, the enzymes they encode are 
all involved in the transfer of an acetate group to oxaloacetate during the synthesis of citrate. 
However, the reason for the linkage between the gltA and gshA genes is unclear. 
It is possible that glutathione may be utilised in the pyruvate dehydroge~ase complex of T. 
ferrooxidans instead of lipoic acid, which would explan the transcriptional linkage of the whole 
aceEF-lpd-gltA-gshA cluster. In E. coli lipoic· acid is found in two multienzyme complexes 
(pyruvate dehydrogenase and a.-ketoglutarate dehydrogenase) where it serves as an acyl carrier 
and as a two electron carrier. It is covalently bound to a lysyl residue of dihydrolipoyl 
transcacety lase. The disulfide bridge of lipoic acid is 1.5 nm from the peptide backbone, and 
this miniature "arm" serves to swing an acyl group from one part of the enzyme complex to 
another (Rawn, 1983). This function is based on the presence of two sulfur atoms that exist as 
either two sulfhydryl groups (-SH) or as a single disulfide linkage (-S-S-). The tripeptide 
glutathione can exist as a dimer (G-S-S-G) or as two monomers (GSH) and thus may be able to 
substitute for lipoic acid in the pyruvate dehydrogenase complex. 
The y-glutamylcysteine synthetases studied to date differ widely in amino acid sequence and 
structure. The mammalian p,roteins are composed of two subunits whereas the bacterial proteins 
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(E. coli and P. mirabilis) are composed of a single subunit. The T. ferrooxidans protein also 
consists of a single 47 kDa subunit which is considerably smaller than the 60 kDa and 64 kDa 
proteins of E. coli and P. mirabilis respectively. As can be seen from the phylogram (Fig. 3.20) 
the two mammalian proteins are closely related (89% identity), and that of S. cerevisiae lies 
within the same cluster. However, the y-glutamylcysteine synthetases of A. thaliana, and the 
two bacterial proteins form deeply branched separate clusters, indicating that these proteins are 
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Fig. 3.20 A phylogram based on y-glutamylcysteine synthetase amino acid sequences. The 
software packages Clustal W and Tree View were used to calculate and draw the phylogram. 
Bootstrapping values were all 100% and the scale of 0.1 indicates 10% amino acid divergence. 
The GenBank accession numbers of the sequences used were as follows: E. coli X03954; A. 
thaliana Z29490; S. cerevisiae D90220; Rat P19468 and Human M90656. 
In spite of the low sequence homology to other gshA genes, there is evidence to indicate that the 
gshA gene ofT. ferrooxidans has been isolated. Firstly, the cloned gene from T. ferrooxidans 
was able to complement the E. coli gshA mutant for growth on minimal medium. Secondly, 
concentrations of glutathione produced by the cloned gene in the E. coli gshA mutant were , 
comparable to those of the wild type E. coli strain, indicating the presence of a functional y-
glutamylcysteine synthetase enzyme. Furthermore, lack of homology between y-
glutamylcysteine synthetases is common as, with the exception of human and rat, y-
glutamylcysteine synthetase genes are generally poorly conserved. 
The reason for the lack of enzyme activity obtained from the partially purified "!: ... 
glutamylcysteine synthetase enzyme remains to be addressed. There are numerous possible 
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explanantions for the production of an inactive enzyme using the maltose binding protein 
expression system. The problem might be that although the enzyme appears to function in vivo, 
once linked to the maltose binding protein, or purified, in vitro activity is lost. The enzyme may 
have been unable to bind the substrates due to incorrect folding of the active site of the enzyme 
when it is translated as a fusion protein. 
It was not possible to assay crude extracts of the cloned gene in E. coli BH5262 using the assay 
described in section 3.4.11, as the breakdown of ATP to ADP and Pi, by components of the 
crude extracts (other than the y-glutamylcysteine synthetase enzyme) was too high. It was also 
not possible to assay for y-glutamylcysteine production in crude extracts using HPLC due to the 
impurity of the samples which would have made peak interpretation too difficult. 
The inactivity of the y-glutamylcysteine synthetase enzyme in vitro could be due to a variety of 
factors. However, there is good evidence that the T. ferrooxidans y-glutamylcysteine 




During the biooxidation of a mineral such as arsenopyrite, large quantities of air are pumped 
into a reactor vessel and the redox po~ential of the solution may rise from less than +300mV 
before oxidation to greater than +700mV when oxidation is complete (Lindstrom et al., 1992). 
The redox potential in the environment of an iron-oxidising bacterium such as T. jerrooxidans is 
a function of the Fe3+JFe2+ ratio. When ferrous iron is oxidised to ferric iron, the redox 
potential of the surrounding medium increases correspondingly, and bacteria which grow in 
such an environment require the ability to maintain their cytoplasmic redox potential within 
certain limits. This implies that an organism such as T. ferrooxidans must have considerable 
redox-controlling capacity and the ability to withstand the toxic affects of oxygen. As discussed 
in Chapter 1, glutathione and thioredoxin are two molecules that play a role in the control of 
redox potential within a cell and in the removal of free radicals generated by oxygen. 
In this study the thioredoxin and y-glutamylcysteine synthetase genes were cloned and 
characterised as part of an investigation of intracellular systems that are likely to play a role in 
the ability of T. jerrooxidans to cope with large changes in its external redox potential. 
It is interesting to note that transposon Tn5467, which is located on T. ferrooxidans plasmid 
pTF-FC2, has recently been shown to encode a protein with highest amino acid sequence 
homology to a glutaredoxin isolated from Methanobacterium thermoautotrophicum (Fig. 4.1; 
Clennel et al., 1995). This glutaredoxin-like protein might be expected to participate in internal 
redox control. The gene for the glutaredoxin-like protein was expressed in E. coli and enabled 
growth of the E. coli trxA gshA double mutant strain BH5262 on minimal medium lacking 
glutathione. In addition, the glutaredoxin-like gene was able to complement the E. coli trxA met 
mutant for growth on minimal medium plus methionine sulfoxide. Methionine sulfoxide 
reductase usually specifically requires thioredoxin as a hydrogen donor for the conversion of 
methionine sulfoxide to methionine (Gonzalez Porque, 1970), however, in this case the 
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Fig. 4.1 A comparison of the amino acid sequences of the M. thermoautotrophicum 
glutaredoxin gene (Grx) and of the glutaredoxin-like protein from Tn 5467. The active sites are 
indicated in bold. 
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Glutaredoxins, like thioredoxins, are ubiquitous, heat-stable proteins which catalyse 
thioVdisulfide exchange reactions (both proteins can act as H-donors for ribonucleotide 
reductase) but glutaredoxins receive their reducing equivalents from glutathione not thioredoxin · 
reductase (Holmgren, 1979). The active site of the glutaredoxin contains two redox-active 
cysteine residues Cys-Pro-Tyr(Phe)-Cys and is well-conserved from E. coli to mammals. The 
glutaredoxin-like protein isolated from the T. ferrooxidans transposon contains this highly 
conserved active site (Fig. 4.1). · There is little similarity in primary structure between 
glutaredoxins and thioredoxins apart from the 14-membered disulfide ring, but they are thought 
to have a similar tertiary structure (Eklund et al., 1984). 
The discovery of a glutaredoxin-like gene encoding a redox-active protein of this type on a 
transposon is unusual (Fig. 4.2, ORF8). Proteins of this type have important biosynthetic 
functions, and the genes encoding these proteins are not normally found on plasmids. Plasmid 
pTF-FC2 is a broad-host-range, mobilizable plasmid that has a copy number of 12 in E. coli. T. 
ferrooxidans could, therefore, have 12 copies of the glutaredoxin gene, depending on the copy 
number of plasmid pTF-FC2 in T.ferrooxidans. It may be advantageous for T.ferrooxidans to 
have the glutaredoxin gene on a multicopy plasmid to generate large quantities of glutaredoxin 
for the maintenance of redox potential within the cell. T. ferrooxidans also may have more than · 
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Fig. 4.2 A map of transposon Tn5467. IR, 38 bp inverted repeats (proximal and distal) with 37 
out of 38 and 38 out of 38 matches to the IR sequences of Tn2J. ORF8 encodes the 
glutaredoxin-like gene. MerR, ORF with similarity to regulators of the mercury reductase 
operons. Res, region with similarity to resolution sites of Tn2 I. TnpR and TnpA show 
homology to the resolvase and transposase proteins, respectively, of Tn2J. 
An additional function of thioredoxin may be to act as a cofactor in the arsenic resistance _ 
mechanism of T. ferrooxidans. As discussed in Chapter 1 and 2, T. ferrooxidans is able to 
tolerate high concentrations of arsenic, when growing on arsenopyrite ores, and thus must have 
some form of resistance to arsenic. Arsenic resistance in S. aureus (Novick & Roth, 1968), E. 
coli (Hedges & Baumberg, 1973) and P. aeruginosa (Cervantes & Chavez, 1992) is due to 
genes located on plasmids of these bacteria. Arsenic resistance genes have also been located on 
the chromosome of E. coli (Diorio et al., 1995). DNA:DNA hybridisation experiments using 
the arsBC genes of E. coli plasmid R773 as a probe have indicated that both Thiobacillus caldus 
(Hallberg, 1995) and T. ferrooxidans (Hallberg personal communication) contain chromosomal 
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DNA that is homologous to the arsBC genes of E. coli. The plasmid-detennined bacterial 
resistance system for arsenic and antimony consists of five genes in E. coli (Chen eta/., 1986; 
San Francisco eta/., 1990; Wu & Rosen, 1993) (arsR, arsD, arsA, arsB and arsC) but only 
three genes (arsR, arsB and arsC) inS. aureus (Ji & Silver, 1992) (Fig. 4.3). 
Staphylococcus aureus 
arsR arsB arsC 
: arsR : arsD arsA 
. 
arsB · · .arsC 
Regulation ATPase subunit Membrane Arsenate 
subunit Reductase 
Escherichia coli 
Fig. 4.3 Structure of the arsenic/antimony resistance detenninants of S. aureus plasmid pi258 
and E. coli plasmid R773 (updated from Silver et al., 1993). 
In both bacteria, the overall process is very similar. The systems are regulated by the repressor 
protein ArsR. A membrane complex consisting of ArsB and ArsA in E. coli (but only ArsB in 
S. aureus) carries out the energy-dependent efflux of arsenite. The ArsC protein reduces 
arsenate to arsenite, which is then exported from the cell by the ArsB membrane protein (Fig. 
4.4). In both S. aureus and E. coli thioredoxin is specifically required as a cofactor by arsenate 
reductase (ArsC) for the maintenance of the cysteine residues of ArsC in the reduced state (Ji & 
Silver, 1992; Silver et al., 1993). A similar mechanism of arsenic resistance that requires 
thioredoxin to reduce ArsC may operate in T.ferrooxidans but this has not been elucidated yet. 
In addition reduced thioredoxin may react directly and irreversibly with arsonous acid to fonn 








Fig. 4.4 Diagram indicating the Ars efflux system of E. coli (updated from Silver et al., 1993). 
A= ArsA protein, B = ArsB protein, C = ArsC protein, Trx-(SHh =reduced thioredoxin, Trx-
S2 = oxidised thioredoxin. 
In order to determine the functions of thioredoxin and glutathione in T. ferrooxidans, such as 
maintenance of intracellular redox potentials or the inactivation of toxic compounds that result 
from high concentrations of oxygen, the genes encoding these molecules would have to be 
inactivated in T. ferrooxidans. The affect of the loss of thioredoxin or glutathione on T. 
ferrooxidans would then have to be assessed. This could be done by insertional inactivation of 
these genes. A procedure for introducing DNA into T.ferrooxidans by direct conjugation with 
E. coli has recently been reported, as discussed in the Introduction (Peng et al., 1994). 
Unfortunately at present attempts to introduce DNA into T. ferrooxidans ATCC 33020 have 
been unsuccessful. 
A comparison ofT. ferrooxidans with well-studied heterotrophic bacteria at the genetic level is 
interesting from an evolutionary point of view. The ecological niche inhabited by the 
chemolithoautotrophic T.ferrooxidans is populated by relatively few other bacterial species and 
there would seem to be limited opportunity for genetic exchange with other organisms. Thus it 
is of interest to determine to what extent operon structures differ from more extensively studied 
bacteria such as E. coli. The trxA gene ofT. ferrooxidans is located upstream of the rho gene, 
as in E. coli. However, the position of the y-glutamylcysteine synthetase gene in T. 
ferrooxidans differs from that of E. coli and all other bacteria studied to date. In E. coli, the y-
glutamylcysteine synthetase gene, the citrate synthase gene and the pyruvate dehydrogenase 
genes are all located at different positions on the chromosome. In T. jerrooxidans these genes 
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are located on a contiguous piece of DNA and their transcripts appear to be linked in a 
physiologically logical manner. 
It is surprising that no other redox-active genes able to complement the trxA or gshA mutations 
of the E. coli strains used in this study were isolated. However, 100 cosmids that were able to 
complement the E. coli trxA gshA double mutant were initially isolated in this study, of which 
only 16 were chosen for further study. Further characterisation of the remaining 84 cosmids 
may reveal additional redox-active proteins, such as other glutaredoxins and thioredoxins. 
122 
.. 
APPENDIX A continued 
Plasmid Description Reference/origin 
pG587 derivative of pBR322 containing John Guest, Universtiy of 
aceEF-lpd region of E. coli Sheffield, England 
pMW264 derivative of pBR322 containing 
g/tA of R. prowazekii 
Wood eta/. (1987) 
pBluescriptSK ApR, cloning vector Stratagene, California 
pB luescriptKS ApR, cloning vector Stratagene, California . 
pUCBM21 ApR, cloinh;tg vector Boehringer Mannheim 
pUCBM20 ApR, cloning vector Boehringer Mannheim 


















Wild type Rockville,1 Md. 
recA1 supE44 endA hsdR17 gyrA96 Promega Corp. USA 
relA1 thi L1(lac-proAB)[F' trad36 
proAB lacNZ8M15] 
K-12 araD139? galU galK hsdR Lim et al. ( 1985) 
rpsL argHl trxA7004 ilvC::TnlO gshA 
K-12 araD139? galU galK hsdR Lim et al. ( 1985) 
rpsL metA46 argH1 trxA 7004 ilvC: :Tn5 
L1(lac-proAB) thi supE Heidecker et al. ( 1980) 
[F'proAB lacN lacZ8M15] 
L1(lac-proAB) thi supE trxA7004 Lim et al. (1986) 
ilvC::Tn5 [F'proAB lacJqzacZ8M15] 
K-12 p- araD139? galU galK hsdR rpsL Britt Persson, University 
L1(araABC-leu)7679 DlacX74 of Umea, Sweden 
p- gltA5lct thi lacY galK hsdR Wood et al., (1987) 
xyl mtl tsx tfr rpsL supE 
recA rpsL [L118(aroP-lpd)] metB John Guest, University of 
thyA azi pps ton Sheffield, England 
APPENDIXB 
Graph indicating the change in fluorescence with changes in glutathione (GSH) concentration. 
Glutathione is complexed with the flourescent compound o-opthalaldehyde. The data represents 


















Standard Curve for GSH 




CODON USAGE OF T. FERROOXIDANS GENES. 
Codon Tfchrom gshA gltA trxA 
Gly GGG 0.99 0.69 1.55 0.98 
GGA 0.56 0.92 1.29 0.98 
GGT 2.13 3.66 2.84 1.30 
GGC 4.85 2.29 2.33 0.98 
Glu GAG 3.12 5.26 2.84 2.29 
GAA 3.84 2.52 3.10 4.58 
Asp GAT 2.54 2.52 3.62 2.61 
GAC 3.45 2.52 1.29 3.27 
Val GTG 3.73 3.89 3.89 1.63 
GTA 0.56 0.69 0.26 1.96 
GIT 0.60 0.69 0.00 0.98 
GTC 2.41 1.83 1.55 0.65 
Ala GCG 3.36 3.66 3~89. 2.61 
GCA 1.08 1.83 0.78 0.65 
GCT 0.80 0.69 1.55 1.63 
GCC 5.02 2.52 5.17 3.92 
Arg AGG 0.17 0.23 0.26 0.65 
AGA 0.09 0.00 0.00 0.65 
Ser AGT 0.65 0.46 1.29 0.65 
AGC 1.31 0.23 1.55 0.65 
Lys AAG 3.69 1.14 1.55 2.61 
AAA 1.31 0.46 1.03 3.27 
Asn AAT 1.12 1.60 2.07 1.31 
AAC 1.75 2.06 1.29 1.63 
Met ATG 3.28 1.83 4.91 1.63 
lie ATA 0.22 0.46 0.00 0.33 
AIT 1.42 2.75 2.58 2.61 
ATC 4.40 1.83 3.36 3.60 
Thr ACG 1.29 1.83 1.03 0.98 
ACA 0.19 0.46 0.26 0.65 
ACT 0.41 0.46 0.26 0.98 
ACC 2.69 1.83 2.84 2.29 
Trp TGG 0.78 1.14 1.03 1.96 
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continued .. 
Codon Tfchrom gltA gshA trxA 
End TGA 0.15 0.23 0.00 0.65 
Cys TGT 0.22 0.46 0.26 0.65 
TGC 0.69 0.69 0.26 1.96 
End TAG 0.04 0.00 0.26 0.00 
TAA 0.11 0.00 0.00 0.65 
Tyr TAT 1.36 2.75 1.81 1.63 
TAC 1.55 1.14 1.03 0.98 
Leu TIG 1.47 2.16 0.78 0.98 
TIA 0.15 0.46 0.00 0.65 
Phe TTI 1.12 2.75 1.55 0.65 
TIC 2.35 1.60 2.33 1.96 
Ser TCG 1.06 1.37 0.78 0.33 
TCA 0.15 0.23 0.26 0.65 
TCT 0.45 0.46 0.26 2.29 
TCC 1.66 0.91 1.55 1.96 
Arg CGG 1.25 3.43 2.07 0.98 
CGA 0.21 0.46 0.26 0.65 
CGT 1.51 2.75 1.55 0.65 
CGC 2.91 2.06 2.33 2.94 
Gln CAG 3.49 2.75 2.58 2.29 
CAA 0.60 1.83 1.03 0.98 
His CAT 1.06 1.37 2.33 0.98 
CAC 1.29 0.92 2.33 0.65 
Leu CTG 4.63 6.41 5.43 4.58 
CTA 0.09 0.00 0.00 0.00 
crr 0.69 0.46 0.78 1.96 
CTC 1.70 1.83 2.33 2.61 
Pro CCG 1.44 1.83 1.55 0.98 
CCA 0.30 1.14 0.26 0.98 
CCT 0.50 1.60 1.81 2.29 
CCC 2.00 1.14 1.03 2.94 
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